Analysing the role of the anterior visceral endoderm in anterior-posterior axis establishment in the mouse embryo by Stuckey, Daniel William & Stuckey, Daniel William
  
 
Analysing the role of the anterior 
visceral endoderm in anterior-posterior 
axis establishment in the mouse 
embryo 
 
 
Daniel William Stuckey 
A thesis submitted for the degree of Doctor of Philosophy 
2008 
Imperial College 
 
 
 
 
 
 
 2
 
 
 
 
 
 
 
 
Dedicated to my family who have offered me endless love and 
support. 
Thank you so much 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3
Abstract 
 
Anterior-posterior (A-P) axis specification requires signalling from a specialised extra-
embryonic tissue called the anterior visceral endoderm (AVE). AVE precursors are 
induced at the distal tip of the pre-gastrulating mammalian embryo and move to the 
prospective anterior. This movement is essential in correctly positioning the A-P axis.  
 
Firstly, the contribution of proliferation to AVE movements has been tested. Previous 
studies have suggested that differential proliferation within the visceral endoderm (VE) is 
required to determine its direction by passive displacement. High-resolution imaging and 
embryo culture experiments have been used to assess the distribution and requirements of 
proliferation during AVE movements. Differential proliferation was not observed along 
the A-P axis of the VE. However, proliferation within the epiblast was found to be 
required for correct AVE movements in a Nodal-dependant manner.  
 
Secondly, to address the function of the AVE in vivo, this tissue was genetically ablated. 
Diphtheria toxin A was knocked-in to the Hex locus (an early AVE marker) by 
homologous recombination in embryonic stem cells. Depending on the time of ablation 
the AVE or its precursors could be ablated as demonstrated by AVE marker analysis. 
Ablation of the AVE precursors prior to 5.5 dpc resulted in embryos that displayed 
greatly disturbed patterning and were unable to gastrulate. AVE ablation between 5.5-6.5 
dpc resulted in delayed formation of the primitive streak, epithelial to mesenchymal 
transition defects and a mispatterning of the anterior primitive streak. A decrease in 
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Nodal signalling was found to be a likely cause for the defects observed in these ablated 
embryos, indicating that AVE maintains Nodal signalling levels in the epiblast.  
 
Together these experiments find a role for epiblast proliferation in AVE migration and 
identify a novel role for the AVE in patterning the primitive streak. Therefore this 
investigation provides a critical insight into how the A-P axis is established in mammals.  
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Chapter 1 
1.1. Aim of the study 
 
How the embryo is patterned remains a fascinating biological conundrum. Conversion 
of a single celled egg into a multi-cellular, multilayered foetus relies upon exquisite 
genetic and cellular coordination. Underpinning these events is the acquisition of 
successive asymmetries that culminate in the establishment of three embryonic axes: 
anterior-posterior (A-P), dorso-ventral (D-V) and left-right. These axes are initiated 
from appropriately positioned signalling centres and form the blueprint for the mature 
body plan.  
 
Fertilization of the egg by the sperm marks the first embryonic asymmetry. However, 
whether this event causally relates to later patterning events is controversial. In 
mouse, formation of the A-P axis is the first definitive embryonic axis to be 
associated with a manifest asymmetry. A complex network of signalling molecules 
and cell movements have been identified that are important in establishing the A-P 
axis; eventually defining the head at the anterior side from trunk and associated 
structures at the posterior.  
 
The anterior visceral endoderm (AVE) is a specialised extra-embryonic signalling 
centre that is essential for A-P patterning. The AVE is characterised by the 
expression of a unique set of molecular markers that are restricted to the distal tip of 
the visceral endoderm at 5.5 dpc. By 5.75-6.0 dpc, the AVE has traversed unilaterally 
along the prospective anterior of the epiblast. The endpoint of this movement will 
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define the anterior of the embryo. The posterior of the embryo, opposite the AVE, is 
where the primitive streak (PS) will form.  
Despite the significant role of the AVE in anterior patterning, many questions 
remain unanswered: The mechanisms involved in its movement and appropriate 
positioning is a contentious issue, as is its exact contribution to A-P patterning 
events. This thesis aims to tackle these two fundamental aspects of AVE function.   
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1.2. Embryogenesis in the mouse 
 
1.2.1. Preimplantation development 
Mammalian preimplantation spans the period from fertilisation to implantation and is 
defined by dynamic genetic programming (reviewed in Wang and Dey, 2006). 
Fertilization occurs when the sperm penetrates the oocyte resulting in a 1-cell embryo 
containing haploid maternal and paternal pronuclei. Both pronuclei undergo DNA 
replication before entering into mitosis and forming a 2-cell zygote. At this point, 
90% of the maternal RNA transcripts have been degraded and activation of the 
zygotic genome commences to enable further development (Nothias et al., 1995). The 
zygote undergoes two additional cleavages, and the 8-cell embryos undergo a process 
of compaction to form the morula. This is followed by differentiation of the morula 
into the blastocyst at 3.5 days post coitum (dpc) (Fig. 1A).  
 At this stage the blastocyst is composed of two cell types: the outer epithelial 
trophectoderm (TE) and the inner cell mass (ICM) positioned to one side of the TE. 
The TE in contact with the ICM is the polar TE, whilst the TE surrounding the 
blastocoel is the mural TE (Fig. 1A). The TE will make the first contact with the 
luminal epithelium of the uterus during implantation. In addition, its lineages will 
give rise to extraembryonic tissues such as the placenta. The pluripotent ICM will 
generate all the future cell lineages of the embryo proper.  
 
At 3.5 dpc, the blastocyst has an embryonic-abembryonic (Em-Ab) axis, defined by 
the position of the ICM. However this axis is topological rather than relating to a 
definitive body axis. 
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Figure 1 – Preimplantation development 
A. Diagrammatic representation of events from fertilisation to implantation. At fertilisation 
the sperm penetrates the female oocyte and the two pro-nuclei fuse to form the diploid 
nucleus. Fertilisation results in completion of the second meiotic division, producing the 
second polar body (2PB) (yellow). In the next 3.5 days the conceptus becomes a multilayered 
blastocyst. The outermost layer is the trophectoderm (TE; shown in light blue), which is 
classified into two hemispheres, the mural and polar TE, relating to the position of the inner 
cell mass (ICM; shown in pink). The TE forms extraembryonic tissues such as the 
ectoplacental cone and eventually forms the placenta. The ICM is a mass of pluripotent cells, 
which go on to form every tissue of the animal itself. The asymmetric location of the ICM 
defines the Embryonic-Abembryonic (Em-Ab) axis, which later becomes the post-
implantation proximal-distal (PD) axis.  By 4.0 dpc a subpopulation of cells within the ICM 
move to the inner surface and form the primitive endoderm (PE; shown in green). At 4.5 dpc 
the blastocyst hatches from the protective outer zona pellucida (ZP) and implants into the 
uterine wall. The conceptus is now referred to as the egg cylinder. The ICM has become the 
embryonic ectoderm, which is referred to as the epiblast (also shown in pink).  
B. Genes responsible for lineage segregation. A flow diagram showing the genes responsible 
for converting a totipotent precursor cell into the three lineages of the hatched blastocyst. Note 
the reciprocal inhibitory interactions which stabilize and reinforce lineage commitment.  
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The existence of prepatterning in the embryo before implantation is controversial but 
to date no irrefutable evidence has proven that asymmetries within the zygote are 
related to establishment of the definitive embryonic axes (reviewed in Rossant and 
Tam, 2004).  
 Important molecular pathways that segregate and differentiate the two cell 
types of the blastocyst at this stage have been identified by genetic analysis. ICM 
formation depends on OCT4, which is encoded by Pou5f1 (Nichols et al., 1998). 
Additionally, the ICM comprises a mixture of Gata6 expressing Primitive Endoderm 
(PE) precursors and Nanog expressing epiblast precursors expressed in a mutually 
exclusive manner (reviewed in Rossant, and Tam 2004; Brewer et al., 2002; Chazaud 
et al., 2006a).  Eventually PE cells move to the surface of the ICM to form the distinct 
PE layer, whilst Nanog expressing cells give rise to the epiblast (Chazaud et al., 
2006a). Maintaining pluripotency of the epiblast also requires the TGF?-related 
molecules Nodal and Bone morphogenetic proteins (BMPs), and in their absence the 
epiblast prematurely differentiates into neurectoderm (Camus et al., 2006; Mesnard et 
al., 2006; Di-Gregorio et al., 2007). The TE lineage not only requires an absence of 
OCT4, but the presence of the caudal-type homeodomain protein, CDX2, to repress 
OCT4 and NANOG in the TE (Strumpf et al., 2005). Together this signalling network 
is responsible for forming the mature blastocyst at 4.5 dpc (Fig. 1B). 
 
Implantation into the uterine wall occurs between 4.5 and 5.0 dpc. The blastocyst 
hatches from the surrounding zona pellucida and attaches to the uterine wall.  TE cells 
invade the uterine wall and eventually form the placenta.  It is at this peri-
implantation stage the embryo begins to form the egg cylinder.  The ICM has now 
become the embryonic ectoderm, which is referred to as the epiblast. Polar TE rapidly 
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proliferates in response to FGF-4, and pushes down the epiblast into the blastocoel 
cavity, forming the extraembryonic ectoderm (ExE) and ectoplacental cone (Tanaka 
et al., 1998). Also around the time of implantation the epiblast is transformed into a 
columnar epithelium around a central cavity, the proamniotic cavity (Coucouvanis 
and Martin, 1995). This is achieved via a process of programmed cell death and 
modulation of cell adhesion. (Coucouvanis and Martin, 1995) and (Murray and Edgar, 
2000) demonstrated that the surrounding visceral endoderm (VE) induces cell death in 
the epiblast and cells are rescued from this fate only if they are in contact with the 
extracellular basement membrane, between the VE and epiblast. Surviving cells are 
now polarised as they have an apical and basal surface, defined by their contact with 
the basement membrane. The epiblast goes on to form the germ layers and thus all the 
precursors of the embryo proper. Between 4.5 and 5.0 dpc the primitive endoderm 
differentiates to become the VE and the parietal endoderm. The VE covers the ExE 
and epiblast and will eventually form part of the yolk sac at later stages. The parietal 
endoderm forms the Reichert’s membrane, a protective membrane that envelops the 
entire egg cylinder; this too will later contribute to the yolk sac. 
 
1.2.2. Peri-implantation development  
 
1.2.2.1. How early is the A-P axis established? 
In many organisms polarity is established in the oocyte, or shortly after fertilisation 
by the reorganisation of positional determinants. Therefore perturbation of the early 
conceptus, such as deletion of a blastomere, results in abnormal development. The 
mouse embryo however, is remarkably tolerant to such manipulations (reviewed in 
Beddington and Robertson, 1999 and Rossant and Tam, 2004). For example, the 
 17
removal of a substantial volume from either the animal or vegetal pole of the egg still 
results in viable offspring (Zernicka-Goetz, 1998). This led to the tentative conclusion 
that mouse development was not determinative, but regulative.  
 This assertion continues to be contentious; although the embryo can seemingly 
bypass major disruptions of the egg, this does not mean that positional events in an 
undisturbed embryo are not important. In light of this, the quest for finding 
asymmetries in the embryo and relating them to definitive embryonic axes remains 
voracious.  
 
1.2.2.2. Morphological asymmetries in the peri-implantation embryo 
A correlation between asymmetries in the attached blastocyst relating to embryonic 
axis orientation was first documented by Smith (Smith, 1980, 1985). Serial 
histological sections of embryos between implantation to 9.5 dpc were examined and 
an axis fate map was constructed. Smith proposed that the ICM/PE tilt observed in the 
implanted blastocyst related to the later bending of the ectoplacental cone, and that 
this bend predicted the future A-P axis (Smith, 1985). This hypothesis was tested by 
marking the VE on the tilted side with horseradish peroxidase, and culturing embryos 
until gastrulation (Gardner et al., 1992). Although the ectoplacental cone tilt did 
generally correspond to the A-P axis, labelled cells were equally likely to reside by or 
opposite the primitive streak; suggesting that the orientation but not polarity of the 
embryo was specified at the blastocyst stage.  
 Weber and colleagues proposed that polarity of the mouse embryo was 
anticipated before implantation (Weber et al., 1999). By injecting single ICM cells of 
a 3.5 dpc blastocyst with mRNA encoding a robust marker, it was possible to lineage 
trace descendants. ICM-derived VE cells originating from near the polar body tended 
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to localise distally in the egg cylinder, whilst VE cells derived from ICM cells 
situated away from the polar body tended to colonise more proximal regions (Weber 
et al., 1999). This suggested that the bilateral asymmetry of the blastocyst did indeed 
anticipate the polarity of the later conceptus, with asymmetric VE movements 
forming along the proximal-distal (P-D) axis of the post-implantation egg cylinder. 
Although this finding was the first of its type, it has yet to be independently 
replicated. 
 
The first unequivocal morphological asymmetry relating to definitive axis 
establishment in the embryo is that of the distal visceral endoderm (DVE). At 
approximately 5.5 dpc, a collection of visceral endoderm (VE) cells at the distal tip of 
the egg cylinder differentiate into a morphologically distinct tissue, known as the 
DVE. Cells of the DVE are a columnar epithelium compared to the squamous 
epithelium of the surrounding VE (Rivera-Perez et al., 2003; Srinivas et al., 2004).  
The distal DVE begins to tilt and then move unilaterally to the future anterior of the 
embryo (Srinivas et al., 2004). The direction of this tilt always predicts the 
prospective anterior of the embryo and is regarded as the first symmetry-breaking 
step; responsible for converting the transient P-D axis into the definitive A-P axis.  
 
1.2.2.3. Evidence of molecular asymmetries in the implanting blastocyst 
Numerous molecular asymmetries have been reported before DVE movements, 
although their exact roles in establishing the future A-P axis are largely speculative 
(reviewed in Pfister et al., 2007). What is apparent is the importance of reciprocal 
interactions between extra-embryonic tissues and the epiblast in refining expression 
domains essential for correct patterning.  
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Molecular asymmetries implicated in A-P patterning have been reported in the 
implanting blastocyst (Takaoka et al., 2006; Chazaud and Rossant, 2006b). In the first 
instance, the Nodal antagonist Lefty1 was found to be expressed in primitive 
endoderm cells located towards the top of the tilted ICM (Takaoka et al., 2006). The 
asymmetric localisation of endogenous Lefty1 transcript was corroborated by Lefty1-
LacZ expression. Furthermore, asymmetric expression was shown not to require 
interaction with the uterus and was induced by Nodal signalling (Takaoka et al., 
2006).  
However, the presence of Lefty1 asymmetry and its functional significance in 
polarity formation should be taken with caution. Firstly, other groups were unable to 
detect the asymmetric localisation of endogenous Lefty1 transcript in the implanting 
blastocyst (Chazaud and Rossant, 2006b; Mesnard et al., 2006). Secondly Lefty1 
expression has not been detected between 4.75-5.0 dpc, before being detected again in 
the DVE at 5.5 dpc (Chazaud and Rossant, 2006b; Mesnard et al., 2006). As Lefty1 is 
not continually expressed between implantation to DVE induction, whether its later 
expression corresponds to the same cell lineage as its early expression is unknown. 
Finally no asymmetry in the expression of Nodal or its effectors have been reported in 
the ICM throughout implantation (Takaoka et al., 2006; Mesnard et al., 2006). This 
leaves the mechanism of asymmetric restriction of Lefty1, and indeed its functional 
significance unknown. 
 
Chazaud and Rossant used fluorescent in situ hybridisation analysis to look for 
molecular asymmetries in the implanting blastocyst (Chazaud and Rossant, 2006b). 
The authors reported non-uniform, transient expression of the homeobox genes Pem 
and Hex (haematopoietically expressed homeobox) in the primitive endoderm, with 
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greater expression in cells next to the trophectoderm (Chazaud and Rossant, 2006b). 
Additionally, in about 15% of the 4.5 dpc blastocysts analysed, ?-catenin nuclear 
localisation was detected in a single trophectoderm cell situated near the primitive 
endoderm. ?-catenin expression was situated opposite the Hex expression domain in a 
non-overlapping manner (Chazaud and Rossant, 2006b). The expression of ?-catenin 
might signify sites of active Wnt signalling although other effector molecules that 
would presumably be asymmetrically localised have not been identified. 
 Although interesting observations, as with Lefty1, the expression of Hex is 
switched off by 5.0 dpc (Mesnard et al., 2006). This hinders the inference that Hex-
expressing primitive endoderm cells correspond to later Hex-expressing cells of the 
DVE. Furthermore, a recent study looking at Cerl expression claim that the AVE is 
established from both preimplantation precursor cells and de novo gene expression 
after implantation  (Torres-Padilla et al., 2007). This finding implies that the ontogeny 
of the AVE comprise multiple cell populations in which AVE commitment occurs at 
different developmental stages.  
 
1.2.2.4. Evidence of molecular asymmetries in the peri-implantation embryo 
It is apparent that in the implanting blastocyst, the detection of molecular asymmetries 
and their biological significance in polarity establishment remains an ongoing topic of 
research and intense debate. However the molecular asymmetries associated with the 
conversion of the P-D axis of the implanted embryo into the A-P axis is equally as 
contentious. 
 
Soon after implantation molecular heterogeneities within the VE can be detected. The 
VE overlying the ExE starts to express a different set of genes compared to the VE 
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overlying the epiblast (EmVE) (reviewed in Pfister et al., 2007). At 5.5 dpc the distal 
EmVE forms a thickening which defines the distal VE (DVE). The DVE expresses a 
unique set of genes including Hex, Lefty1 and Cerl, which set them apart from the 
surrounding EmVE (reviewed in Pfister et al., 2007). Careful examination has 
revealed that these domains of expression do not completely overlap; Hex is distally 
restricted in a symmetrical domain, while Cerl and Lefty1 both extend asymmetrically 
to one side (Takaoka et al., 2006; Yamamoto et al., 2004). This tilt is presumed to be 
towards the prospective anterior of the embryo as both genes are expressed in the 
AVE, although this has not been formally proven.  
 Another asymmetry has been observed before DVE movements. On one side 
of the VE overlying the proximal epiblast, Wnt3 transcript is evident (Rivera-Perez 
and Magnuson, 2005). Again this tilt is regarded to mark the prospective posterior of 
the embryo, as Wnt3 is expressed in the primitive streak, although this too has yet to 
be proven.  
 As well as asymmetries existing within the VE prior to DVE movements, 
there also appears to be regionalised signalling within the ExE. Rodriguez et al. 
(2005) demonstrated that signalling within this tissue represses the expression of 
DVE-specific genes such as Hex. Moreover, the source of signalling activity was 
proposed to emanate from the posterior portion, but not the anterior portion of the 
ExE (Richardson et al., 2006). However this study relied on the tilt of the DVE to 
demarcate the A-P axis, suggesting that the observed signalling asymmetry might 
follow those initially required to tilt the DVE.  
Nevertheless a growing body of evidence indicates that A-P axis 
establishment may be initiated prior to DVE movements. Whilst the patterns of gene 
expression remain radially symmetrical and widespread within the epiblast in the 
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DVE stage embryo, it is asymmetries within extra-embryonic tissues that initiate 
subsequent patterning events. This will be discussed in the next section.  
 
1.2.2.5. Induction of the DVE 
Recently much progress has been made in understanding how the DVE is induced 
(reviewed in Takaoka, et al., 2007; Srinivas, 2006). Analysis of mouse mutants and 
embryological manipulation has enabled the identification of signalling pathways and 
tissue interactions required. The TGF?-related family member Nodal has a central 
role in this process, although is not the sole contributor. This section will first focus 
on Nodal’s involvement in these events, then describe recent evidence implicating the 
Wnt pathway. 
 
Nodal is a secreted TGF?-related protein that is crucial in establishing polarity in the 
early mouse embryo (reviewed in Ang and Constam, 2004). Nodal signals via the 
Alk4 or Alk7 type I receptor in association with either the ActRIIA or ActRIIB type II 
receptor (reviewed in Whitman, 2001). This activated receptor complex 
phosphorylates the intracellular molecules Smad2 and Smad3, which associate with 
Smad4 and translocate to the nucleus (Massague et al., 2000). Smad proteins interact 
with DNA-binding proteins to regulate the transcription of target genes (reviewed in 
Wotton and Massague, 2001).  
Embryos null for Nodal display an absence of DVE markers including Hex, 
Lefty1 and Lim1 at 5.5 dpc, indicating its fundamental requirement in the induction of 
this tissue (Brennan, et al., 2001). Careful analysis of embryos at peri-implantation 
stages have shown Nodal and its effector genes including the proprotein convertases 
Furin and Pace4, are expressed in the hatched blastocyst (Mesnard et al., 2006). At 
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5.5 dpc these two serine proteases are expressed in the ExE and are required for the 
proteolytic maturation of Nodal; converting an inactive proprotein into one that is 
cleaved and active (Beck et al., 2002). Interestingly, compound mutants lacking both 
convertases phenocopy Nodal null mutants by failing to induce a DVE (Beck et al., 
2002), indicating that active Nodal is required to induce this tissue.  
 
Whilst Nodal is essential in specifying the DVE, how its widespread expression is 
able to induce the DVE towards the distal portion of the egg cylinder remains unclear. 
Rodriguez et al., (2005) demonstrated that the ExE was responsible for restricting the 
DVE to the distal tip of the 5.5 dpc embryo. Firstly, microsurgical removal of the 
entire extra-embryonic region lead to ectopic, de novo expression of HexGFP, Lim1 
and Cerl throughout the VE (Rodriguez et al., 2005). Furthermore injection of 
dissociated ExE cells into the distal tips of 5.5 dpc embryos resulted in the inhibition 
of AVE markers (Rodriguez et al., 2005). The precise mechanism of how the ExE 
inhibits AVE formation is unclear. 
One possibility is that the ExE could secrete an inhibitor that actively 
represses the expansion of the DVE. In support of this hypothesis is the fact that 
upregulation of AVE genes is observed one hour after ExE ablation, with no apparent 
change in Nodal transcript levels as AVE expression is expanding (Rodriguez et al., 
2005), making an indirect effect temporally unlikely. Alternatively the removal of the 
ExE could expose the proximal visceral endoderm to low levels of Nodal compatible 
with AVE induction. Indeed, removal of the ExE will effectively remove Furin and 
Pace4, resulting in a block in Nodal activation. As lowest levels of Nodal signalling 
are required to specify the AVE (Robertson et al., 2003; Norris et al., 2002), this 
might explain the ectopic expansion of AVE observed.  
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Interestingly Elf5 null mutants lack an ExE, yet still induce and correctly position the 
AVE (Donnison et al., 2005). These mutants do possess an ectoplacental cone which 
expresse Furin and Pace4 (Donnison et al., 2005). Thus the ectoplacental cone could 
take over the signalling role from the absent ExE. However, this does not preclude the 
possibility that the ectoplacental cone also expresses an unknown inhibitor expressed 
in the ExE, responsible for directly repressing DVE expansion.  
  
Although the repressive effects of the ExE on DVE induction have been demonstrated 
(Rodriguez et al., 2005; Richardson et al., 2006), they are not sufficient in this 
process. As previously reported, culturing embryo explants in which the 
extraembryonic portion had been removed resulted in ectopic DVE formation 
(Rodriguez et al., 2005). However, culturing these explants in the Nodal inhibitor SB-
431542 abolished DVE expansion as shown by a loss of Hex-GFP and Lim1 mRNA 
(Mesnard et al., 2006). This suggests that Nodal signalling is required even in the 
absence of the negative influence of the ExE. 
 
Additional roles for Nodal in DVE specification arose from careful in situ 
hybridisation analysis of Nodal and its effector genes in embryos during implantation. 
An early role was inferred by the observation that Nodal mutants at 5.0 dpc also 
exhibit a failure to specify EmVE markers (including Lim1, Bmp2 and Otx2), and 
instead express ectopic ExE VE markers such as Gata4, Hnf4 and Ttr (Mesnard et al., 
2006). This suggested that even before DVE induction, Nodal is required to define an 
EmVE compartment, which is then competent to give rise to a DVE lineage 
depending upon subsequent signalling events (Mesnard et al., 2006).  
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Mesnard and colleagues then noted that DVE was induced only when the distance 
between the ExE and distal tip of the egg cylinder exceeded 70 μm, and when the 
conceptus reached a minimum length of 180 μm (Mesnard et al., 2006). Furthermore, 
in Nodal mutants lacking a DVE, the average length of the egg cylinder at 5.5 dpc 
was reduced by 24%, suggesting Nodal had an indirect role by promoting 
proliferation and thereby increasing the egg cylinder to a permissive length (Mesnard 
et al., 2006).  
This lead to proposal of a dual role for Nodal during the process of DVE 
induction (Mesnard et al., 2006). Firstly Nodal is required to define the EmVE 
compartment. At a later stage Nodal is required to promote proliferation in the egg 
cylinder allowing the distal EmVE to escape the negative influence of the ExE 
(Rodriguez et al., 2005; Richardson et al., 2006). 
   
Nodal signalling is clearly important for the induction of the DVE, though evidence 
suggests that the canonical Wnt pathway is also required. Wnt/?-catenin signalling is 
involved in many developmental events, and the formation of the A-P axis is no 
exception (reviewed in Logan and Nusse, 2004). Briefly, Wnt proteins bind to the 
Frizzled (Fz)/low density lipoprotein (LDL) receptor-related protein (LRP) complex 
at the cell surface. Successful binding results in signal transduction to several 
intracellular proteins including Dishevelled (Dsh), glycogen synthase kinase-3? 
(GSK-3), Axin, Adenomatous Polyposis Coli (APC) and the transcriptional regulator, 
?-catenin. In the absence of Wnt signalling, cytosolic ?-catenin levels are kept low by 
continual proteosome-mediated degradation, via the GSK-3/APC/Axin complex. 
When Wnt binds, the degradation pathway is inhibited resulting in an increase in free 
?-catenin, which translocates into the nucleus and interacts with members of the 
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Lef/Tcf transcription factor family to affect transcription (Logan and Nusse, 2004, 
and references within).  
 Loss of function in the Apc gene leads to constitutive ?-catenin activity, as the 
degradation pathway is unable to function properly. The embryological consequences 
of having high levels of widespread nuclear ?-catenin is the proximalisation of the 
epiblast and inability to pattern the overlying VE and induce a DVE, as shown by an 
absence of Hex, Cerl and Gsc expression (Chazaud and Rossant, 2006b). This defect 
in DVE induction and/or embryonic VE formation appears to be independent from 
Nodal signalling defects, as its expression and that of its co-receptor Cripto were 
unaffected (Chazaud and Rossant, 2006b).   
Taken together, it is evident that DVE induction requires reciprocal 
interactions between extra-embryonic tissues and the epiblast to regulate Nodal and 
Wnt signalling. Perturbation in the spatial or molecular regulation of these events can 
profoundly affect this process. It remains to be seen whether additional signalling 
pathways participate in these events.  
 
1.2.2.6. Movements of the AVE  
The first morphological evidence of asymmetry relating to the future A-P axis is the 
tilt of the DVE at 5.5 dpc (reviewed in Srinivas, 2006). VE cells at the distal tip of the 
egg cylinder adopt a tall, columnar epithelial morphology, distinguishing them from 
the surrounding squamous VE (Kimura et al., 2000; Rivera-Perez et al., 2003; 
Srinivas et al., 2004). The columnar nature of the DVE might be modulated by the 
extracellular matrix (ECM), as when embryonic stem (ES) cells were seeded on the 
ECM protein hensin, a terminally differentiated epithelium formed that resembled the 
columnar epithelia of the DVE (Takito and Al-Awqati, 2004). Furthermore, in vivo 
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hensin expression coincides with the formation of columnar cells, and is lost as the 
cells moved to the prospective anterior of the egg cylinder (Takito and Al-Awqati, 
2004).  
 DVE movements were first described in 1998 by Thomas et al., who labelled 
VE cells at the distal tip of a 5.5 dpc conceptus with DiI (Thomas et al., 1998). 
Surprisingly, labelled VE cells were shown to move unilaterally, and always towards 
the prospective anterior of the embryo where they are referred to as the anterior VE 
(AVE) (Thomas et al., 1998). This finding has since been supported by iontophoretic 
lineage tracing (Rivera-Perez et al., 2003) and directly observing DVE movements 
using transgenic lines that express GFP in a DVE-specific manner (Srinivas, et al., 
2004; Mesnard et al., 2004) (Fig. 2).  
This latter technology combined with high resolution imaging has allowed the 
direct observation of DVE movements, enabling a more thorough understanding of 
this process. Time-lapse imaging of transgenic embryos that drive GFP using Hex 
regulatory elements (Rodriguez et al., 2001) has afforded the greatest cellular insight 
into DVE movements (Srinivas et al., 2004, and movie links within). This paper 
describes the dynamic morphological events during this anteriorwards movement with 
cells becoming flatter and starting to project filopodial processes in the direction of 
their movement-indicative of active cell migration (Srinivas et al., 2004). AVE cells 
migrated as a single layer in direct contact with the epiblast.  
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Figure 2 – Conversion of the proximal-distal axis into the anterior posterior axis 
in the post-implantation embryo 
At about 5.5 dpc the first definitive embryonic axis, the anterior-posterior (A-P) axis begins to 
form. A group of VE cells at the distal tip become morphologically different from their 
neighbours and begin to express a distinct of set markers. These cells are referred to as the 
distal VE (DVE; shown in green). They actively migrate towards the prospective anterior of 
the egg cylinder (red arrows). It remains unclear how early the first asymmetries are present 
in the DVE. Once at the anterior, these cells are referred to as the anterior VE (AVE) and they 
signal to the underlying epiblast to form anterior structures such as forebrain (shown in light 
blue). The AVE restricts posteriorising signals such as Nodal (purple dots and white 
inhibitory arrows), to the opposite side of the epiblast (black arrow), therefore defining a clear 
A-P axis. At 6.5 dpc this results in formation of the primitive streak at the posterior of the 
epiblast (also purple). (Adapted from  Beddington and Robertson, 1999).  
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When the leading cells reached the junction between the epiblast and the ExE, 
migration halted, and cells began spreading laterally (Srinivas et al., 2004). The 
inability of AVE cells to pass beyond this juncture is corroborated in other studies 
looking at cell movements within the VE (Lawson and Pederson, 1987; Thomas et al., 
1998; Rivera-Perez et al., 2003), although the mechanism for migratory arrest is 
currently unknown.  
 
Nevertheless, the migratory behaviour of the DVE was supported by the analysis of 
Nap1 mutants (Rakeman and Anderson, 2006). Nap1 is a regulator of WAVE-
mediated actin branching, and therefore important in the process of polarised cell 
movements. In Nap1 null embryos the DVE fails to migrate away from the distal tip 
and show a rounded, non-polarised morphology, highlighting the importance of 
dynamic intracellular rearrangements during migration (Rakeman and Anderson, 
2006).  
 
Interestingly, between 5.5-6.0 dpc the embryo is transformed from a radially 
symmetrical egg cylinder, to one that is bilaterally symmetrical (possessing a long and 
short axis in the transverse plane). The A-P axis is first aligned with the short axis as 
the DVE begins to migrate (Mesnard et al., 2004; Perea-Gomez et al., 2004). 
However, at the onset of gastrulation the A-P axis has shifted to the long axis 
(Mesnard et al., 2004; Perea-Gomez et al., 2004). Both groups agree that this 
apparent shift in A-P axis orientation is associated with tissue remodelling of the 
epiblast, rather than altering gene expression patterns or cell migration, such that the 
initial transverse ellipse forms a circle, then reforms another ellipse perpendicular to 
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the first (Mesnard et al., 2004; Perea-Gomez et al., 2004). Following this logic, the 
DVE migrates initially from the distal tip along the short axis of the embryo.  
 
The process of DVE cells located at the distal tip reaching the epiblast-ExE boundary 
takes between 4-5 hours, as determined by time-lapse analysis (Srinivas et al., 2004). 
This anteriorwards movement of HexGFP-expressing cells is reflected in the 
expression of other AVE markers such as Cerberus-like (Cerl) (and CerlGFP), Lim1 
(Belo et al., 1997; Mesnard et al., 2004), Frizzled-8 (Fz8) (Lu et al., 2004a) and left-
right determination factor 1 (Lefty1) (and Lefty-LacZ) (Meno et al., 1999; Perea-
Gomez et al., 1999; Takaoka et al., 2006). However, it should be noted that the AVE 
and its precursors are heterogeneous tissues comprising multiple subpopulations of 
cells (Srinivas et al., 2004; Yamamoto et al., 2004; Takaoka et al., 2006). The 
significance of variegated gene expression within the AVE on its function is only 
beginning to be understood. Two examples will be discussed below; both relating to 
the fundamental question of what determines the direction of the DVE.  
 
The migration of the DVE defines the orientation of the A-P axis, but the 
mechanism(s) responsible for this movement are currently a source of active 
investigation. Two possibilities exist: either DVE movements are stochastic, with the 
DVE traversing randomly up one side of the egg cylinder, or the direction of DVE 
movements are molecularly pre-determined. A growing body of evidence suggests the 
latter scenario is likely. Molecular asymmetries prior to DVE movements have been 
discussed in an earlier section, but two examples are particularly pertinent to DVE 
directional determination.  
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Kimura-Yoshida and colleagues proposed that Wnt/?-catenin signalling mediates 
DVE movements by guiding cell migration towards the prospective anterior of the 
embryo (Kimura-Yoshida et al., 2005). Specifically, the Wnt antagonist Dkk1 can act 
as a guidance cue, whilst canonical Wnt can act as a repulsive cue to DVE migration 
(Kimura-Yoshida et al., 2005). In vivo, prior to migration, Dkk1 is initially detected in 
the proximal portion of the VE. As the DVE tilts, Dkk1 expression is shifted to the 
future anterior side and is absent from the posterior side, forming a crescent over the 
leading front of Cerl-positive migratory cells (Kimura-Yoshida et al., 2005). 
Moreover, Otx2 null embryos form a functional DVE that is unable to move (Kimura 
et al., 2000). Notably Dkk1 expression is absent from all mutant embryos, suggesting 
that Otx2 is essential for Dkk1 induction, and its induction might play an important 
role in affecting DVE movement (Kimura-Yoshida et al., 2005).   
Indeed, the migration defects caused by Otx2 deficiency could be rescued by 
knocking-in Dkk1 into the Otx2 locus, strongly suggesting that Dkk1 was necessary in 
this process (Kimura-Yoshida et al., 2005). Furthermore, partial rescue of migratory 
behaviour in Otx2 mutants could be elicited by reducing the level of ?-catenin in the 
embryo, implicating the Wnt/?-catenin pathway in establishing A-P polarity (Kimura-
Yoshida et al., 2005). In support of this possibility Kimura-Yoshida and colleagues 
demonstrated that misexpression of the canonical Wnt ligand, Wnt8, perturbed cell 
movement; whilst in an in vitro situation, beads soaked in Dkk1 or Wnt3a could act as 
attractive and repulsive guidance cues respectively, controlling directional migration 
of VE cells (Kimura-Yoshida et al., 2005). Taken together this paper provides 
compelling evidence that DVE movements are directed along a Wnt/?-catenin 
signalling gradient, towards a region where Wnt is antagonised and levels of activated 
?-catenin are low. This movement is reinforced by the repulsive effect of Wnt ligands 
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expressed in the prospective posterior of the VE (Kimura-Yoshida et al., 2005; 
Rivera-Perez and Magnuson, 2005). It should be noted that Dkk1 null embryos are 
able to undergo normal A-P axis formation at an early stage (Mukhopadhyay et al., 
2001). Although other Wnt antagonists and negative regulators of the Wnt/?-catenin 
signalling pathway are expressed in the anterior VE at the right time including Cerl, 
Sfrp5 and Axin, all of which might functionally compensate for the absence of Dkk1 
in correctly forming the A-P axis (Logan and Nusse, 2004; reviewed in Pfister et al., 
2007).  
 
Another putative mechanism for directing DVE migration was put forward by 
Yamamoto and colleagues who proposed that differential proliferation within the VE 
was responsible for directing DVE movements (Yamamoto et al., 2004). This group 
observed that the Nodal antagonists Cerl and Lefty1 were shifted to one side of the 
embryo before the onset of DVE migration (Yamamoto et al., 2004); a finding that 
they later corroborated (Takaoka et al., 2006). It was presumed that the shift 
corresponded to the prospective anterior of the embryo, resulting in localised 
antagonism of Nodal along the A-P axis of the VE, with lower levels on the anterior. 
 To test if Nodal antagonism could direct DVE movements, Nodal and Cerl 
and/or Lefty1 were ectopically expressed in the embryo just prior to the DVE tilt 
(Yamamoto et al., 2004). The DVE tended to migrate away from the side with higher 
Nodal activity, and towards the region of low Nodal activity elicited by the co-
injection of Cerl and Lefty1, indicating that the level of Nodal did influence DVE 
directionality (Yamamoto et al., 2004). This was consistent with previous findings 
that Nodal activity has a crucial role in promoting cell movements that position the A-
P axis (Norris et al., 2002; Ding et al., 1998). Additionally, an absence of cell 
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proliferation in the VE was shown to correspond to the region of VE co-expressing 
Cerl and Lefty1, as demonstrated by a failure to incorporate Bromodeoxyuridine 
(BrdU) (Yamamoto et al., 2004). The implication that Nodal itself was responsible for 
promoting cell division was demonstrated by injecting VE cells with a Nodal vector 
and showing that the replicative capacity of these VE cells was increased compared to 
non-treated control embryos. Conversely, a decrease in the replicative capacity of VE 
cells was observed when embryos were co-injected with Cerl and Lefty1 effector 
genes (Yamamoto et al., 2004). Furthermore, DVE cells tended to move away from 
areas of high proliferation, as induced by Cdk2, whilst dominant negative Cdk2 was 
unable to affect DVE directionality (Yamamoto et al., 2004).  
 In summary, Yamamoto et al., (2004) proposed that the driving force of DVE 
movement was due to Nodal stimulating the proliferation of VE cells, whilst 
directionality was determined by the asymmetric antagonism of Nodal by Cerl and 
Lefty1 on the future anterior side. How this passive model mechanism incorporates 
the migratory cell movements of the DVE is not clear, and has formed the basis of 
one of my PhD projects. It is possible that both active and passive movements of the 
DVE both contribute, thus enabling a reconciliatory model to be constructed 
(Srinivas, 2006). Alternatively, other mechanisms might be involved that are yet to be 
described. Only careful analysis of cell movements and gene expression patterns will 
resolve this fascinating and essential biological phenomenon.  
 
1.2.2.7. Roles of the AVE 
The function of the AVE has been inferred by using a combination of microsurgical 
ablation experiments, explant experiments and by analysing the phenotype of 
embryos carrying mutations in genes expressed in the AVE.  These approaches have 
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given invaluable insights into the role of the AVE, yet assigning exact function(s) 
remains controversial. The following section will summarise what is currently known 
about AVE function and how this fits with the contemporary model of A-P axis 
establishment.  
 
1.2.2.8. The AVE determines the site of primitive streak formation 
The unilateral movement of AVE cells is mirrored by a shift in the expression of 
genes from the embryonic-extraembryonic boundary towards the prospective 
posterior of the epiblast. These events effectively convert the proximal-distal (P-D) 
axis of the pregastrula embryo into that of the A-P axis (reviewed in Beddington and 
Robertson, 1999; Rossant and Tam, 2004) (Fig. 2). The DVE (AVE precursors) 
expresses a number of secreted antagonists that can act upon the underlying epiblast, 
prior to their movement. Cerl and Lefty1 both inhibit Nodal signalling, and are 
responsible for restricting its expression firstly to the proximal epiblast, then as the 
AVE moves anteriorly, to the posterior side (Norris and Robertson, 1999; Perea-
Gomez et al., 2001a; Perea-Gomez et al., 2002). Likewise, the WNT antagonists 
Dkk1, Sfrp1 (Kemp et al., 2005) and Sfrp5 (Finley et al., 2003) are expressed in the 
AVE and might act to suppress WNT signalling in the anterior epiblast (reviewed in 
Tam and Loebel, 2007). The pattern of Nodal mRNA restriction to the proximal then 
posterior epiblast is replicated by the expression of its co-receptor Cripto (Ding et al., 
1998) and Wnt3 (Liu et al., 1999), whilst Brachyury, which is initially expressed 
throughout the distal ExE becomes posteriorly restricted during AVE movements 
(Perea-Gomez et al., 2004; Rivera-Perez and Magnuson, 2005). Thus a radially 
symmetrical pattern of gene expression in a P-D orientation is rotated into an A-P 
axis, perpendicular to that of the original P-D axis (Thomas et al., 1998). The anterior 
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side of the epiblast cup will give rise to anterior structures, whilst the posterior side 
will form the primitive streak in which epiblast cells undergo an epithelial to 
mesenchymal transition (EMT) before delaminating and migrating through the 
primitive streak (Fig. 2). The process of gastrulation will be discussed in more detail 
later.  
  
A role for the AVE can be inferred by analysing mouse mutants that form a functional 
AVE, but which fail to move anteriorwards. Two such examples are Cripto (Ding et 
al., 1998) and Otx2 (Acampora et al., 1998; Rhinn et al., 1998; Kimura et al., 2000) 
mutants in which the primitive streak is ectopically formed in the proximal epiblast. 
These observations led to the logical conclusion that the AVE was responsible for 
positioning the site of primitive streak formation (Kimura et al., 2000; Perea-Gomez 
et al., 2001a; reviewed in Perea-Gomez et al., 2001b).  
 It is not clear exactly how the primitive streak is initiated, although genetic 
analysis in mouse has indicated the essential requirements of Wnt, Nodal and BMP 
signalling pathways. Embryos lacking Wnt3 (Liu et al., 1999) or its co-receptor 
proteins Lrp5 and Lrp6 (Kelly et al., 2004) fail to initiate Brachyury (and Nodal in the 
case of Wnt3 mutants) or form a primitive streak. Furthermore, Brachyury is a direct 
transcriptional target gene of the Wnt signalling pathway (Arnold et al., 2000; 
Yamaguchi et al., 1999). Mutant embryos lacking Nodal also fail to correctly form a 
primitive streak and fail to express Wnt3 (Conlon et al., 1994; Brennan et al., 2001). 
BMP4 is required for the formation of the node and primitive streak morphogenesis 
(Fujiwara et al., 2002; Winnier et al., 1995). In sum a complex interplay between 
these signalling pathways is required to initiate the primitive streak and restrict its 
formation to the posterior (Constam and Robertson, 2000; reviewed in Perea-Gomez 
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et al., 2001b). Failure of the AVE to move results in ectopic initiation of primitive 
streak gene expression in the proximal epiblast, as the secreted antagonists within the 
AVE fail to act in an A-P orientation. This is best exemplified in Cerl
-/-
;Lefty1
-/-
 
compound mutants in which inappropriate posterior restriction of Nodal results in 
ectopic primitive streak formation (Perea-Gomez et al., 2002).  
 
The widely accepted idea that the P-D axis is converted into the A-P axis has recently 
been challenged in light of evidence suggesting that molecular asymmetries relating 
to the A-P axis are already present before AVE movements. Specifically, Rivera-
Perez and Magnuson (2005) reported that Wnt3 is expressed in the prospective 
posterior VE at 5.5 dpc before the DVE has moved (Rivera-Perez and Magnuson, 
2005). The implication is that formation of the primitive streak does not depend on 
the regionalisation of gene expression from proximal epiblast cells, but that the 
epiblast has already pre-determined the site of the primitive streak. However, studies 
thus far have failed to corroborate or repudiate such a notion.  
  
1.2.2.9. Role of AVE in forebrain development 
Heterotopic transplantation of the mouse node from gastrulating embryos was shown 
to induce a secondary neural axis in the host, although midbrain and forebrain regions 
failed to develop (Beddington, 1994; Tam and Steiner, 1999). This suggested that 
unlike amphibians and chick, the node alone was not the sole organiser but required 
an additional signalling contribution to form a complete A-P axis. Embryological and 
genetic analysis has since revealed the AVE to be required for anterior patterning 
(reviewed in Beddington and Robertson, 1998 and 1999; Martinez-Barbera and 
Beddington, 2001). Microsurgical ablation of the AVE at the onset of gastrulation 
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reduces or abolishes the forebrain marker Hesx1 in the underlying anterior neural 
ectoderm (Thomas and Beddington, 1996). The role for the AVE in anterior 
patterning was strengthened by the fact that many of the genes expressed in the node 
and its derivatives were also expressed in the AVE; these include Hex (Thomas et al., 
1998), HNF3? (Ang and Rossant, 1994), Lim1 (Shawlot and Behringer, 1995), Cerl 
(Belo et al., 1997) and Otx2 (Ang and Rossant, 1994; Acampora et al., 1995).  
 Not surprisingly in light of the AVE ablation experiment, mutants 
homozygous for many of these genes result in severe forebrain defects. Loss of Lim1 
(Shawlot and Behringer, 1995), HNF3? (Ang and Rossant, 1994) and Otx2 (Ang and 
Rossant, 1994; Acampora et al., 1995) causes anterior truncations. Chimeric embryos 
possessing different embryonic and extraembryonic genotypes were used to show a 
requirement for these genes in the AVE (Beddington and Robertson, 1989; reviewed 
in Martinez-Barbera and Beddington, 2001).  
 Using Lim1 as an example, when wildtype ES cells were injected into Lim1
-/- 
blastocysts, the extraembryonic tissues of the resulting chimeras were almost 
exclusively of the genotype Lim1
-/-
. These embryos were phenotypically 
indistinguishable from Lim1
-/-
 embryos which lack rostral brain structures, suggesting 
that Lim1 was required in extraembryonic tissues for normal forebrain formation 
(Shawlot et al., 1999). When the converse experiment was performed and Lim1
-/-
 ES 
cells were injected into wildtype blastocysts, mutant cells contributed to the entire 
embryo proper, and constrictions observed between the embryonic and 
extraembryonic regions in Lim1
-/-
 mutants at 7.5 dpc were rescued (Shawlot et al., 
1999). This rescue was presumably a consequence of the chimera possessing largely 
wildtype extraembryonic tissues, thus strengthening the requirements of Lim1 in the 
VE for correct head formation.  
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The sufficiency of wildtype extraembryonic tissue rescuing chimeras in which the 
embryo proper is predominantly mutant was phenocopied in nodal, Otx2, and HNF3? 
chimeras (Varlet et al., 1997; Rhinn et al., 1998; Acampora et al., 1998; Dufort et al., 
1998). Therefore in combination with the AVE ablation experiment and this genetic 
evidence, the general consensus is that visceral endoderm is required in normal 
forebrain and midbrain development.  
 
This is only part of the story; whilst it is true that AVE is required to establish anterior 
character in the underlying ectoderm, this signalling centre alone is insufficient to 
initiate rostral patterning. Firstly, grafts of mouse AVE fail to induce neural character 
in non-neural ectoderm (Tam and Steiner, 1999), but do suppress posterior markers 
(Kimura et al., 2000). A complete ectopic axis requires a combination of a posterior 
epiblast fragment (or early gastrula organiser (EGO)), AVE and anterior epiblast, 
suggesting that a combinatorial mode of action between these germ layers is 
necessary (Tam and Steiner, 1999), in addition to preventing posteriorising signals 
(Kimura et al., 2000). Furthermore, as previously discussed, chimeras with a mutant 
embryonic but wildtype extraembryonic tissues are able to induce normal anterior 
development (reviewed in Beddington and Robertson, 1999). However, anterior 
neural structures degenerate at later stages suggesting that after induction additional 
signals are required to maintain and/or embellish neural development.  
 
Are the roles of the AVE and node and its derivatives interdependent or functionally 
separable? It is true that both structures co-express a number of the same genes, and 
that axial mesendoderm (comprising the anterior definitive endoderm (ADE), 
prechordal and notochordal plates) displaces the AVE at 7.0 dpc, and so is apposed to 
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the same portion of anterior epiblast previously subjected to the AVE (Thomas and 
Beddington, 1996) (Fig. 3A). There are examples of genes that are expendable in the 
AVE, but are absolutely required in the derivatives of the node. Both Hex and Hesx1 
are expressed in the AVE, and then later in the ADE and AME respectively (Thomas 
et al., 1998; Hermesz et al., 1996; Thomas and Beddington, 1996). When either gene 
is knocked out, patterning of the AVE is normal as assessed by marker analysis, 
although at later stages embryos develop variable forebrain truncations (Martinez-
Barbera et al., 2000a; Martinez-Barbera et al., 2000b; Dattani et al., 1998). Chimeric 
analysis has indicated that both genes are required in epiblast-derived tissues for 
normal forebrain development; ADE in the case of Hex, and anterior neurectoderm 
(ANE) in the case of Hesx1 (Martinez-Barbera et al., 2000a; Martinez-Barbera et al., 
2000b). This provides solid evidence that it is tissues derived from the epiblast that 
are important in the maintenance of anterior neural character. The fact that these 
genes are not required in the AVE might reflect redundancy within this tissue.  
  
To summarise, this wealth of embryological and genetic data has led to the 
construction of a model for forebrain development. The model comprises a sequence 
of inductive steps starting with the initiation of neural patterning from the AVE and 
EGO on the underlying ectoderm. This is shortly followed by signalling from the 
AME which passes through the node and displaces the AVE, resulting in maintenance 
and embellishment of neural patterning (reviewed in Beddington and Robertson, 1998 
and 1999; Martinez-Barbera and Beddington, 2001).  
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1.2.3. Gastrulation 
 
Gastrulation is a defining point in the post-implantation embryo in which the three 
definitive germ layers are established. At about 6.5 dpc the primitive streak forms at 
the posterior of the epiblast. The primitive streak is the morphological landmark of 
the site of gastrulation. It is here that cells of the epiblast delaminate from their 
epithelial sheet and move towards the posterior, through the streak, and emerge 
having taken on either an endodermal or mesodermal fate. Those cells that do not 
ingress through the streak are fated to become the ectoderm (reviewed in Tam and 
Behringer, 1997; Tam and Loebel, 2007) (Fig. 3A). The proceeding sections will 
outline the signalling pathways involved in the formation of the primitive streak, and 
also how these signals are integrated to produce the necessary tissue movements and 
lineage choices that encompass gastrulation.  
 
1.2.3.1. Formation of the Primitive Streak 
The onset of gastrulation is marked by the formation of the primitive streak. As 
previously discussed, the correct site of primitive streak formation depends on the 
correct establishment of the A-P axis, where the AVE has an integral role by 
antagonising the activity of Nodal. Nodal has multiple roles in primitive streak 
formation, both directly and more indirectly in feedback loops (reviewed in Tam and 
Loebel, 1997). For example, Nodal precursor protein in the proximal epiblast is 
required to maintain Bmp4 expression in the ExE, which in turn is necessary to induce 
expression of primitive streak markers and activate the transcription of Nodal 
convertases, which perpetuate its activity (Winnier et al., 1995; Mishina et al., 1995; 
Beppu et al., 2000; Ben-Haim et al., 2006). Uncleaved Nodal also activates Fgf8 and 
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Wnt3, which indirectly maintains Nodal expression in the epiblast (Brennan et al., 
2001; Ben-Haim et al., 2006) and positions the site of primitive streak formation via 
?-catenin and the Wnt co-receptors Lrp5/6 (Liu et al., 1999; Huelsken et al., 2000; 
Kelly et al., 2004; Mohamed et al., 2004).  
 
However, the epiblast must also reach a certain number of cells for gastrulation to 
take place, confirmed by ultrastructural analysis and the study of proliferation rates 
and its perturbation in pregastrulae embryos (reviewed in Tam et al., 1993; Tam and 
Behringer, 1997). Snow calculated a 4.5- to 5-fold increase in epiblast population 
between 5.5 and 6.5 dpc, which increased by 12-fold between 6.5 and 7.5 dpc (Snow, 
1977). This dramatic growth in epiblast number is required to sustain the recruitment 
of ectoderm cells through the primitive streak. Mouse embryos can compensate for an 
earlier loss of cells, showing the highly regulative nature of the embryo. This was 
demonstrated by removing 1 cell from a 4-cell embryo and showing that a complete 
restoration of body size was possible by compensatory growth at gastrulation (Power 
and Tam, 1993; reviewed in Tam and Behringer, 1997). What factors are responsible 
for eliciting proliferation of the epiblast? Nodal is a growth factor that can promote 
cell proliferation (Yamamoto et al., 2004; Mesnard et al., 2006), so presumably 
another role for this important molecule is to enable the epiblast to reach a critical 
threshold of cells prior to gastrulation. Whether other growth factors that are present 
contribute to proliferation in the epiblast is not clear; nevertheless the epiblast 
requires approximately 660 cells for gastrulation to commence (Snow, 1977).  
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1.2.3.2. Cell movement through the primitive streak 
The primitive streak marks the site where epithelial cells of the epiblast delaminate 
from their epithelium, undergo an epithelial to mesenchymal transition (EMT) and 
emerge as mesoderm or endoderm. EMT describes the process by which an epithelial 
layer, such as the epiblast, loses integrity via changes in cell shape and adhesion 
(reviewed in Shook and Keller, 2003). As cells move through the primitive streak 
they must disassemble their basement membrane and change shape, thus facilitating 
morphogenesis of the tissue and ultimately ingression through the streak (Tam et al., 
1993).  
As gastrulation progresses, the primitive streak lengthens and eventually 
reaches the distal tip of the egg cylinder. Epiblast cells ingress through the primitive 
streak when it has extended into their vicinity, establishing a sequential recruitment of 
epiblast cells dependent upon their distance from the primitive streak. Accordingly, 
epiblast cell fates have been mapped onto the pre-gastrula stage egg cylinder by 
lineage tracing studies, thereby determining the temporal and morphological sequence 
of gastrulation (Lawson et al., 1991; Tam and Behringer, 1997).  
It appears that clonal descendants of single cells passing through the streak 
often intermingle, suggesting that mesodermal and endodermal derivatives do not 
comprise distinct epiblast cell clones (Lawson et al., 1991; Tam and Behringer, 
1997). The mesoderm emerges as a new layer between the epiblast and the overlying 
VE, which moves around the egg cylinder as lateral ‘wings’ (Tam et al., 1993). 
Gastrulating cells that emerge from the node intercalate into the surrounding VE and 
form the definitive endoderm, displacing the AVE and ultimately giving rise to the 
gut, and organs including the liver and pancreas (Tam et al., 2007) (Fig. 3A). The 
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ectoderm forms from those anterior and distal epiblast cells that do not ingress 
through the streak (Lawson et al., 1991).   
 
The migration of mesodermal cells is dependent on FGF signalling, and the absence 
of either Fgf8 or its receptor Fgfr1 (fibroblast growth factor receptor 1) result in 
problems in cell movement through the primitive streak (Sun et al., 1999; Ciruna and 
Rossant, 2001). In embryos lacking FGF-8, epiblast cells undergo an EMT and move 
to the streak, but are then retained, resulting in the absence of any mesoderm- or 
endoderm-derived tissues (Sun et al., 1999). When the Fgfr1 receptor is knocked-out, 
epiblast cells are unable to undergo EMT, most likely a result of the inability to 
upregulate Snail1 (Snail homologue 1) and therefore downregulate E-cadherin 
(Ciruna and Rossant, 2001). Furthermore, mesoderm cell fate specification is 
hindered, as shown by the downregulation of Brachyury and Tbx6 (Ciruna and 
Rossant, 2001). Brachyury is necessary for correct mesoderm migration (Wilson et 
al., 1995) and is also a direct target of Wnt3a (Yamaguchi et al., 1999). Therefore 
FGF and Wnt signalling are intimately linked at the primitive streak, involved in both 
morphogenetic cell movement and cell fate specification.  
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Figure 3 – Formation of the primitive streak and gastrulation 
A. Primitive streak formation. By 7.0 dpc, extraembryonic mesoderm (red) emanates 
from the posterior portion of the primitive streak. Cells from the embryonic ectoderm 
ingress through the anterior primitive streak and form the organiser (node, purple). 
These cells give rise to axial mesendoderm (brown) which move anteriorly (red 
arrow) and displace the AVE (green). Axial mesendoderm and its derivatives will 
give rise to dorsal mesoderm and gut endoderm.  
B. Lineage allocation during gastrulation. Brachyury transcript (dark blue) marks the 
entire primitive streak in a 7.5 dpc embryo. Epiblast cells delaminate from the epithelium 
and ingress through the primitive streak. This process results in the formation of the 
embryonic germ layers. Cells that move through the streak emerge as either definitive 
endoderm or various mesodermal derivatives depending upon their location within the 
primitive streak (red, node/some axial mesendoderm; orange, paraxial mesoderm; green, 
lateral plate mesoderm; yellow, extraembryonic mesoderm). Cells that do not ingress through 
the streak will become embryonic ectoderm (blue) (adapted from Tam and Loebel, 2007).  
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1.2.3.3. Signals regulating lineage choice during gastrulation 
Fate map studies of the primitive streak have revealed that different regions of the 
streak display different mesodermal and endodermal fates (Tam and Beddington, 
1987; Lawson et al., 1991). The primitive streak can be divided into individual but 
overlapping regions depending on the contribution of labelled cells to a particular 
tissue-type (Fig. 3B). For example, the node region of the late gastrula will give rise 
to axial mesoderm and definitive endoderm, the anterior-third of the primitive streak 
will give rise to the paraxial mesoderm, the middle-third lateral plate mesoderm and 
the posterior-third will form extraembryonic mesoderm. Cells that remain in the 
epiblast are allocated to the ectoderm (reviewed in Tam and Behringer, 1997; Tam 
and Loebel, 2007). It is becoming increasingly clear that the allocation of these 
different lineages depend upon varying combinations of TGF? signalling molecules 
Nodal and BMP, as well as FGF and Wnt signalling (Tam and Loebel, 2007).  
Genetic studies have shown a loss of Nodal signalling results in the abolition 
of anterior primitive streak-derived tissue including axial and paraxial mesoderm and 
definitive endoderm (Beck et al., 2002; Hoodless et al., 2001; Episkopou et al., 
2001). Conversely, loss of Bmp4 results in the loss of posterior primitive streak 
derivatives such as extraembryonic mesoderm (Winnier et al., 1995). Paraxial 
mesoderm, derived from anterior and middle primitive streak, is not formed when 
Fgfr1 is absent (Deng et al., 1994; Yamaguchi et al., 1994) or when Wnt3a is deleted 
(Yoshikawa et al., 1997) implicating both FGF and Wnt signalling in the formation of 
the paraxial mesoderm lineage. Therefore, a model can be proposed whereby BMP 
and Nodal signalling are required in the posterior and anterior primitive streak 
respectively, with middle-streak derivatives requiring a combination of FGF and Wnt 
signalling (reviewed in Tam and Behringer, 1997; Tam and Loebel, 2007).  
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To conclude, gastrulation is a complex process involving the integration of signalling 
pathways and morphogenetic movements. Many aspects remain elusive. A recent 
paper proposed that the Argonaute2 protein was essential for proper mesoderm 
formation in mouse by modulating FGF signalling (Alisch et al., 2007). Argonaute2 is 
involved in the process of RNA interference (RNAi), opening up the possibility that 
this method of post-transcriptional gene regulation is implicit during gastrulation. 
What we know is continually being built upon; the process becoming both better 
understood and evermore intriguing. It is this resolution of this dichotomy that 
continues to drive research forward.  
 
1.3. This investigation 
 
It is clear that the AVE is inexorably linked to A-P axis establishment, although its 
exact functions are poorly defined. This PhD has focused on two aspects of AVE 
function; firstly, what role does cell proliferation have in defining its movements, and 
secondly, is this signalling centre responsible for other undefined events in the 
embryo? 
 
The movement of the AVE not only defines the anterior side of the embryo, but is 
also essential in positioning the site of primitive streak formation. What is not well 
understood are the mechanisms responsible for its appropriate localisation. As 
discussed, hypotheses have been proposed tending towards active or passive cell 
movements. Evidence of differential proliferation and its involvement in AVE 
movements was published in 2004 (Yamamoto et al, 2004). This project has 
investigated this possibility by analysing patterns of cell proliferation during AVE 
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movements in detail using a combination of high resolution imaging and culturing 
techniques. 
 
Functions of the AVE have been ascribed using embryological micromanipulation 
and genetic mutation techniques. To address the function of the AVE as a whole and 
in vivo, the AVE has been genetically ablated. This was achieved by targeting 
Diphtheria toxin A (DTA) into the Hex locus by homologous recombination. DTA is 
placed under the control of the endogenous Hex regulatory sequence and is inducible 
using the Cre-loxP recombinase system. This project describes the making of this 
mouse line and the subsequent characterisation of embryos in which, depending on 
the timing of genetic ablation, have provided further insights into the function of the 
DVE and AVE.  
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Chapter 2 - Materials and Methods 
 
Note all chemicals were obtained from Sigma-Aldrich UK unless otherwise stated. 
 
2.1. Mice and procedures 
 
2.1.1. Mouse strains 
All mice used in this investigation were maintained in the Biological Services Unit, 
Clinical Sciences Centre, Imperial College, UK. All transgenic strains were purchased 
from Harlan Olac, UK. All transgenic strains were produced by the Transgenic 
Facility, Clinical Sciences Centre, Imperial College, UK. Hexd32 mice were derived 
by ES cell injection into C57BL/6 blastocysts. This was carried out in house by the 
CSC Transgenic facility. These mice were studied on either a mixed 129sv, C57BL/6 
or CD1, C57BL/6 background. All mice were maintained and treated under the Home 
Office’s animals (scientific procedures) Act 1986.  
 
2.1.2. Transgenic lines 
In total six transgenic mouse lines were used during this investigation. The Hexd32 
line was generated by homologous recombination of a DTA cassette into the 
endogenous Hex locus. The ATG start codon of DTA was separated from its open 
reading frame (ORF) by an intervening Neomycin-resistant cassette flanked by LoxP 
sites (Neo
R
-STOP). Cre recombination excised Neo
R
-STOP and resulted in the DTA’s 
ORF uniting inframe to its start codon. This event placed DTA under the control of 
the Hex regulatory sequences allowing activation of DTA in Hex-expressing cells.  
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Two Cre-expressing lines were crossed to the Hexd32 line. The first was ?-actin-Cre 
that expresses Cre recombinase ubiquitously under the control of the ?-actin 
promoter/CMV enhancer (Lewandoski et al., 1997). The second Cre-expressing 
mouse line was Sox2Cre that expresses Cre under the upstream regulatory sequence 
of the Sox2 gene (Hayashi et al., 2002). If the Sox2Cre transgene is inherited 
maternally all of the offspring will carry Cre ubiquitously (Hayashi et al., 2003, 
Vincent et al., 2003), whilst paternal transmission is restricted to epiblast-derived 
tissues in progeny possessing the Cre transgene (Hayashi et al., 2002). Both Cre 
mouse lines were crossed to Hexd32 mice and embryos were characterised throughout 
development. A small number of embryos resulting from the ?-actin-Cre;Hexd32 
cross escaped genetic ablation, were born and were fertile.  These mice carried one 
activated DTA allele, negating the need for further Cre mediated recombination. 
These mice were named Hexd
act
 and the nature of the genetic ablation in mice 
harbouring the activated DTA allele was characterised by crossing to either 129sv or 
CD1 wildtypes, or other Hexd
act
 mice to double the level of activated DTA to test if 
the efficiency of the ablation system was enhanced. Hexd
act
 mice were also crossed to 
Nodal.LacZ mice in which the endogenous nodal minimal promoter drives ?-
galactosidase expression (Norris and Robertson, 1999).  
Throughout the investigation HexGFP mice were used as a way of visualising 
Hex-expressing cells (Rodriguez et al., 2001). GFP expression in these mice is driven 
by Hex regulatory elements and embryos carrying the HexGFP transgene were 
generated by crossing homozygous/heterozygous HexGFP males to CD1 females. 
Additionally Hexd32:HexGFP studs were generated to give another means to 
characterise the genetic ablation.  
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The final transgenic line used to study the efficiency of ?-actin-Cre recombination 
was the ROSA26 Cre (R26R) reporter strain (Soriano, 1999). This line possesses an 
interrupted LacZ cassette in the constitutively expressed Rosa26 locus. Cre-mediated 
recombination is required for reporter activity, and once expressed all descendents 
will express LacZ.  
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2.2. Embryology methods 
 
2.2.1. Embryo recovery 
Mice were maintained on a 12 hour light, 12 hour dark cycle. Mice were mated and 
noon of finding a vaginal plug was designated 0.5 days post coitum (dpc). Pregnant 
females were sacrificed at the dpc required for the procedure and the uterus was 
removed. Embryos were dissected from the uterus in M2 media (see Appendix I). 
Embryos were then processed according to the appropriate protocol.  
 
2.2.2. Wholemount RNA in situ hybridization 
2.2.2.1. Fixation 
Harvested embryos were immediately fixed in 4% Paraformaldehyde in PBS at 4 °C 
overnight. The following day they were dehydrated through a Methanol series (25%, 
50%, 75% in PBS and 100%) at room temperature (RT), 5 mins for each condition. 
Embryos were stored at -20 °C until use. 
 
2.2.2.2. Embryo processing 
Embryos were rehydrated through a Methanol series (75%, 50%, 25% in PBS) at RT 
then washed twice in PBT (0.1% Tween-20 in PBS), 5 mins for each condition. 
Embryos were sorted and placed in 15 mm Netwells with either a 500 μm or 74 μm 
mesh depending on embryo size. The Netwells were positioned into 12-well plates 
(VWR, UK). All steps were carried out in this format. Embryos were bleached in 6% 
Hydrogen peroxide in PBT for 1 hr at RT and washed in PBT three times, 5 mins 
each. They were placed in 10 μg/ml Proteinase K in PBT and incubated at room 
temperature for the following times: 5.5 dpc for 1 min, 6.5 dpc for 2.5 mins, 7.5-8.5 
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dpc for 4 mins and 9.5 dpc 6 mins. Embryos were immediately placed in 2 mg/ml 
Glycine in PBT for 5 mins followed by two, 5 min washes in PBT. Embryos were 
then re-fixed in a solution of 4% Paraformaldehyde, 0.2% Gluteraldehyde in PBT at 
RT for 20 mins. This was followed by two, 5 min washes in PBT.  
 
2.2.2.3. Hybridisation of riboprobe 
Embryos were placed in Pre-hyb buffer (50% Formamide, 5x SSC, 50 μg/ml Heparin 
sulphate and 0.1% Tween-20 in dH2O) and incubated at 70 °C for 1-2 hrs. Embryos 
were then placed in pre-warmed hybridisation buffer (1 mg/ml torula RNA and 1 
mg/ml Herring sperm DNA in Pre-hyb buffer) containing the denatured riboprobe. 
Probes were used at a dilution between 1:100 or 1:200 depending on their quality and 
approximate concentration. Hybridisation was carried out at 70 °C overnight.  
 
2.2.2.4. Incubation with anti-DIG antibody 
Next day embryos were placed in Solution I (50% Formamide, 4x SSC pH 4.5, 10% 
SDS in dH2O) two times for 30 mins at 70 °C. Following this was a 10 min 
incubation at 70 °C in 1:1 Solution I: Solution II (500 mM NaCl, 10mM Tris-HCl pH 
7.5 and 0.1% Tween-20 in dH2O). Embryos were then washed twice at RT in Solution 
II for 5 mins each. Unbound riboprobe was removed by two incubations in 100 μg/ml 
RNAse A (Roche Diagnostics, Germany) in Solution II for 30 mins each at 37 °C. 
Embryos were washed once more in Solution II and once in pre-warmed Solution III 
(50% Formamide, 2x SSC pH 4.5 in dH2O) for 5 mins at RT. They were then 
incubated at 65 °C in pre-warmed Solution III twice for 30 mins each. Embryos were 
washed three times at RT in TBST (137 mM NaCl, 1.34 mM Potassium chloride, 12.5 
mM Tris-HCl pH 7.5 and 0.1% Tween-20 in dH2O). Embryos were blocked at RT in 
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10% sheep serum in TBST for 1-2.5 hrs. After blocking embryos were incubated with 
1:2000 anti-Digioxin FAB antibody (Roche Diagnostics, Germany) in 1% Sheep 
serum in TBST at 4 °C overnight while rocking. Next day embryos underwent six 1 
hr washes at RT in TBST to remove unbound antibody and thus reduce unspecific 
signal. Embryos were left rocking overnight in TBST at 4 °C.  
 
2.2.2.5. Signal detection 
Next day embryos were carefully removed from the Netwells and placed into glass 
embryo dishes (RA Lamb, UK) containing NTMT (100 Mm NaCl, 100 mM Tris-HCl 
pH 9.5, 50 mM MgCl2 and 0.1% Tween-20 made up in dH2O). The embryo dishes 
had been previously treated with Repelcote (BDH, UK). Embryos were washed three 
times in NTMT, for 10 mins each at RT. The staining reaction was carried out with 20 
μl NBT/BCIP solution (Roche Diagnostics, Germany) in 1 ml NTMT at room 
temperature in the dark. The reaction was left to proceed until a clean specific staining 
was achieved. In cases where staining took a long time to appear embryos were 
washed and left in fresh NTMT, overnight at 4 °C and the NBT/BCIP stain replaced 
the following day to continue the reaction. This allowed the reaction to proceed more 
slowly overnight therefore preventing the appearance of background staining.  
 
2.2.3. Wholemount ?-galactosidase staining 
2.2.3.1. Fixation 
After harvesting, embryos were immediately fixed at 4 °C as follows: preimplantation 
stages were fixed in 0.2% Gluteraldehyde in PBT for 10 mins. Postimplantation stage 
6.5 dpc were fixed in 0.2% Gluteraldehyde, 2% Formaldehyde in PBT for 7 mins.  
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2.2.3.2. Staining 
Embryos were then washed three times, 5 mins each at RT in rinse solution, pH 7.3 
(21 parts 0.1 M NaHPO4 to 4 parts 0.1 M NaH2PO4, 0.1% Sodium deoxycholate, 
0.2% Igepal, 5 mM EGTA, 2 mM MgCl2). Embryos were then placed in Stain (5 mM 
Potassium ferrocyanide, 5 mM Potassium ferricyanide and 1 mg/ml X-gal in the rinse 
solution). Embryos were incubated in stain at 37 °C in a humid chamber overnight or 
until an adequate level of staining was achieved.  
 
2.2.4. TUNEL staining 
Embryos were fixed, dehydrated, rehydrated and PK-treated using exactly the same 
procedure as the wholemount in situ hybridisation protocol as described previously. 
Embryos were re-fixed in fresh 4% PFA/0.1% Tween-20 for 20 mins and washed 5 
times with PBT (0.1% Tween-20 in PBS), 5 mins. Embryos were plunged into ice-
cold Ethanol:Acetic acid (2:1), and incubated at -20°C for 20 mins. Embryos were 
then washed 5 times in PBT (0.1% Tween-20 in PBS), 5 mins, and transferred in the 
smallest possible volume into a 1.5 ml Eppendorf tube. Embryos were treated as 
described in the TUNEL Staining kit (Upstate Cat. No: S7101). Briefly, 100 μl 
equilibration buffer was added to the embryos for 4 mins, removed and repeated, this 
time for 1 hr at RT. Equilibration buffer was removed and 100 μl Reaction buffer and 
TdT enzyme (1:2) added. The embryos were incubated at 37°C overnight. The 
following day the Reaction mix was aspirated and 100 μl Stop buffer/dH2O (34:1) 
was added and incubated for 1 hr. This was repeated 4 times, before washing in PBT 
(0.1% Tween-20 in PBS), 3 times, 20 mins each. Embryos were then blocked in 10% 
Sheep serum and signal was detected using NBT/BCIP in exactly the same way as 
described in the wholemount in situ hybridisation protocol. It should be noted that 
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unlike the majority of the in situ cases, signal develops quickly using the TUNEL kit, 
and often needed stopping before 5 mins.  
 
2.2.5. Antibody staining 
2.2.5.1. Wholemount anti-phospho-Histone H3 staining 
Freshly dissected 5.5-7.5 dpc HexGFP embryos were fixed in 4% Paraformaldehyde 
overnight at 4 °C. After fixation they were washed three times for 5 mins each in PBS 
at RT. Embryos were then incubated in blocking solution (5% Goat serum, 1% Fish 
skin gelatin, 0.5% Triton X-100 in PBS) for 1 hr, then transferred to primary antibody 
solution [rabbit anti-phospho-Histone H3 (Ser28) (Upstate Cat No. 07-145) diluted 
1:500 in blocking solution] and incubated at 4 °C overnight. The following morning 
embryos were washed three times in blocking solution and incubated in secondary 
antibody solution [Alexa Fluor 568 goat anti-rabbit IgG (Molecular Probes Cat No. 
A-11036) diluted 1:250 in secondary block (1% Fish skin gelatin, 0.5% Triton X-100 
in PBS)] for 4 hrs at RT. Embryos were rinsed three times in PBT and once in PBS 
for 5 mins and counterstained with DAPI-Vectashield mounting medium (4’, 6-
diamidino-2-phenylindole dihydrochloride) for 20 mins.  
 
2.2.5.2. Wholemount GFP and BrdU staining – Embryo culture protocol I 
This protocol has been modified from the Whole mount BrdU staining protocol as 
found on the Rossant web page (www.sickkids.ca/rossant/protocols). BrdU was 
prepared as a stock concentration of 10 mg/ml in PBS. Aliquots were kept at -20 °C 
and diluted to a final concentration of 20 μM in 1:1 DMEM: rat serum. Culture 
medium containing BrdU was pipetted into 80 μl drops in 10 cm culture dishes 
(VWR, UK). Drops were covered in mineral oil and equilibrated at 37 °C, 5% CO2 
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for 2-3 hrs. Freshly dissected 5.5-6.25 dpc HexGFP embryos were placed into the 
drops and cultured for 1 hr. Control embryos underwent culture in medium in which 
BrdU had been omitted. Following culture embryos were transferred to a 4-well dish 
and washed three times in PBS for 5 mins and fixed in 4% Paraformaldehyde 
overnight at 4 °C. Typically embryos in a 4-well dish were placed in a volume of 400 
μl solution. This format was maintained throughout all culture protocols.  
 After fixation embryos were washed three times, 5 mins each with 0.1% PBS 
Triton X-100 at RT. Embryos were blocked in 10% heat-inactivated Sheep serum 
(inactivated at 56 °C for 20 mins then aliquoted and stored at -20 °C) in 0.1% PBS 
Triton X-100 for 20 mins at RT with constant rocking. Blocking solution was 
removed and replaced with the first primary antibody solution [Rabbit anti-GFP 
(Molecular Probes, Cat No.A11122) diluted 1:1000 in blocking solution] thus 
amplifying the GFP signal which would otherwise be abolished in the harsh 
conditions later in the protcol. The embryos were incubated for 5 hrs at RT with 
constant rocking. The primary antibody solution was then removed and embryos were 
washed three times for 5 mins in 0.1% Triton X-100, followed by one more wash for 
1 hr at RT. Embryos were incubated in secondary antibody [Alexa Fluor 488 goat 
anti-rabbit IgG (Molecular Probes, Cat No.A11008) diluted 1:500 in blocking 
solution] for 2 hrs at RT with rocking. Embryos were washed three times for 5 mins 
in 0.1% Triton X-100, followed by one more wash for 1 hr at RT.  
 After removing non-bound secondary antibody embryos were post-fixed in 
4% Paraformaldehyde for 10 mins at RT, then washed three times in 0.1% Triton X-
100, 5 mins each. For the BrdU to be detected its antigenic sites must be accessible to 
the antibody. To achieve this DNA must be denatured. Embryos were placed in 2M 
HCl for 30 mins at 37 °C. Following DNA denaturation the HCl was neutralized by 
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washing the embryos three times, 5 mins each at RT in Borate buffer (6.18 g Boric 
acid in 1 L dH2O, pH 8.5) with constant rocking. Embryos were then incubated with 
the second primary antibody solution [rat anti-BrdU (Oxford Biotech, Cat No. 
OBT0030S) diluted 1:100 in blocking solution] overnight at RT with constant 
rocking. The following day embryos were washed three times for 5 mins in 0.1% 
Triton X-100, followed by one more wash for 1 hr at RT. Incubation with the second 
secondary solution followed [Alexa Fluor Cy3 Goat anti-rat IgG (Abcam, Cat 
No.ab6953) diluted 1:500 with blocking solution] for 2 hrs at RT with rocking. 
Embryos were washed three times, 5 min at RT to remove any non-bound secondary 
antibody, followed by one more wash for 1 hr. Embryos were counterstained with To-
pro-3 iodide (Molecular Probes, Cat No. T3605) to visualise DNA, mounted and 
acquired using confocal microscopy.  
 
2.2.5.3. Wholemount GFP and BrdU staining – Injection of BrdU   
Matings between HexGFP homozygous stud males and CD1 female mice were set up. 
At 6.5 dpc, pregnant mice were administered 50 mg/kg BrdU by intraperitoneal (IP) 
injection and sacrificed 1 or 3 hrs later. Control mice were injected with PBS alone. 
Embryos were recovered from the uterus, washed three times, 5 mins each with PBS 
at RT and fixed overnight in 4% Paraformaldehyde. The immunofluorescent detection 
of GFP and BrdU was conducted identically to the relevant part of the protocol as 
previously described. 
 
2.2.5.4. Wholemount GFP and BrdU staining – Embryo culture protocol II 
This protocol has been modified from the Wholemount BrdU staining protocol as 
found on the Rossant web page (www.sickkids.ca/rossant/protocols). BrdU (32.56 
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mM) was diluted to a final concentration of 20 μM in 1:1 DMEM: rat serum and 
pipetted into 80 μl drops in 10 cm culture dishes (VWR, UK). Drops were covered in 
mineral oil and equilibrated at 37 °C, 5% CO2 for 2-3 hrs. Freshly dissected 5.5-6.25 
dpc HexGFP embryos were placed into the drops and cultured for 30 mins. Control 
embryos underwent culture in medium in which BrdU had been omitted. Following 
culture embryos were transferred to a 4-well dish, washed three times in PBS for 5 
mins and fixed in 4% Paraformaldehyde containing 2 mM EGTA for 1.5 hrs at 4 °C. 
Embryos were washed in PBT (PBS containing 0.1% Tween-20) for 1 hr at 4 °C then 
blocked in 10% Normal goat serum (NGS) in 0.1% PBS Triton X-100 at RT for 1.5 
hrs. Embryos were transferred to the first primary antibody solution [Rabbit anti-GFP 
(Molecular Probes, Cat No.A11122) diluted 1:1000 in blocking solution] and 
incubated at 4 °C for a minimum of 2 days. 
 Non-bound primary antibody was removed during three 5 min rinses in 0.1% 
Triton X-100, and followed by one more wash for 1 hr at RT. Incubation with the 
second secondary solution followed [Alexa Fluor 488 Goat anti-rabbit IgG 
(Molecular Probes, Cat No.A11008) diluted to 1:500 with blocking solution] for 2 hrs 
at RT with rocking. Embryos were washed three times, 5 min at RT to remove any 
non-bound secondary antibody, followed by one more wash for 1 hr. Embryos were 
then post-fixed in 4% Paraformaldehyde for 10 mins and transferred to 2M HCl in 
PBS 0.1% Tween-20 for 30 mins at 37 °C to denature the DNA.  The HCl was 
quenched by washing three times for 5 mins in borate buffer at RT. Quenching was 
followed by blocking in MABT (100 mM Maleic acid, pH 7.5, 150 mM NaCl in 0.1% 
Tween-20) containing 10% Sheep serum for a minimum of 1.5 hrs at RT. The 
embryos were then incubated overnight in the second primary antibody solution [Rat 
 61
anti-BrdU (Abcam, Cat no. ab6326) diluted 1:100 in MABT, 1% Sheep serum] at RT 
with constant rocking. 
 The following day embryos were washed three times, 5 mins each in MABT 
containing 10% Sheep serum, then an additional five times, 1 hr each in MABT. 
Embryos were blocked in MABT containing 10% sheep serum for 1.5 hrs at RT. 
Secondary antibody was then added [polyclonal Cy3 Goat anti-rat IgG (Abcam, Cat 
No.ab6953) diluted to 1:500 with the same blocking solution and To-pro-3 iodide 
(Molecular Probes, Cat No. T3605) diluted 1:500] and embryos were incubated at 4 
°C overnight. Finally embryos were washed five times, 1 hr each in MABT to 
removed non-bound secondary antibody, mounted and acquired using confocal 
microscopy. 
 
2.2.6. Embryo culture 
2.2.6.1. Nocodazole, Genistein and Okadaic acid 
The basic protocol for embryo culture is as described when embryos were cultured 
with BrdU. The basic format is stock solutions are made, aliquoted and stored at -20 
°C. The mitotic inhibitors used in this investigation were all diluted in 
Dimethylsulfoxide (DMSO) to a stock concentration as follows: Nocodazole (5 mM), 
Genistein (5 mM) and Okadaic acid (1 μM). Stock solutions were thawed when 
required and diluted to the appropriate concentration in 1:1 DMEM: rat serum. The 
culture medium containing mitotic inhibitor was pipetted into 10 cm culture dishes as 
80 μl drops. Drops were covered in mineral oil and equilibrated at 37 °C, 5% CO2 for 
2-3 hrs. Non-treated controls contained an equivalent volume of DMSO in the embryo 
culture medium.  
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During equilibration of the culture medium, embryos were dissected from the uterus 
and if necessary screened for the HexGFP transgene under a fluorescent lamp with a 
GFP filter. GFP positive embryos were placed in the drop and pictures were taken 
before and after culture (usually 16 hrs, but in the case of nocodazole at multiple time 
points) using a Leica MZ FLIII dissection microscope with a Leica Image Manager 
50 software package. These images were processed in Adobe Photoshop CS2. Post-
culture embryos were washed three times in PBS for 5 mins and fixed in 4% 
Paraformaldehyde overnight at 4 °C. They then underwent antibody staining as 
described. 
 
2.2.6.2. SB-431542 
Freshly dissected 5.5 dpc embryos were cultured for 16 hrs in the chemical inhibitor 
of activin/nodal, SB-431542 at a concentration of 10 μM. 30 mins before completion 
the embryos were transferred to another drop containing both SB-431542 and 20 μM 
BrdU. These embryos were cultured for a further 30 mins at which point they were 
washed three times, 5 mins in PBS and fixed in 4% PFA containing 2 mM EGTA for 
1.5 hrs at 4 °C. These embryos then underwent GFP and BrdU staining as previously 
described. 
 
2.2.7. Confocal acquisition 
Stained embryos were mounted on either a Glass Bottom Microwell dish (MatTek 
Corp, USA, Cat No. P35G-1.5-14-C) or a μ-Slide (Ibidi, Germany, Cat No. 81821) in 
a drop of 1:1 Glycerol:PBS. Confocal images of each embryo were captured on a 
Leica DM IRB upright confocal microscope through either a 10x/0.30 PH1 air 
objective or 40x/1.00 PH3 oil immersion objective. The microscope was equipped 
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with an argon, helium-neon and UV laser. Stacks were generally taken at 4 μm 
intervals through the embryo, with each channel being acquired sequentially. Stacks 
were reconstructed using the downloadable package, ImageJ 1.33u.  
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2.3. Molecular biology 
 
2.3.1. Transcription of riboprobes for wholemount RNA in situ hybridisation 
Table 1 
Gene Enzyme for antisense 
linearisation 
RNA 
polymerase 
(Roche, 
Germany) 
Source of probe 
Brachyury BamHI T7 Wilkinson et al., 1990 
Cerberus SalI SP6 Shawlot et al., 1998 
Cripto BamHI T7 Ding et al., 1998 
Dkk1 SalI T7 Glinka et al., 1998 
Eomesodermin SalI T7 Ciruna and Rossant, 1999 
FGF 8 EcoRI T3 Mahmood et al., 1995 
Frizzled 8 EcoRI T3 Lu et al., 2004 
Hesx1 BamHI T3 Thomas et al., 1995 
Hex EcoRI T3 Bedford et al., 1993 
HNF3? HindIII T7 Ang et al., 1993 
Lefty1/2 XhoI T7 Meno et al., 1997 
Lim1 HindIII T7 Shawlot and Behringer, 1995 
Nodal EcoRI T3 Varlet et al., 1997 
Oct4 HindIII T7 Rosner et al., 1990 
Otx2 EcoRI SP6 Ang et al., 1996 
Sfrp5 EcoRI T3 Leaf et al., 2006 
Six3 XbaI  Oliver et al., 1995 
Snail BamHI SP6 Nieto et al., 1992 
Sox17 EcoRI T3 Kanai et al., 1996 
Tbx6 NotI  Chapman et al., 1996 
TTR XbaI T3 Makover et al., 1998 
Wnt3 XbaI T3 Roelink et al., 1990 
 
Plasmids containing the appropriate cDNAs were first linearised using restriction 
enzymes as listed in Table 1. All enzymes were obtained from New England Biolabs. 
Digests were set up in a 50 μl volume according to their specifications and 1.5 mg 
total plasmid was digested. Complete linearisation was confirmed by agarose gel 
separation after which the DNA was purified by phenol/chloroform/isoamyl alcohol 
(25:24:1) extraction. DNA was precipitated using 1/10 volume of 3 M Sodium acetate 
pH 5.2 and 2 volumes of 100% Ethanol (Fisher Scientific, UK) at -20 °C. Samples 
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were then centrifuged at 16, 000 x g, 4 °C for 15 mins. Precipitated DNA was washed 
in 70% Ethanol, re-suspended in 10 ml dH2O, and if necessary stored at -20 °C until 
transcription of the riboprobe.  
 In vitro transcription of riboprobes was carried out using the appropriate RNA 
polymerase, shown in Table 1. Reactions were as follows: 50 μl total volume 
containing 1 mg plasmid DNA, 100 units of T3, T7 or SP6 polymerase, 1x 
transcription buffer, 25 units RNAse Inhibitor and 5 μl DIG-labelled nucleotide mix 
(all Roche Diagnostics, Germany). Transcription was carried out at 37 °C for 2 hrs 
after which 30 units of RNAse-free DNAse I (Roche, Germany) was added to the 
reaction and incubated at 37 °C for 15 mins to destroy the plasmid template. 3 μl of 
the reaction was fractionated by electrophoresis in a 1% agarose gel containing 
Ethidium bromide and visualised under UV light to assess the yield of the 
transcription reaction. Riboprobes were purified using ChromoSpin columns (BD 
Biosciences, UK) and 3 μl was again fractionated on a 1% agarose gel to assess the 
quality and approximate concentration of the probe to determine its working dilution.  
 
2.3.2. Generation of targeting vector Hex-XneoSTOP
R
X-DTA 
The Hex-XneoSTOP
R
X-DTA targeting construct was generated by inserting a 3 kb 
cassette consisting of an internal ribosome entry site (IRES), followed by a reverse 
PGK-Neomycin gene flanked by loxP sites, and the DTA coding sequence (a gift from 
T. Jessell) into a Hex genomic clone at an ApaI site immediately 3’ to the Hex start 
ATG.  
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2.3.3. Isolation and restriction digestion of genomic DNA from ES cells for 
Southern blot 
DNA was isolated from ES cells and expanded in 96 well format. Cells were grown 
until confluent and growth media turned yellow daily. Growth medium was aspirated 
from the plate and cells were washed twice with PBS. 50 μl lysis buffer (10 mM Tris-
HCl, pH 7.5, 10 mM EDTA, 10 mM NaCl, 0.5% Sarcosyl) containing 1 mg/ml 
Proteinase K (Roche, Germany) was added to each well and the plate incubated 
overnight at 55 °C in a humidified chamber. 
 Next day 100 μl of -20 °C Ethanol/salt solution (75 mM NaCl in 100% 
Ethanol) was added to each well. The plate was incubated at RT for 30 mins and 
subsequently inverted onto paper towels so the liquid drained away. Genomic DNA 
was left attached to the base of each well. DNA was washed three times with 70% 
Ethanol, 150 μl per well. After the final wash the plate was left inverted on paper 
towels for 5 mins to dry the DNA. During this time the restriction digest mix was 
prepared (1x NEB buffer, 1 mM Spermidine, 100 μg/ml BSA, 100 μg/ml RNAse A, 
20 units of enzyme made up to a total of 30 μl with dH2O per well). After loading the 
digest mix the plate was incubated overnight at 37 °C in a humidified chamber. 
EcoRV was used to digest the targeted clones. 
 
2.3.4. Synthesis and purification of DNA probes for Southern blot 
Two DNA probes were used to screen for homologous recombinant clones. The first 
sequence hybridised 5’ external to the site of recombination. This was created by 
cutting the targeting vector with KpnI which liberated a 400 bp fragment. In wildtype 
clones this probe bound to an EcoRV-cut fragment 11.8 kb in length. This could be 
differentiated from the targeted allele by the additional binding of the 5’ probe to a 7 
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kb fragment, brought about by the addition of another EcoRV site situated within the 
Neomycin gene. To confirm single insertion of the targeting vector blots were also 
hybridised with a DTA probe that recognised a single 5 kb EcoRV-cut fragment. The 
probes were labelled with 
32
P-dCTP using the Megaprime? Random labelling kit 
according to the manufacturer’s instructions, and purified using Sephadex G50 
columns (all Amersham Biosciences, UK). Radiolabelling was measured using a 
scintillation counter. 15 million counts per minute (cpm) total activity was used for 
hybridisation to each membrane.  
 
2.3.5. Southern blot analysis of Hexd targeted ES cell clones  
Southern blot analysis was used to identify successfully targeted ES cell clones with a 
single copy of the targeted vector in the Hex locus. Southern blots were conducted 
according to the Amersham Biosciences Hybond membrane product protocol.  
 Digested genomic DNA was separated alongside a 1 kb ladder (Invitrogen, 
UK) on a 0.75% agarose gel run at 50 V for 8-10 hrs. DNA samples were visualised 
under UV against a ruler to allow accurate sizing of bands on the eventual Phosphor-
imager scan. The agarose gel was placed in 0.125 M HCl to depurinate the DNA. The 
gel was gently rocked for 10 mins, after which it was rinsed twice in dH2O. DNA was 
placed in denaturing buffer (0.5 M NaOH, 1.5 M NaCl) for 30 mins, and again gently 
rocked. This was followed by two rinses in dH2O. Finally the gel was placed in 
neutralising buffer (0.5 M Tris, 1.5 M NaCl, pH 7.5) for 30 mins with gentle rocking 
and washed in dH2O.  
 DNA was transferred by capillary blot from the gel to a PVDF membrane 
(Polyscreen, Perkin Elmer) using Transfer buffer (20x SSC containing 3 M NaCl, 0.3 
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M Sodium citrate) to promote binding of DNA to the membrane. DNA was then 
covalently bound to the membrane via UV crosslinking.  
The membrane was placed in a hybridisation bottle to allow rolling incubation in the 
hybridisation oven. The membrane was incubated in RapidHyb buffer (Amersham 
Biosciences, UK) at 65 °C for a minimum of 1 hr to block non-specific binding. The 
membrane was incubated with 
32
P-dCTP-labelled probe in RapidHyb buffer overnight 
at 65 °C allowing the probe to bind to the membrane-bound DNA. After 
hybridisation, the membrane was washed twice at high stringency (2x SSC/0.1% 
SDS) at 65 °C for 10 mins each, and twice at low stringency (0.2x SSC/0.1% SDS) at 
65 °C for 10 mins each. Between washes the radioactive signal on the membrane was 
monitored using a Geiger counter. Washing in low stringency continued until the 
average signal over the membrane was less than 10 cpm.  
 The membrane was then wrapped in Saran Wrap and placed in a Phosphor-
imager detection cassette (Amersham Biosciences, UK) and exposed overnight. 
Cassettes were analysed on a Storm Phosphor-imager (Amersham Biosciences, UK).  
 
2.3.6. Extraction of genomic DNA from murine tail biopsies for Southern blot 
analysis 
Tail biopsies obtained from transgenic mice were digested in tail buffer (50 mM Tris, 
pH 7.6, 100 mM EDTA, 0.5 % SDS, 100 mM NaCl) overnight at 55 °C in the 
presence of 400 μg/ml Proteinase K. DNA was purified by two 
phenol/chloroform/isoamyl alcohol (25:24:1) extractions, followed by a chloroform 
extraction. Genomic DNA was then precipitated by adding 1/10
 
volume of Sodium 
acetate (3 M, pH 5.2) and 1 volume of 100% Isopropanol (Fisher Scientific, UK). 
Precipitated DNA was washed in 70% Ethanol and resuspended in dH2O. DNA 
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concentration was determined spectrophotometrically (Nanodrop?, ND1000), and 10 
μg were digested with EcoRV overnight at 37 °C. These samples were then run on a 
0.75% agarose gel and probed as previously described. 
 
2.3.7. Extraction of genomic DNA from murine tail biopsies for PCR genotyping 
Tail biopsies obtained from transgenic mice were digested in Rossant buffer (50 mM 
KCl, 10 mM Tris-HCl, pH 8.3, 2 mM MgCl2, 0.1 mg/ml gelatin, 0.45% IGEPAL and 
0.45% Tween-20) overnight at 55 °C in the presence of 500 μg/ml Proteinase K. The 
following morning, Proteinase K was inactivated at 95 °C for 10 mins. Samples were 
vortexed, spun down and stored at 4 °C. Typically 3 μl lysate was used for PCR 
genotyping.  
 
2.3.8. Digestion of transgenic embryos for genotyping 
Embryos obtained from transgenic mice were digested in embryo lysis buffer (50 mM 
Tris-HCl, pH 8.5, 1 mM EDTA, 0.5% Tween-20) overnight at 55 °C in the presence 
of 6 μg/ml Proteinase K. Proteinase K was inactivated by incubation of lysates at 95 
°C for 10 mins. Samples were vortexed, spun down and stored at 4 °C. Depending on 
the size of the embryo different volumes of embryo buffer were used. Typically 5.5 
dpc embryos were digested in 20 μl, 6.5 dpc embryos 30 μl, 7.5 dpc embryos 50 μl, 
8.5 dpc embryos 70 μl and tail tips of 9.5 dpc embryos were digested in 90 μl. 
Depending on the specific PCR or embryo stage, between 3 and 7 μl of lysate were 
used per 50 μl PCR reaction.  
 
2.3.9. Genotyping of transgenic mouse lines by PCR 
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Hexd32 transgenic mice were crossed to ?-actin Cre mice to produce offspring of 
which one quarter harboured both transgenes. To identify Hexd
act
 mice three sets of 
primers were used. A single 5’ and 3’ oligo were used to amplify part of the DTA 
coding region and are thus referred to as 5’ DTA and 3’ DTA. Presence of ?-actin Cre 
was confirmed by using a single 5’ and 3’ oligo that amplified a portion of the Cre 
recombinase coding region. To verify that the Neomycin cassette had been excised in 
embryos harbouring DTA and Cre recombinase a third pair of 5’ and 3’ oligos were 
used to amplify part of the Neomycin coding region (Table 2).  
 In subsequent crosses, surviving Hexd
act
 mice were intercrossed to produce 
offspring of which one quarter harboured two copies of the activated DTA allele. To 
distinguish the heterozygous (Hexd
act
/+) from homozygous (Hexd
act
/Hexd
act
) allele an 
additional PCR strategy was designed which amplified a portion of Exon 1 of the 
endogenous Hex locus. Exon 1 is the site of targeting and is therefore disrupted by the 
exogenous targeting vector sequence. 5’ and 3’ oligos were designed to amplify up a 
portion of  Exon 1, referred to as 5’ Exon 1 and 3’ Exon 1. The homozygous allele 
would fail to amplify this sequence whilst the heterozygous allele would produce a 
product.  
 HexGFP mice were genotyped using 5’/3’ GFP oligos, and nodal.LacZ and 
R26R were genotyped using 5’/3’ LacZ oligos as summerised in Table 2 
Name 5’ Primer 3’ Primer 
DTA CGACAATAAATACGACGCTGCGGG CATCGCATCTTGGCCACGTTTTCC 
Cre CCAGCTAAACATGCTTCATC CGCTCGACCAGTTTAGTTAC 
Neo CAAGATGGATTGCACGCAGG CGGCAGGAGCAAGGTGAGAT 
Exon 
1 
CGGAGGCGAATCTGAAGCCAG GCATACAGCGGGACTCCCACG 
GFP TGCAGTGCTTCAGCCGCTAC CCAGCAGGACCATGTGATCG 
LacZ CGCCAGCTGGCGTAATAGCGAAG GATGGGCGCATCGTAACCGTGCA 
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2.3.9.1. The standard PCR reaction 
Each PCR reaction was made up in 50 μl total volume containing 3-7 μl DNA lysate, 
1 unit of Amplitaq, 125 ng of each primer (Sigma, UK), 5 μl 10x buffer and 0.2 mM 
of each dNTP (All Roche Diagnostics, Germany) made up in dH2O. PCR was 
performed on a Peltier thermal cycler (PTC-100?) using the following program: 
Initial denaturation step at 95°C for 5 mins, then 39 amplification cycles of 30 secs at 
94 °C, 30 secs annealing (60 °C for Cre and GFP, 59 °C for Neo, 56 °C DTA and 58 
°C for LacZ), 45 secs at 72 °C, followed by a final elongation step of 7 mins at 72 °C. 
The resulting PCR products were size-fractionated by electrophoresis in 1% agarose 
gels containing Ethidium bromide and visualised under UV light. 
 
2.3.9.2. Exon 1 PCR reaction 
The Exon 1 PCR was made up in 50 μl total volume containing 3 μl DNA lysate, 
0.625 μl of Taq DNA polymerase, 5 μl 10x buffer and 10 μl Q solution (Qiagen, UK), 
125 ng of each primer (Sigma, UK), and 0.2 mM of each dNTP (Roche Diagnostics, 
Germany) made up in dH2O. The following PCR program was used: Initial 
denaturation step at 94 °C for 2 mins, then 30 amplification cycles of 20 secs at 94 
°C, 20 secs annealing at 58 °C, 20 secs at 72 °C followed by a final elongation step of 
7 mins at 72 °C. The resulting PCR products were size-fractionated by electrophoresis 
in 1% agarose gels containing Ethidium bromide and visualised under UV light. 
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2.4. Tissue Culture 
 
2.4.1. General passaging techniques 
All ES cells used in this investigation were cultured in feeder-free conditions on 
gelatinised plasticware. Growth media was Glasgow Minimum Essential Medium 
(GMEM) supplemented with 80 nM ?-mercaptoethanol, 100 nM non-essential amino 
acids, 2 mM L-glutamine, 1 mM Sodium pyruvate (all Gibco), plus 10% characterised 
fetal calf serum (FCS; Chemicon-Millipore, UK) and 9 x 10
5
 units of ESGRO? 
Leukocyte Inhibitory Factor (LIF; Chemicon-Millipore, UK). ES cells were frozen in 
media containing 90% FCS, 10% tissue culture grade DMSO.  
 
2.4.2. Generation of targeted clones 
2.4.2.1. Preparation of DNA  
50 μg of Hexd targeting vector was linearised by NotI restriction digest in a 50 μl 
volume. Complete linearization was assessed by visualisation of DNA in a 1% 
agarose gel containing Ethidium bromide under UV light. The Linearised vector was 
purified by phenol/chloroform/isoamyl alcohol (25:24:1) extraction. DNA was 
precipitated using 1/10 volume of 3 M Sodium acetate, pH 5.2 and 2 volumes of 
100% Ethanol at -20 °C. DNA was centrifuged at 16,000 x g, 4 °C for 15 mins. 
Precipitated DNA was washed in 70% Ethanol, resuspended in dH2O to a final 
concentration of 2 μg/μl.  
 
2.4.2.2. Electroporation and processing of targeted clones 
Low passage number (<10 times) ES cells were plated into a 75 cm
2
 tissue culture 
flask (VWR, UK) and grown until confluent. Cells were trypsinised, collected, 
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resuspended in PBS and counted using a haemocytometer. Approximately 3 x 10
7
 
cells were used for electroporation in 1 ml PBS. 
 30 μg of linearised DNA was added to the 1 ml cells and transferred to a 0.4 
cm electroporation cuvette (BioRad). Cells were electroporated using a BioRad 
Genepulser electroporation unit. Cells were exposed to two pulses: the first was at 
0.23 Kv, and the second at 0.24 Kv with resistance set to 960 μF. Following the 
second pulse the cuvette was tapped on the bench and placed on ice for 10 mins. After 
this cells were plated on gelatinised 10 cm culture plates (VWR, UK) in their normal 
growth medium, GMEM.  
 After 24 hrs, selection media was added to the plates. For selection of positive 
clones cells were cultured in G418 (Sigma, UK) at a final concentration of 2 μg/ml. 
After 10 days selection colonies were well established on the plates. 96 colonies were 
picked into gelatinised, flat bottom 96 well plates and cultured. Once confluent, the 
clones were split into two duplicate 48 well plates. Approximately one fifth of cells 
were left in the 96 well plate and cultured until confluent to be used for DNA 
extraction and Southern blot analysis. The 48 well plates were also grown to 
confluency and then frozen down and stored at -80 °C for up to one month. A number 
of clones were indicated as containing correct Hex insertions in the initial Southern 
blot analysis. These were thawed and expanded and underwent further analysis by 
Southern blot to confirm the position of the insertion site and the presence of a single 
targeting event. Two correctly targeted clones were determined. These were thawed, 
expanded and used for injection into blastocysts to derive the Hexd mouse line.  
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2.4.2.3. Karyotyping ES cells 
ES cells were plated into a 25 cm
2
 tissue culture flask (VWR, UK) and grown until 
50-75% confluent on the day of karyotyping. Medium was changed first thing in the 
morning and 2 hrs later Demecoline (Sigma, D6279) was added directly to the 
medium to a final concentration of 20 ng/ml. After 1 hr, cells were gently washed 
with PBS then thoroughly trypsinized and spun down (750 rpm, 5 mins). The pellet 
was washed once in PBS and respun. The pellet was resuspended in 5 ml hypotonic 
solution (0.56% w/v KCl) until a single cell suspension was obtained. Cells were kept 
in hypotonic solution at RT for exactly 6 mins, then spun at 750 rpm for 5 mins. The 
supernatent was removed, leaving a drop to resuspend the pellet in. Flicking the tube, 
5 ml of ice-cold fixative (Methanol: Acetic acid, 3:1 made up fresh) was added 
dropwise. After 5 mins at RT, cells were spun down, and the fixing procedure was 
repeated a further 3 times. Each time the cells were spun down, a loose and flocculent 
pellet formed. To avoid losing the pellet 0.5-1.0 ml fixative was always left behind. 
After the last fixation step, cells were resuspended in a final volume of 1 ml fixative.  
 To observe mitotic spreads, cells were dropped using a Pasteur pipette from a 
height of around 40 cm onto acid-washed slides (slides were placed overnight into 5% 
acetic acid in ethanol). When slides have dryed thoroughly, they were stained in 10% 
Giemsa’s (BDH Lab Supplies, Cat No. 35086 4X) in PBS for 20 mins. Slides were 
then washed gently in tap water twice, with a final wash in dH2O. Slides were left to 
dry overnight and coverslips were mounted using DPX medium (BDH Lab Supplies, 
Cat No. 36029 4H). Slides were observed on a normal dissection microscope. Murine 
nuclei possess a full complement of 40 chromosomes. A 10% tolerance was allowable 
if ES cells were to be blastocyst injected. 
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2.4.2.4. Transient transfection of targeted ES cells with pTurboCre 
To test the efficiency of DTA ablation in vitro, one of the targeted cell lines was 
transiently transfected with the Cre expression plasmid pTurboCre (Gibco).  Cells 
were split onto a gelatinised 6 well plate (Nunc?) the day before transfection so they 
would be approximately 90% confluent on the day of transfection. Cells were grown 
overnight in GMEM (as previously described). Prior to transfection cells were washed 
with PBS and transfected according to the Lipofectamine 2000 reagent protocol 
(Invitrogen, UK). For each well 4.0 μg of pTurboCre or the positive control plasmid 
pTriExGFP was mixed with 250 μl OptiMEM. At the same time 10 μl Lipofectamine 
2000 was mixed with 250 μl OptiMEM per well. These two mixes were combined 
and left at RT for 30 mins. Cells were washed once in OptiMEM, aspirated and 500 
μl of the incubated mix was added to each well and incubated at 37 °C, 5% CO2 for 5 
hrs. All conditions were carried out in duplicate wells.  
 After incubation the transfection mix was aspirated and replaced with GMEM 
ES cell media. Given that Hex is only expressed in differentiating ES cells (T. 
Rodriguez, personal communication) media was changed daily using complete 
GMEM without LIF to allow differentiation of the ES cells. Pictures were taken daily 
for the duration of the three day experiment. 
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Chapter 3 – Proliferation at the time of DVE movements 
3.1. Introduction 
Cell proliferation has been shown to have multiple functions in developmental 
processes. Examples are diverse and include refining tissue shape during 
organogenesis, cell fate determination and regulating pattern formation (Schmahl and 
Capel., 2003; Baena-Lopez et al., 2005). In rodents, proliferation in the post-
implantation embryo has been investigated. Many of the early studies calculated cell 
cycle length in tissues of the pre-gastrulae embryo providing a descriptive map of 
proliferation (Snow, 1977; Poelmann, 1980; Lawson et al., 1991). For example, 
Snow estimated the mean cell cycle length in the pregastrulating endoderm to be 
approximately 17 hrs, whilst cells of the epiblast could range from 9.5 hrs to as little 
as 3 hrs in a region termed the proliferative zone (Snow, 1977). Lawson’s study 
calculated the cell cycle length of the endoderm to be 10.5 hrs, and the epiblast a 
mean length of 7.5 hrs, whilst evidence for a proliferative zone was not found 
(Lawson et al., 1991). There appears to be an apparent degree of discordance when 
comparing studies, although there is agreement that tremendous variation in 
proliferative rates between and within tissues exists.  
A more recent study used a stathmokinetic approach in rat embryos to 
calculate the cell cycle structure of epiblast cell populations (Mac Auley et al., 1993). 
They found, like Snow did, that epiblast cells of the primitive streak (PS) divided 
unusually rapidly compared to surrounding epiblast cells (Snow, 1977; Snow and 
Bennett, 1978). Furthermore this increase in growth rate during gastrulation was 
shown to be associated with extensive modification of the cell cycle.  
Lewis and Rossant investigated size regulation in normal and double-sized 
pre-gastrulae mouse embryos and demonstrated that normal embryos were able to 
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alter their size by shortening cell cycle length such that gastrulation commenced at 
the same time, despite the initial discrepancy in total cell number (Lewis and 
Rossant, 1982). Taken together it is apparent that the post-implantation embryo 
possesses a tremendous capacity to regulate cell cycle composition in certain tissues. 
However to what extent this occurs, the mechanisms involved in achieving this 
regulation and the processes that are affected are poorly understood.  
 
3.1.1. Proliferation and DVE movement 
 
The unilateral movement of the DVE from the distal tip of the embryo to the future 
anterior side is essential in correctly establishing the A-P axis. However, the 
mechanisms involved in initiating, driving and halting this process are not well 
understood. In 2004, Yamamoto and colleagues proposed that differential 
proliferation in the VE along the future A-P axis regulated DVE direction and 
constituted the engine for its movement (Yamamoto et al., 2004). They demonstrated 
that around the time of DVE movements, anterior VE cells were unable to 
incorporate BrdU, whilst the rest of the VE did.  
Nodal signalling was proposed to drive distal DVE movement by stimulating 
the proliferation of VE cells, whilst the Nodal antagonists Lefty1 and Cerl determined 
the direction of migration by asymmetrically inhibiting Nodal activity on the future 
anterior side of the epiblast and thus creating differential proliferation between the 
anterior and posterior of the embryo (Yamamoto et al., 2004). This was demonstrated 
by injecting embryos with a Nodal expression vector and observing an increase in cell 
proliferation. Conversely co-injection of the Nodal antagonists Lefty1 and Cerl 
resulted in the inhibition of proliferation. Moreover the DVE tended to move away 
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from the side where proliferation was stimulated and towards the side where 
proliferation had been inhibited (Yamamoto et al., 2004).  
 
In the same year, another study indicated that an active cell migration process drove 
DVE cells towards the prospective anterior of the embryo (Srinivas et al., 2004). In 
this study, embryos at the time of DVE movement were imaged in real time at single 
cell resolution. DVE cells were shown to migrate as a single layer in direct contact 
with the epiblast, projecting filopodial processes in the direction of motion. These 
migrating cells took 4-5 hours to reach the boundary between the epiblast and the 
extra-embryonic ectoderm, whereupon they halted. This paper provided good 
evidence for active migration driving AVE movement. 
 Shortly after, a report implicated canonical Wnt signalling in controlling 
directional movement of VE cells (Kimura-Yoshida et al., 2005). In vivo and in vitro 
experiments demonstrated that the Wnt antagonist dickkopf1 (Dkk1) could act as an 
attractive guidance cue for DVE cells. Furthermore, Dkk1-positive cells are located at 
the forefront of migrating VE cells and were shown to attract Cerl-positive DVE 
cells; providing a possible cue that could guide migrating AVE cells. 
 
Therefore despite the differential proliferation mechanism being an attractive model, 
how it accounts for the following findings has remained unresolved: (a) DVE cells 
move in as little as 4-5 hours in a proposed active migration process, possibly in 
response to a molecular cue (Srinivas et al., 2004; Kimura-Yoshida et al., 2005 ); (b) 
the average cell cycle length in the VE at the time of DVE movement is estimated to 
be 17 hours (Snow, 1977); (c) detailed analysis of clonal populations in the VE at this 
stage failed to outline major differences in proliferation rates between the 4 sub-
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regions of the distal VE (Perea-Gomez, 2001a); (d) the patch of BrdU-negative cells 
on the anterior side expands considerably despite being non-proliferating.  
Is it possible to reconcile these points in the context of a differential 
proliferation model?  
 
This Chapter aims to resolve these contradictions by providing a detailed 
characterisation of proliferation levels and distribution within the embryo at the time 
DVE movements are initiated. Proliferation will be assessed by BrdU incorporation 
(S phase) and by anti-phospho-Histone-H3 staining (M phase) in combination with 
high resolution imaging and culturing techniques. HexGFP transgenic mice will be 
used which express GFP in the Hex-expressing cells of the DVE (Rodriguez et al., 
2001). Thus proliferation within the VE can be mapped with respect to the exact 
position of the DVE. Using this approach it will be possible to confirm the presence 
of differential proliferation within the VE, and if so, accurately relate these patterns of 
proliferation to DVE movements. 
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3.2. Results 
 
3.2.1. BrdU incorporation shows no regional bias in the VE at the onset of DVE 
movements 
BrdU incorporation was the first method used to measure proliferation in the VE 
during DVE movements. HexGFP embryos that express GFP in the DVE, were 
cultured in 20 μM BrdU for 15 mins, and analysed by confocal microscopy allowing 
cellular resolution and accurate visualisation of DVE position in relation to 
proliferating cells of the VE.  
A total of 16 HexGFP embryos were acquired and divided into three groups 
depending upon the position of the DVE. The first was named the pre-distal group 
and displayed low level GFP expression throughout the VE (Fig. 1A+A’). Group two 
constituted those embryos in which the DVE had resolved to the distal tip, referred to 
as the distal group (Fig. 1D+D’). The final group showed a definite tilt of the DVE 
and was therefore referred to as the tilted group (Fig. 1H+H’).  
Several longitudinal sections were acquired at different levels for each 
embryo. The number of BrdU-positive nuclei were counted and expressed as a 
percentage of the total cell number, referred to as the incorporation index. In the pre-
distal group, due to the diffuse expression of GFP throughout the VE this tissue was 
not regionally sub-divided (Fig. 1B). The mean incorporation index of the VE in this 
group was 76% (n=5, SEM ± 2.66%)(Fig. 1C), with non-incorporated nuclei not 
appearing to cluster in any particular region of the VE.  
Although an A-P axis could not be assigned to the distal group, embryos were 
divided into DVE and VE domains (Fig. 1E).  
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Figure 1 - BrdU incorporation at the onset of the DVE movement 
Freshly dissected HexGFP embryos were cultured in 20 μM BrdU for 15 mins and 
immunofluorescently stained for BrdU and GFP. Longitudinal sections were acquired 
on the confocal microscope at multiple levels. Embryos were divided into three 
groups depending on their developmental stage. (A+A’) The pre-distal group 
exhibited GFP (green) at low levels throughout the entire VE. Nuclei (blue) and 
BrdU-positive nuclei (red) are easily distinguishable. (B) The number of BrdU-
positive nuclei in the embryonic VE was counted and expressed as a percentage of the 
total cell number, referred to as the incorporation index. (C) Mean incorporation 
index in pre-distal embryonic VE (n=5). (D+D’) The distal group exhibits strong GFP 
staining at the distal tip. (E) Embryonic VE was divided into two portions: DVE and 
flanking VE. The incorporation index for both regions were calculated. (F) Mean 
incorporation index in the distal group (n=6). (G) Relative fold difference of BrdU 
incorporation between the flanking VE regions. The red line indicates no relative 
difference between the two areas. Any deviation from the red line indicates a relative 
difference in proliferation. (H+H’) The tilted group exhibits strong GFP staining in a 
tilted DVE. (I) Embryonic VE was divided into three portions: Anterior VE, DVE and 
posterior VE. (J) Mean incorporation index in tilted embryonic VE group (n=5). Error 
bar = ± SEM. (K) Relative fold difference of BrdU incorporation between anterior VE 
and posterior VE were calculated for each embryo (anterior VE /posterior VE). The 
red line indicates no relative difference between the two areas. A positive deviation 
from the red line indicates relatively more proliferation in the anterior VE compared 
to the posterior VE. A negative deviation would imply the converse was true. Scale 
bar 40 μm.  
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The mean incorporation index of these areas was quantified: DVE, 76.85% (n=6, 
SEM ± 6.33%) and VE, 76.07% (n=6, SEM ± 8.45%)(Fig. 1F). The two VE areas 
flanking the DVE for each embryo were then plotted as a ratio of each other to give 
an indication of differential proliferation within individual embryos. If each side 
divided at an equal rate then a value of 1 would be obtained. Any relative difference 
in proliferation would result in a deviation from this number, proportional to the 
degree of difference.  
4/6 embryos showed a relative fold difference of no greater than 1.17 
indicating the two regions of VE possessed similar levels of proliferating cells (Fig. 
1G). Two embryos did exhibit more pronounced differential proliferation with values 
of 1.78 and 0.66 (Fig. 1G). However whether differential proliferation was greatest in 
the prospective anterior or posterior VE could not be determined in this experiment. 
 
The tilted group could be assigned an A-P axis and the VE was divided up according 
to the position relative to the DVE (Fig. 1I). The mean incorporation index of these 
areas was quantified: VE anterior to the DVE, 73.83% (n=5, SEM ± 4.84%), DVE, 
75.05% (n=5, SEM ± 7.93%) and posterior VE, 78.74% (n=5, SEM ±7.18%) (Fig. 
1J). There was a slight increase in proliferation from anterior to posterior VE with 
DVE having an incorporation index intermediate of the two, though this difference 
was not statistically significant (?2 P=0.587). As in the distal group, each embryo had 
the ratio of its anterior versus posterior VE proliferation index plotted (Fig. 1K). This 
time a value exceeding 1 would indicate more proliferation in the anterior compared 
to the posterior VE, whilst a value less than 1 would indicate the converse was true. 
Of the five embryos in the group, two displayed values exceeding 1 (1.24 and 1.40). 
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The remaining embryos had values of 0.75, 0.88 and 0.67 indicating a marginal 
increase in posterior VE proliferation compared to anterior VE.  
This BrdU-incorporation experiment showed firstly that following a 15 min 
pulse, between 70-80% of VE cells were in S phase at the time DVE movements are 
being initiated. Furthermore unlike the Yamamoto et al (2004) study, at no point 
during this process was there evidence of any consistent or marked differential 
proliferation between the anterior and posterior VE.  
 
3.2.2. Low levels of mitosis in the VE at the onset of DVE movements 
In order to confirm the BrdU findings it was necessary to assess levels and 
distribution of proliferation using a different cell cycle marker. For this purpose an 
antibody raised against phospho-Histone-H3 (PH3) was used. This antibody 
specifically binds to nuclei in M phase of the cell cycle, providing another means to 
investigate the proliferative capacity of the embryo at the time of DVE movement. 
Again HexGFP embryos were used to allow visualisation of the DVE. 
 Embryos were harvested at 5.5 dpc and stained with anti-PH3 antibody. 
Confocal stacks were taken through the whole embryo, allowing the entire embryo to 
be reconstructed and complete quantification to be performed. Initially, 53 embryos 
were acquired and numbers of mitotic nuclei were pooled irrespective of their exact 
stage. This provided a general indicator of the proliferative capacity of each tissue 
compartment during DVE movement (Fig. 2A). The ectoplacental cone was excluded 
from the study as different amounts of tissue were lost during dissection. It is clear, at 
least when comparing absolute numbers of mitotic nuclei within each tissue, that there 
were large variations in the numbers of dividing cells in each tissue compartment 
(Fig. 2B).  
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Figure 2 – Embryonic distribution of mitotic nuclei at the onset of the DVE 
movement 
Freshly dissected HexGFP embryos were immunofluorescently stained with the M 
phase marker anti-phospho-Histone-H3. Complete stacks of 53 embryos were taken at 
4 μm intervals by confocal microscopy. The number of mitotic nuclei were counted 
allowing the mean number of divisions in each tissue per embryo to be calculated. (A) 
Confocal section of a stained embryo divided into its tissue compartments: visceral 
endoderm (VE), epiblast, extra-embryonic ectoderm (ExE) and ectoplacental cone 
(EPC). Mitotic nuclei (red), all nuclei (blue), DVE domain expressing GFP (green). 
(B) A mitotic map of the embryo at the time of DVE movement. Colour key 
represents mean number of divisions found in tissue compartment per embryo. EPC 
was excluded as tissue was lost during dissection. (C) Embryos were divided into 
three groups by virtue of GFP expression. The pre-distal group displayed weak GFP 
expression throughout the VE. Strong GFP expression at the distal tip defined the 
distal group whilst embryos with a tilt in the GFP domain defined the tilted group. It 
was possible to assign an A-P axis to embryos in the tilted group. (D) Mean number 
of mitotic nuclei in the VE, epiblast and ExE per embryo, plotted for the three groups.  
Embryos in each group: pre-distal (n=11), distal (n=22), tilted (n=20). (E) Five 
embryos from each group were randomly picked and the mitotic index was calculated  
in the epiblast and VE. The mitotic index (MI) was defined as the percentage of 
mitotic nuclei. 4-6 confocal sections were quantified per embryo and mean values 
have been presented. Error bar = ± SEM. 
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The epiblast displayed the greatest number of mitotic nuclei, with a mean of 6.77 per 
embryo (n=53, SEM ± 0.51). Next was the extra-embryonic ectoderm (ExE) with a 
mean value of 3.45 divisions per embryo (n=53, SEM ±0.35), followed by the VE 
with a mean value of 1.92 divisions per embryo (n=53, SEM ± 0.19) (Fig. 2B).  
 
To address whether this relatively low level of division was maintained in the VE 
throughout DVE movement, pooled embryos were divided into three groups by virtue 
of their morphology and location of GFP-expression (Fig. 2C). The total number of 
divisions between the three groups remained remarkably similar (Fig. 2D), as 
observed in the previous BrdU-labelling experiment. The mean number of divisions 
in the VE of the pre-distal group was 3.27 (n=11, SEM ± 0.86), slightly greater than 
levels found in the distal group, 1.45 (n=22, SEM ± 0.39) or tilted group, 1.7 (n=20, 
SEM ± 0.45). Levels of mitosis were slightly lower in the epiblast of the pre-distal 
group (5.27 divisions per epiblast, SEM ± 2.61), compared to the distal group (7.0 
divisions per epiblast, SEM ± 4.14) or tilted group (7.35 divisions per epiblast, SEM 
± 3.67) (Fig. 2D).  
Instead of comparing absolute numbers of dividing cells, a more accurate way 
was to calculate the mitotic index (MI). The MI was calculated as the percentage of 
dividing nuclei and provided an estimate of the proportion of cells in M phase of the 
cell cycle at a given time. Five embryos from each stage of DVE movement were 
selected and the MI was calculated in the epiblast and VE (Fig. 2E). The epiblast 
displayed little variation in its MI between stages with almost identical mean values 
(pre-distal group, 9.07%; distal group, 9.14%; tilted group, 9.0%). As seen when 
looking at absolute numbers, the VE in the pre-distal group displayed a greater MI 
compared to either the distal or tilted groups (3.65% versus 1.56% and 1.11% 
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respectively) indicating a decrease in proliferation within the VE just prior to the 
initiation of the DVE movements. Furthermore the VE irrespective of stage clearly 
proliferates relatively slowly compared to the underlying epiblast. 
 
3.2.3. Distribution of mitotic nuclei within the VE during DVE movement 
Despite the low proportion of mitotic cells in the VE at the time when DVE 
movements are initiated, it was important to assess their regional distribution within 
the tissue in relation to DVE position. It was possible that, although the proliferative 
capacity of the VE was low, mitotic nuclei were regionalised such that differential 
accretion could produce mechanical forces within the plane of the VE.  
 The VE of six distal embryos were divided into three regions; DVE, 
Embryonic VE (Emb VE) and Extra-embryonic VE (ExE VE) (Fig. 3A). Dividing 
nuclei were then counted with respect to which region they resided, and the mitotic 
index was calculated. The mean mitotic index of the DVE was 2.34% (SEM ± 
1.71%), which represented a significantly greater value than that of the Emb VE at 
1.33% (SEM ± 0.99%) and ExE VE at 1.63% (SEM ± 0.89%) (?2 P=0.039). This 
indicates that just prior to the DVE movements, greater levels of cell division occur in 
the DVE compared to the rest of the VE, although effectively this equates to a relative 
increase in levels of mitosis of approximately 1% (Fig. 3A).  
 
In the tilted group it was possible to assign an A-P axis, allowing us to readily test the 
presence of differential division. Five embryos from the tilted group were randomly 
chosen and the mitotic index for each quadrant was calculated. The anterior quadrant 
possessed a mean MI of 1.44% (SEM ± 0.62%), similar to the 1.43% (SEM ± 0.66%) 
calculated in the posterior quadrant (Fig. 3B).  
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Figure 3 – Distribution of mitotic nuclei within the VE at the onset of DVE 
movement 
(A) The VE of six distal embryos were divided into three regions; DVE, Embryonic 
VE (Emb VE) and extra-embryonic VE (ExE VE). The mitotic index of each region 
was counted and represented as a percentage of the total number. Values equal actual 
mean mitotic index. (B) Five embryos from the tilted group were randomly selected. 
This time the VE was divided into anterior, posterior, lateral left and lateral right 
quadrants. The mitotic index of each quadrant was counted and represented as a 
percentage of the total number. Values equal actual mean mitotic index.  (C+C’) A 
3D reconstruction of one of the two embryos that displayed a proliferative burst, 
defined as a region of the VE with 4 or more mitotic nuclei relative to the other VE 
quadrants. Mitotic nuclei (red), all nuclei (blue), DVE expressing GFP (green).  
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The lateral left quadrant possessed an MI of 0.56% (SEM ± 0.55%), whilst the lateral 
right quadrant possessed an MI of 1.01% (SEM ± 0.65%). The distribution of cell 
division within the VE did deviate from the expected 25% in each quadrant assuming 
a random distribution (?2 P=0.02). This experiment indicates that although the 
greatest proportion of dividing cells fall along the anterior-posterior axis, there is no 
difference in the relative MI between the anterior and posterior regions of the VE. 
This supports the previous BrdU experiment. 
 
3.2.4. No evidence of a proliferative burst during DVE movement 
A proliferative burst, defined here as a region of VE with more than 4 mitotic nuclei 
relative to the other quadrants, was observed in 2/53 of the embryos in this study (Fig. 
3B+B’). It was important to test if these embryos represented a random distribution of 
mitotic nuclei or were examples of synchronisation within the VE that were being 
missed in the majority of the embryos. To differentiate these two possibilities 
embryos were cultured in the mitotic inhibitor nocodazole at the time of DVE 
movements. Nocodazole disrupts microtubule formation, preventing sister chromatids 
from separating during mitosis. It was therefore possible to culture embryos in 
nocodazole to allow mitotic nuclei to accumulate. Any patterns of division such as a 
proliferative burst would be readily observable (Fig. 4A).  
 HexGFP embryos were cultured for 4 hrs in 200 nM nocodazole (Fig. 4B) and 
stained with an antibody against phospho-Histone-H3 (Fig. 4C). Treated embryos 
showed a mean number of total dividing cells of 69.29 ± 18.48 compared to 22.44 ± 
7.98 divisions in control embryos-in excess of a 3-fold difference (Fig. 4D).  
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Figure 4 – Testing for the presence of a proliferative burst in the VE at the onset 
of DVE movement 
(A) Schematic representation of the approach taken (B) A freshly dissected HexGFP 
embryo used for culture. (C) Cultured embryos were immunofluorescently stained 
with anti-PH3 and stacks taken at 5 μm intervals were acquired on the confocal 
microscope. Mitotic nuclei (red), all nuclei (blue), DVE expressing GFP (green). (D) 
Accumulated mitotic nuclei in the total embryo and VE were quantified in control 
(n=16) and treated (n=14) groups. Values indicate mean cell division ± SD. (E) 
Distribution of mitotic nuclei within the VE was determined. The VE was divided 
into anterior, posterior, lateral left and lateral right quadrants and the mitotic index of 
each quadrant was calculated. This has been represented diagrammatically showing 
the relative mitotic index values as a percentage. Actual mitotic index values can be 
found in the Results section.  
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Within the VE, treated embryos showed a mean number of dividing cells of 10.79 ± 
3.29 compared to 3.13 ± 2.70 divisions in control embryos, again displaying a similar 
fold increase in dividing cells (Fig. 4D).  
Dividing nuclei were positioned in relation to the quadrant with which they resided 
and a mitotic index was calculated. The anterior quadrant in the treated group 
possessed an MI of 9.89% (SEM ± 3.08%) whilst the posterior quadrant had an MI of 
7.01% (SEM ± 2.86%). The lateral right quadrant had an MI of 12.36% (SEM ± 
1.54%) and the lateral left quadrant had an MI of 4.89% (SEM ± 2.16%) (Fig. 4E). 
These values represented a statistically significant deviation from the expected 25% 
per quadrant assuming a random distribution (?2 P=0.0119), although not in the A-P 
orientation (?2 P=0.2579). This indicates that reduced proliferation in the anterior VE 
relative to the posterior VE does not exist.  
This experiment demonstrates that there is not a proliferative burst in the VE 
at the onset of DVE movement, though there exists a tendency for dividing cells to 
fall into the lateral right quadrant. The biological significance of this observation is 
not understood but possible implications will be discussed. 
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3.3. Discussion 
 
This Chapter aimed to assess the levels of proliferation within the embryo at the time 
of DVE movements. More specifically, proliferation within the VE was analysed to 
test if differential proliferation along the future A-P axis exists, as had previously 
been reported (Yamamoto et al., 2004). These experiments demonstrate that at the 
time of the DVE movements, low levels of cell division are present within the VE. 
Furthermore, no evidence of differential proliferation between the anterior and 
posterior quadrants of the VE were observed which argues against a differential 
proliferation model being responsible for directing DVE movements.  
 
Proliferation levels in this study were assessed in two ways: BrdU incorporation and 
phospho-Histone-H3 (PH3) staining. The former is incorporated in the S phase of the 
cell cycle and therefore gives an indication of cycling cells, whilst the latter allows the 
direct observation of actively dividing cells in M phase. This distinction is important 
in light of the Srinivas et al (2004) study that used time lapse imaging of DVE 
movement to show anterior movement of the DVE to occur within a 4-5 hr period 
(Srinivas et al. 2004). Despite 70-80% of the VE cycling at the time of DVE 
movements as demonstrated by BrdU incorporation, only mitotic cells dividing in this 
time frame could feasibly contribute to a passive displacement by providing a 
mechanical force within the VE. 
 
The VE was the least mitotically active tissue in the embryo at the time of DVE 
movements. In fact the proportion of mitotic nuclei actually decreased as the DVE 
was induced, and this low level was then maintained when the DVE movements 
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began. Considering the low mitotic index of the VE described here, as well as the 
long estimated cell cycle length of the VE in the literature (Snow, 1977; Lawson et 
al., 1991), cell division would have to be regionalised to contribute to the movement 
of the DVE.  
 
BrdU-incorporation analysis suggested that the distribution of cycling cells in the VE 
did not show a marked or consistent regional difference between the anterior and 
posterior regions during the DVE movement. Analysis of the distribution of mitotic 
cells confirmed this finding; whilst a slightly greater proportion of dividing cells were 
distributed along the A-P axis, both sides displayed an almost identical mitotic index. 
To test if this static analysis had missed a transient proliferative burst, dividing cells 
were accumulated by treating embryos with a short pulse of nocodazole. This analysis 
demonstrated that not only did anterior and posterior VE possess a similar mitotic 
index, but that both populations cycled at similar rates. Taken together these results 
suggest that at the time of DVE movements, differential proliferation between the 
anterior and posterior VE does not exist.  
In the literature a lack of regional bias within the VE can also be inferred by 
looking at clone doubling time in the endoderm at the time of DVE movements. 
When single cells from different regions of the VE were labelled and embryos 
cultured for 18-28.5 hrs, no significant difference in the number of clonal descendants 
between the injected regions could be found, further suggesting that no regional bias 
of proliferation within the VE exists at this stage (Perea-Gomez et al. 2001a). 
 
These findings seemingly contradict with Yamamoto et al’s proposal that 
proliferation levels are greater in the posterior VE relative to the anterior VE at 5.7 
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dpc (Yamamoto et al., 2004). Embryos at 5.7 dpc correspond to the tilted group in 
this study, where BrdU-incorporation and the distribution of mitotic cells are shown 
not to exhibit a regional A-P bias. However, before DVE movements, Yamamoto et 
al describe BrdU-incorporation levels to be uniform throughout the VE (Yamamoto et 
al., 2004). Indeed 5.5 dpc embryos correspond to embryos in the distal group in this 
study where levels of BrdU-incorporated nuclei are similar in the DVE and flanking 
VE. Similarly, the percentage of mitotic nuclei throughout the VE is maintained to 
within 1% in a proximal-distal orientation; supporting the assertion that no regional 
proliferative bias exists prior to DVE movements. Reasons for this discrepancy at 
later stages between this work and that of Yamamoto et al (2004) have been 
addressed in the next Chapter.  
 
Interestingly, although evidence of differential proliferation in an A-P orientation was 
not found, at later stages there did appear to be differential levels of dividing cells 
between the left and right VE quadrants. Analysis of mitotic nuclei distribution 
demonstrated that the lateral left quadrant had the smallest mitotic index compared to 
the lateral right quadrant. This difference was statistically significant, and was 
observed both in freshly dissected embryos, and those cultured in nocodazole 
suggesting that the observation might reflect a bona fide biological phenomenon.  
Mechanistically, during the DVE movements, the radially symmetrical egg 
cylinder is converted to a bilaterally symmetrical egg cylinder (Perea-Gomez et al., 
2004; Mesnard et al., 2004). Perhaps the differential growth of these lateral regions of 
the VE is a consequence of the shifting morphology of the embryo.  
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This Chapter reports that during the initiation of DVE movements, no evidence for 
differential proliferation between the anterior and posterior VE could be found. It is 
therefore unlikely that the movement of the DVE can be attributed to a passive 
displacement mechanism.  
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Chapter 4 – The role of proliferation at 6.25 dpc 
4.1. Introduction 
Time lapse studies of DVE movements have shown that a pioneering population of 
cells reach the boundary between the epiblast and extra-embryonic ectoderm within 4-
5 hrs (Srinivas et al., 2004). However much of the DVE remains distally localised 
over this period (Fig. 1A). This observation seems to be at odds with a passive 
displacement mechanism as the DVE/AVE does not appear to be moving as a 
coherent epithelial sheet. Yamamoto proposed that Nodal signalling is required in the 
VE, and the asymmetric inhibition of Nodal results in an imbalance in cell 
proliferation in the posterior versus anterior VE (Yamamoto et al., 2004). The 
previous Chapter could find no evidence for differential proliferation between anterior 
and posterior VE at the time of DVE movement. Moreover levels of cell division 
were simply not great enough to account for the passive displacement of these DVE 
cells.  
 It is clear that by 6.5 dpc, these distally located DVE cells have caught up with 
the pioneer cells, and the AVE forms a continuous tissue (Fig1. A). Is it possible that 
differential proliferation is the mechanism that drives the later movement of the 
DVE? This hypothesis is supported by the observations that; (a) movement of these 
cells occur over a longer time period (approximately 12 hrs), which considering the 
long cell cycle lengths is a more plausible time frame; (b) Yamamoto observed 
absence of BrdU incorporation in a large patch of the anterior VE between 6.0-6.5 
dpc (Yamamoto et al., 2004). The overall process of DVE movement might therefore 
combine an initial, relatively fast migration of a pioneering DVE population, followed 
by a slower passive movement of the remaining DVE (Fig. 1B).  
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This Chapter aims to test this hypothesis in two ways. Firstly a detailed 
characterisation of proliferation levels in the VE of 6.25 dpc embryos will be assessed 
using BrdU incorporation and PH3 staining as markers of proliferation. If the 
hypothesis is robust then one would predict a decrease in proliferation within the 
anterior VE versus the rest of the VE. Secondly, the functional requirements of cell 
division, and in particular Nodal on the process of AVE movements will be tested. 
Embryo culture experiments will utilise a variety of cell cycle inhibitors and the 
Nodal inhibitor, SB-431542 to perturb proliferation. If the AVE fails to position 
appropriately during culture this will strengthen the hypothesis that differential 
proliferation might have a role in this process.  
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Figure 1 – Model of AVE movement incorporating active migration and 
differential proliferation 
 (A) Longitudinal confocal sections of three HexGFP embryos at different stages of 
AVE movement. DVE/AVE is expressing GFP (green) and nuclei are in blue. The 
DVE initially tilts and migrates (5.5 dpc), although at 5.75 dpc some DVE cells 
persist at the distal tip. By 6.25 dpc, all DVE cells have moved to the anterior. (B) A 
schematic representation of a two wave model of DVE/AVE movement: At 5.5 dpc a 
pioneering population of DVE cells move anteriorwards in an active migratory 
process that is completed within 4-5 hrs. By 6.25 dpc all of the AVE is now situated 
on the anterior side of the embryo in a process involving passive displacement of the 
DVE cells by differential proliferation in the VE along the A-P axis.  
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4.2. Results  
 
4.2.1. The AVE shows a similar incorporation index to the rest of the VE, but the 
success of BrdU detection is sensitive to the protocol used 
To test for the presence of a non-BrdU incorporating patch of anterior VE cells, 6.25 
dpc HexGFP embryos were administered BrdU, which was subsequently detected 
immunofluorescently. Two different BrdU-labelling protocols were used. 
Initially embryos were cultured in 20 μM BrdU for 1 hr. Culturing embryos 
was favoured over in utero administration as exposure time could be more accurately 
and reproducibly regulated. Whilst embryos cultured in the absence of BrdU 
produced no detectable signal (0/4 embryos, Fig. 2A+A’), those exposed to BrdU 
clearly showed nuclear staining within the VE, but was excluded from the bulk of the 
GFP-positive AVE (6/7 embryos, Fig. 2B+B’). One embryo displayed no BrdU-
positive nuclei. This result supported Yamamoto’s observations that no proliferation 
in the anterior VE exists, although the absence of any epiblast staining was cause for 
concern.  
 In an attempt to recapitulate this result using Yamamoto’s reported protocol, 
pregnant HexGFP mice were injected intraperitonealy with BrdU (50 mg/kg) and 
dissected 1 or 3 hrs thereafter. The staining protocol was exactly the same as before 
so the only difference was the method of BrdU administration. As expected, no 
staining was detected in non-injected mice (0/4 embryos, Fig. 2C+C’). In treated mice 
dissected after 1 hr BrdU staining could be detected in VE, but not AVE as seen in the 
previous culture experiment (3/3 embryos, Fig. 2D+D’). Surprisingly, when treated 
mice were dissected after 3 hrs, BrdU-positive nuclei were distributed throughout the 
VE including the AVE (10/10 embryos, Fig. 2E+E’).  
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Figure 2 – BrdU incorporation at 6.25 dpc 
HexGFP embryos underwent three different BrdU staining protocols. All protocols 
involved immunofluorescent staining for BrdU (red) and GFP (green). Longitudinal 
sections were acquired on the confocal microscope at multiple levels. Nuclei are 
stained in blue and representative embryo sections are presented. (A-B’) BrdU 
Culture - Protocol 1. Freshly dissected HexGFP embryos were cultured in the absence 
of BrdU (A+A’) or 20 μM BrdU for 1 hr (B+B’). (C-E’) BrdU injection protocol. 
Pregnant HexGFP mice were injected i.p. with BrdU at 50 mg/kg and dissected 1 or 3 
hrs thereafter. Embryos underwent the same BrdU staining protocol as Protocol 1. 
(C+C’) Negative control embryos dissected from a mother injected with PBS vehicle 
alone. (D+D’) Treated embryos dissected 1 hr after BrdU injection. (E+E’) Treated 
embryos dissected 3 hrs after BrdU injection. (F+F’) BrdU Culture - Protocol 2. 
Freshly dissected HexGFP embryos were cultured in 20 μM BrdU for 30 mins. (G) 
The number of BrdU-positive nuclei in the AVE and VE were counted and expressed 
as a percentage of the total cell number, referred to as the incorporation index. Three 
confocal sections were quantified per embryo (n=11), and mean values have been 
presented. Error bar = ± SEM. Scale bar 40 μm.  
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Again the epiblast failed to stain in any of the treated embryos strongly suggesting 
there were problems with this protocol. These might have consisted of a failure of the 
antibody to bind the BrdU epitope due to insufficient HCl treatment, insufficient 
permeabilisation of the tissue, a failure of BrdU incorporation into the underlying 
epiblast or a combination of these factors. Therefore another staining protocol was 
used; adapted from the Wholemount BrdU staining protocol found on the Rossant 
web page (www.sickkids.ca/rossant/protocols), and differing from the previous 
protocol in the BrdU antibody used, recipe of the permeabilisation solution and 
method of DNA denaturation. 
Embryos were cultured in 20 μM BrdU for 30 mins. This time robust staining 
was detected throughout the epiblast and VE including the AVE (11/11 embryos, Fig. 
2F+F’). As all nuclei had been counterstained it was possible to calculate the 
incorporation index, or the number of BrdU-positive nuclei expressed as a percentage 
of the total cell number. Several longitudinal sections were acquired at different levels 
for each embryo and BrdU-positive versus negative nuclei were quantified (Fig. 2G). 
The AVE had a mean incorporation index of 61.44% (n=11, SEM ± 5.25%), a similar 
value to the 64.13% obtained in the rest of the VE (n=11, SEM ± 4.61%) (Fig. 2G). 
This result does not support the differential proliferation model.  
 
4.2.2. At 6.25 dpc the VE displays low levels of randomly distributed mitotic 
nuclei 
The anterior and posterior VE display similar levels of proliferation at 6.25 dpc, with 
both VE populations having in excess of 60% of its cells in S phase. To confirm this 
finding it was necessary to use a different cell cycle marker. For this purpose an 
antibody against phospho-Histone-H3 (PH3) was used to mark M phase nuclei. If the 
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BrdU result was correct then it could be presumed that anterior VE would exhibit 
similar levels of mitotic nuclei as the rest of the VE.  
 Eleven HexGFP embryos were dissected at 6.25 dpc and mitotic nuclei were 
stained. Complete stacks were taken through each embryo and reconstructed. The 
number of dividing cells within the epiblast and VE were calculated and the mean 
number expected to be found in each tissue expressed graphically (Fig. 3A+B). The 
epiblast had a mean value of 20.91 mitotic cells per embryo (n=11, SEM ± 2.23) 
whilst the VE had a total number of 3.91 mitotic cells per embryo (n=11, SEM ± 
0.69). At this stage the epiblast contained 5-fold more dividing cells than the VE. 
However looking at the actual numbers of dividing cells is not useful as the numbers 
are not directly comparable. In order to directly compare the mitotic capacity of these 
two tissues it was necessary to determine what proportion of the total number in each 
tissue compartment were dividing, ie the mitotic index. 
To calculate the mitotic index, 4-5 non-overlapping longitudinal sections from 
five randomly selected embryos were quantified with respect to the total number of 
cells and mitotic nuclei in the VE and epiblast. The epiblast had a mean mitotic index 
of 5.74% (n=5, SEM ± 0.84%) whilst the VE had a mean mitotic index of 1.56% 
(n=5, SEM ± 0.66%) (Fig. 3C). Despite the low proportion of mitotic cells in the VE 
it was important to assess their regional distribution within the tissue in relation to 
AVE position. It was possible that, although the proliferative capacity of the VE was 
low, synchronised mitotic nuclei could produce passive movement of an intervening 
tissue.  
As Hex-expressing cells of the AVE expressed GFP, embryos could easily be 
divided into anterior, posterior, lateral left and lateral right quadrants.  
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Figure 3 – Distribution of mitotic nuclei within the VE and epiblast at 6.25 dpc 
Freshly dissected HexGFP embryos at 6.25 dpc were immunofluorescently stained 
with the M phase marker anti-phospho-Histone-H3. Complete stacks of 11 embryos 
were taken at 4 μm intervals by confocal microscopy. The number of mitotic nuclei 
were counted allowing the mean number of divisions in each tissue per embryo to be 
calculated. (A) Confocal section of a stained embryo divided into its tissue 
compartments: visceral endoderm (VE) and epiblast. Mitotic nuclei (red), all nuclei 
(blue), AVE domain expressing GFP (green). (B) Mean number of mitotic nuclei in 
the VE and epiblast were plotted (n=11). (C) Five embryos were randomly picked and 
the mitotic index was calculated in the epiblast and VE. The mitotic index (MI) was 
defined as the percentage of mitotic nuclei. 4-6 confocal sections were quantified per 
embryo and mean values have been presented. Error bar = ± SEM. (D) The VE from 
eight embryos was divided into anterior, posterior, lateral left and lateral right 
quadrants. The mitotic index in each quadrant was counted and represented as a 
percentage of the total number. 
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The number of dividing nuclei within the VE of eight embryos were scored in relation 
to which quadrant they were situated (Fig. 3D). The anterior quadrant had an MI of 
1.81% (n=8, SEM ± 0.82%) compared to 1.59% (n=8, SEM ± 0.67%) in the posterior 
quadrant. The lateral left quadrant had an MI of 1.33% (n=8, SEM ± 0.65%), and the 
lateral right quadrant had an MI of 1.66% (n=8, SEM ± 1.12%) (Fig. 3D). The small 
variation in MI values between the quadrants was not statistically significant as 
assessed using a ?2 test (P=0.756), and therefore suggested that the low levels of cell 
division within the VE show no regional bias. This finding conflicts with the 
differential proliferation model.  
 
4.2.3. At 6.25 dpc the AVE and VE cycle at a similar rate  
Phospho-Histone-H3  (PH3) staining on fixed embryos indicated that less than 2% of 
the VE population were mitotic. What could not be assessed using this ‘molecular 
snapshot’ approach was the dynamics of cell division within the VE. The increase in 
mitotic index over time during nocodazole-induced mitotic arrest was analysed to 
determine whether there was an identifiable difference between the cycling rates of 
AVE and VE. HexGFP embryos were cultured in nocodazole from 0-5 hrs, and 
embryos were periodically removed and stained for PH3 (Fig. 4A). The mitotic index 
was calculated for each embryo at each time point by taking an average of 2-4 
longitudinal sections per embryo acquired at different non-overlapping planes. The 
VE was divided into two populations: GFP-positive AVE and GFP-negative cells that 
constituted the rest of the VE. The percentage of cells in mitosis for both populations 
was plotted as a function of time in the presence of nocodazole (Fig. 4B).  
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Figure 4 – Testing for cell cycle differences in AVE and VE 
Freshly dissected 6.25 dpc HexGFP embryos were cultured in 200 nM nocodazole for 
0, 0.5, 1, 1.5, 2, 3, 4 and 5 hrs (n=11, 6, 11, 8, 9, 10, 6 and 4 respectively). Cultured 
embryos were immunofluorescently stained withan anti-PH3 antibody and stacks 
taken at 5 μm intervals were acquired on the confocal microscope. (A) Representative 
longitudinal confocal sections of stained embryos at each time point. Mitotic nuclei 
(red), all nuclei (blue), AVE expressing GFP (green). (B) Accumulated mitotic nuclei 
in the AVE and VE were quantified in each embryo and the mean mitotic indices in 
both tissues were plotted as a function of length of nocodazole exposure. Error bars = 
± SEM.  
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Non-cultured embryos had a mean basal mitotic index of 2.06% (n=11, SEM ± 
0.77%) in the AVE compared to 1.06% (n=11, SEM ± 0.56%) in the rest of the VE. 
These values were similar to those obtained previously (Fig. 3C). Accumulation of 
mitotic nuclei was observed after only 30 mins. This initial mitotic arrest constituted 
the largest fold difference between the basal mitotic index, with 4.17% (n=6, SEM ± 
1.29) of cells in the AVE dividing compared to 5.41% (n=6, SEM ± 1.71) in the 
remaining VE. The percentage of mitotic cells continued to increase modestly with 
nocodazole exposure up to the 5 hr timepoint.  
The most important point to be derived from these results is that at no time did 
the mitotic index between the two populations significantly deviate from one another, 
and therefore the AVE cycles at a similar rate to cells in the rest of the VE.  
 
4.2.4. Nodal is not required for proliferation in the VE, but is required for AVE 
movement 
Taking together the BrdU-labelling experiments and PH3 staining, approximately 
63% of the VE is either in S- or M-phase of the cell cycle. Yamamoto proposed that 
Nodal signalling was responsible for promoting cell proliferation in the VE and 
demonstrated that Nodal null embryos displayed a markedly impaired BrdU uptake in 
the VE and epiblast compared to wild type patterns of incorporation (Yamamoto et 
al., 2004). To test this hypothesis in our culture system, the potent inhibitor of the 
Nodal signalling pathway, SB-431542, was used to block Nodal signalling. 
Proliferation was assessed by BrdU uptake, whilst the position of the AVE was 
determined by using HexGFP embryos.  
 Embryos were subdivided into three regions for analysis: the GFP-positive 
AVE, the GFP-negative VE and the epiblast.  
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Figure 5 – The effect of Nodal inhibition on proliferation and AVE movement 
Freshly dissected 5.5 dpc embryos were cultured for 16 hrs in the chemical inhibitor 
of activin/nodal, SB-431542 at a concentration of 20 μM. 30 mins before fixation, 
embryos were transferred to another drop containing both SB-431542 and 20 μM 
BrdU and cultured for a further 30 mins. Embryos were immunofluorescently stained 
for BrdU and GFP and longitudinal sections were acquired on the confocal 
microscope at multiple levels. (A-B’) Representative untreated embryos in 
longitudinal (A+A’) and transverse (B+B’) section showing robust BrdU 
incorporation  (red) and correct AVE movement (green). All nuclei are labelled blue. 
(C-E’) Treated embryos in longitudinal (C+C’, E+E’) and transverse (D+D’) section. 
Notice the low number of BrdU-positive nuclei within the epiblast compared to the 
VE and ExE. (E+E’) Approximately one third of treated embryos had VE detaching 
from the epiblast. (F) Treated (n=14) and non-treated (n=11) embryos were divided 
into three populations: epiblast, AVE and VE. The number of BrdU-positive nuclei in 
each population was quantified and expressed as a percentage of the total cell number, 
referred to as the incorporation index. Bars = ± SEM. Scale bar 40 μm. 
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An incorporation index was calculated for each sub-population per embryo and these 
were pooled together. Untreated embryos consistently displayed staining throughout 
all of its tissues including the epiblast and VE as previously observed (compare Fig. 5 
A-B’ with Fig. 2F+F’). The AVE had moved anteriorly in all embryos (11/11), with 
GFP-positive cells reaching the boundary between the epiblast and extra-embryonic 
ectoderm. The mean incorporation index of the AVE was 46.23% (n=11, SEM ± 
2.49%), similar to the rest of the VE at 50.85% (n=11, SEM ± 3.47%). The epiblast 
displayed the greatest incorporation index at 66.26% (n=11, SEM ± 3.25%) reflecting 
the shorter cell cycle length in this tissue (Fig. 5F).  
 Embryos treated with SB-431542 showed a very striking expression of BrdU 
incorporation; whilst the extra-embryonic ectoderm and VE displayed staining of a 
similar intensity and distribution as non-treated controls, the epiblast was almost 
completely devoid of any BrdU-positive nuclei (Fig. 5C-D’). Furthermore, the AVE 
failed to move appropriately and was either located at the distal tip of the epiblast 
(10/14 embryos), or very weakly on one side of the embryo (4/14 embryos). Five 
embryos also displayed a VE that had detached from the epiblast, presumably a 
consequence of the non-proliferating epiblast failing to maintain physical contact with 
the overlying VE (Fig. 5E+E’). This was compounded by the fact that VE was still 
dividing, with AVE possessing an incorporation index of 43.97% (n=18, SEM ± 
3.17%) and the remaining VE, 53.12% (n=14, SEM ± 2.60%) (Fig. 5F). The epiblast 
had a mean incorporation index of just 8.78% (n=14, SEM ± 2.43)-a huge decrease 
compared to non-treated controls.  
 This experiment suggests that proliferation within the VE is Nodal-
independent, but that Nodal signalling is required for anterior movement of the AVE.  
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4.2.5. Disrupting cell division throughout the embryo perturbs AVE movement 
Low levels of randomly distributed mitotic cells in the VE suggest that differential 
proliferation is unlikely to play a role in passively displacing the AVE. However the 
previous experiment demonstrated that by blocking Nodal signalling and 
consequently proliferation in the epiblast, the AVE was unable to move. This suggests 
that proliferation in the epiblast may be required for AVE movements. To test this 
possibility, embryos at the time of DVE movement were cultured overnight in cell 
cycle inhibitors. Genistein and Okadaic acid were used, previously shown to halt the 
cell cycle during G2-M transition (DiPaola, 2002; Alexandre et al., 1991). Nocodazole 
was also used, shown to block cells in M phase. Mitotic arrest was confirmed by 
staining treated embryos for PH3 and looking for a change in numbers of mitotic 
nuclei compared to non-treated controls. 
 Embryos cultured without (Fig. 6A+A’), or in the presence of 15 nM Okadaic 
acid (Fig. 6B+B’) displayed a typical distribution of PH3-positive nuclei.  
Furthermore the AVE had moved to an anteriorwards position in the vast majority of 
embryos (23/23 control embryos; 10/13 15 nM Okadaic acid-treated embryos). 
However, embryos cultured in 20 nM Okadaic acid showed a loss of dividing nuclei 
(Fig. 6C+C’). Furthermore, GFP-expressing AVE cells remained in a distal position 
(5/24 20 nM Okadaic acid-treated embryos had a correctly positioned AVE), despite 
embryos maintaining a grossly normal morphology. A similar outcome was found 
when embryos were cultured in the cell cycle inhibitor, Genistein. Non-treated control 
embryos (Fig. 6 D+D’) and embryos treated with 50 μM Genistein (Fig. 6E+E’) 
displayed indistinguishable PH3 staining, and the AVE had moved anteriorwards in 
the vast majority of embryos (19/20 control embryos; 9/11 15 nM 50 μM Genistein-
treated embryos).  
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Figure 6 – The effects of blocking cell division on AVE movements 
Freshly dissected 5.5 dpc HexGFP embryos were cultured for 16 hrs in the cell cycle 
inhibitors Okadaic acid (15/20 nM), Genistein (50/100 μM) and Nocodazole (50/200 
nM). Pictures of embryos were acquired on a fluorescent microscope post-culture and 
then immunofluorescently stained for mitotic nuclei using an anti-PH3 antibody. 
Stained embryos were re-acquired on the confocal microscope, with longitudinal 
sections captured at multiple levels. Mitotic nuclei (red), AVE (green), all nuclei 
(blue).  
(A-C’) Okadaic acid culture: (A) Non-treated control embryos after culture, 
(A’) and PH3 staining; (B) Embryos treated with 15 nM Okadaic acid after culture, 
(B’) and PH3 staining; (C) Embryos treated with 20 nM Okadaic acid after culture, 
(C’) and PH3 staining. Notice the absence of PH3-positive nuclei and distal AVE at 
this concentration. (D-F’) Genistein culture: (D) Non-treated control embryos after 
culture, (D’) and PH3 staining; (E) Embryos treated with 50 μM Genistein after 
culture, (E’) and PH3 staining; (F) Embryos treated with 100 μM Genistein after 
culture, (F’) and PH3 staining. Notice the reduction of PH3-positive nuclei and distal 
AVE at this concentration. (G-I) Nocodazole culture: (G) Non-treated embryos after 
culture; (H) Embryos treated with 50 nM Nocodazole; (I) Embryos treated with 200 
nM Nocodazole. Notice the distal AVE in embryos cultured at 200 nM Nocodazole. 
Scale bar 50 μm for A,B,C,D,E,F,G,H, and I; 35 μm for A’,B’, C’ D’ E’ and F’. 
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When the concentration of Genistein was increased to 100 μM, embryos not only 
displayed a sharp decrease in the levels of mitotic cells, but the AVE failed to move in 
17/18 embryos analysed (Fig. 6F+F’). Once again post-cultured embryos displayed a 
grossly normal morphology compared to non-treated cultured controls.  
Finally embryos were treated overnight in nocodazole. Embryos treated with 
50 nM nocodazole appeared indistinguishable from non-treated control embryos, with 
the AVE moving appropriately in all embryos (12/12 control embryos; 7/7 50 nM 
nocodazole-treated embryos). (Fig. 6G+H). However at a concentration of 200 nM 
the AVE failed to move in 16/18 treated embryos (Fig. 6I), as previously described 
(Section 3.2.4, Fig. 4). At this concentration the number of mitotic nuclei increased by 
approximately 3-fold compared to non-treated controls.  
Unlike embryos cultured in either Okadaic acid or Genistein, embryos 
cultured overnight in 200 nM nocodazole appeared morphologically atypical, with the 
absence of a well defined pro-amniotic cavity and a rough-looking VE. This 
suggested that 200 nM nocodazole treatment had other secondary effects on embryo 
development, most likely affecting such processes as intracellular transport and cell 
movement due to the static nature of the microtubule network. Nevertheless, it 
appears that by inhibiting cell division throughout the embryo, AVE movements were 
perturbed. This strengthens the argument that division within the epiblast is necessary 
for these movements to be successfully completed.   
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4.3. Discussion  
 
This Chapter aimed to test the hypothesis that differential proliferation in the VE 
could contribute in later AVE movements by passive displacement. Two approaches 
were used to address this possibility. Firstly, a detailed analysis of proliferation within 
the VE was undertaken, using BrdU incorporation and PH3 staining as cell cycle 
markers. HexGFP embryos allowed visualisation of the AVE, thus the proliferative 
capacity of the AVE versus the rest of the VE could be compared. Secondly a variety 
of embryo culture experiments were performed to demonstrate the functional 
significance of perturbing cell division on AVE movements. 
 
Initially, BrdU incorporation was used to assess differences in the proliferative 
capacity of the AVE and surrounding VE. When Protocol 1 was used, the AVE was 
initially shown to be unable to incorporate BrdU 1 hour after BrdU administration. 
Staining using this protocol was restricted to the VE and excluded from the epiblast 
which was surprising as the epiblast was shown by PH3 staining to comprise a 3-fold 
greater mitotic index than its surrounding VE. When the length of time between BrdU 
exposure and fixation was increased to 3 hours the AVE became stained, but still no 
staining was observed in the epiblast, suggesting that the uptake of BrdU may vary 
between cell types. Furthermore, the published staining pattern of a 6.5 dpc transverse 
section, using the same protocol, showed no AVE staining and weak or no epiblast 
staining (Yamamoto et al., 2004). These observations suggest that when using 
Protocol 1, certain cell types may be refractory to the uptake of BrdU. 
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When Protocol 2 was used, BrdU incorporation was found throughout all tissues of 
the embryo, including the epiblast. Furthermore the AVE was shown to have a similar 
percentage of BrdU-incorporated nuclei compared to the rest of the VE. This 
observation conflicted with the differential proliferation model and indicated that by 
altering the protocol, BrdU incorporation could be detected in all cell types of the 
early post-implantation embryo. 
 
The lack of differential proliferation between the AVE and the rest of the VE as 
assessed by BrdU incorporation, was confirmed by examining the distribution of 
mitotic nuclei. Analysis of mitotic cells in 6.25 dpc embryos was reminiscent to the 
levels and distribution observed in tilted embryos, 18 hrs earlier (see previous 
Chapter). The mitotic index continued to remain at under 2%, whilst the proportion of 
mitotic nuclei in the VE between all quadrants displayed no regional bias, further 
contradicting the differential proliferation hypothesis, and adding strength to the 
validity of the refined BrdU staining protocol.          
Further evidence that the AVE and VE display no differences in their relative 
cell cycle rates comes from taking a stathmokinetic approach using nocodazole. The 
rate of mitotic arrest between the AVE and the VE did not significantly deviate from 
one another at any length of nocodazole exposure, suggesting that the two populations 
contained similar numbers of mitotic cells, with comparable cell cycle lengths. 
 
Yamamoto and colleagues proposed that Nodal signalling promotes cell proliferation 
in the VE and differential proliferation within this tissue is due to differential Nodal 
signalling (Yamamoto et al., 2004). They demonstrated that by injecting embryos 
with a Nodal expression vector, cell proliferation was stimulated, whilst injection of 
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the Nodal antagonists Lefty1 and Cerl resulted in the inhibition of proliferation. 
Moreover the DVE tended to move away from the side where proliferation was 
stimulated and towards the side where proliferation had been inhibited (Yamamoto et 
al., 2004).  
 
Although differential proliferation was not observed in this study between the 
anterior and posterior VE, it is still possible that Nodal signalling is required for the 
migration of AVE cells. To investigate this, Nodal signalling was blocked in embryos 
by treating with the small molecular inhibitor SB-431542. When this was done, two 
interesting observations could be made. Firstly whilst levels of proliferation were 
maintained in the VE and ExE compared to non-treated controls, levels in the epiblast 
were drastically reduced. Secondly, the AVE failed to move to the anterior of the 
embryo in SB-431542 treated embryos. These results suggest that (a) Proliferation 
within the VE and ExE occurs through a Nodal-independent mechanism, whilst 
proliferation in the epiblast requires Nodal signalling; (b) Nodal signalling is required 
for the movement of the AVE.  
 
If AVE movement does require an interaction with the epiblast in a Nodal-dependant 
manner what could be the possible mechanism? The epiblast is always closely 
apposed to the overlying VE during AVE movements and presumably the epiblast 
must proliferate to maintain this contact. If this contact is disrupted, for example by 
blocking proliferation in the epiblast, this tissue interaction will be affected. The 
epiblast might be responsible for ‘stretching’ the VE to allow room for migratory 
behaviour. Indeed in a proportion of the SB-431542 treated embryos the VE could be 
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seen to detach from the epiblast. Furthermore, if the epiblast failed to maintain contact 
with the VE then reciprocal signalling interactions could be perturbed.  
The failure of AVE to move as a result of decreased Nodal signalling is recapitulated 
in a number of mutants. Loss of the Nodal co-factor Cripto causes a failure of the 
AVE to rotate at 6.0 dpc (Ding et al., 1998). A similar phenotype is seen in some 
Nodal?
600/-
 embryos where the autoregulatory enhancer (ASE) is removed (Norris et 
al., 2002). The ASE is essential for transcription of Nodal in the VE and epiblast. 
However this paper demonstrated it was the strength of Nodal signalling in the 
epiblast specifically that was crucial in activating Nodal targets in the VE, resulting in 
normal morphogenesis including AVE rotation (Norris et al., 2002).   
 
The results presented here suggest that one of the roles of Nodal in the epiblast is to 
promote proliferation, and thereby maintain contact with the VE necessary to activate 
Nodal targets in the VE. Mesnard et al. (2006) proposed that Nodal signalling is 
required to promote the growth of the egg cylinder by increasing cell division in the 
epiblast. Our finding are consistent with this hypothesis, although the fact that levels 
of proliferation within the VE are unaffected when Nodal signalling is inhibited does 
not agree with Yamamoto et al’s observations. Why are these findings at odds with 
one another? 
One possible explanation could come from the method used in the Yamamoto 
et al (2004) manuscript to modulate the levels of Nodal signalling in the 5.5 dpc 
embryo. In the study, Nodal or its antagonists were transfected into embryos by 
injecting liposomes into the VE that containing the appropriate vectors and 
Lipofectamine 2000. It is possible that these liposomes also transfected epiblast cells 
and therefore affected Nodal signalling in this tissue. Alternatively, it is possible that 
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changing the levels of Nodal expression in the VE at 5.5 dpc might have affected the 
fate of these VE cells, and this in turn altered their migratory behaviour.  
To understand if proliferation in the epiblast is necessary for AVE movements, 
embryos were cultured in three different cell cycle inhibitors: Okadaic acid, Genistein 
and Nocodazole. The AVE failed to move when proliferation was inhibited with all 
three inhibitors, suggesting that reducing cell division throughout the embryo can 
affect AVE positioning. Due to the different mechanisms of action of the inhibitors it 
seems unlikely that the inability to affect AVE movement is attributable to secondary 
effects. Moreover, considering the difference between levels of proliferation in the 
epiblast compared to the VE, it seems reasonable to assume that the failure of AVE 
movements could be due specifically to the lack of division in the epiblast. For 
example, by impairing the interactions with the juxtaposed VE. This observation 
strengthens the argument that one of the roles of Nodal is to promote proliferation in 
the epiblast and thus maintain contact with the VE.  
 
This report indicates that differential proliferation within the VE is unlikely to be the 
mechanism used by the embryo to contribute to later AVE movements. However 
evidence presented here suggests that Nodal-dependant proliferation in the epiblast 
might be implicated in AVE movements by maintaining contact with the closely 
apposed VE.  
 
 
 
 
 
 126
Chapter 5 – Creation of the Hexd mouse line 
5.1. Introduction 
The AVE is an essential extraembryonic tissue required for the correct specification 
of the A-P axis. Its secretion of various Wnt and Nodal antagonists are responsible 
for restricting these signalling molecules towards the posterior of the embryo, thereby 
determining the site of primitive streak formation (reviewed in Perea-Gomez et al., 
2001b; Beddington and Robertson, 1999). Furthermore, its role in initiating anterior 
character to the underlying ectoderm has been confirmed genetically and 
embryologically as discussed in the Introduction (reviewed in Martinez-Barbera and 
Beddington, 2001). However does this tissue, or that of its precursor, the DVE, have 
additional roles? Using the very methods that have enabled us to understand its 
function, they have also hindered the ability to completely answer the question. This 
statement seems counterintuitive, but both microsurgical ablation studies and analysis 
of mutant embryos carry with them inherent drawbacks.  
 
To date, two studies have used microsurgical ablation to address the function of the 
AVE (Thomas and Beddington, 1996) and DVE (Miura and Mishina, 2007). The 
latter study reported that DVE ablation was successful in 50% of the embryos, with 
an additional 10% failing to grow when cultured due to damage of the epiblast 
(Miura and Mishina, 2007). Microsurgical ablation experiments require that embryos 
be cultured in vitro, meaning embryos are able to recapitulate their in vivo situation 
for a limited period of time. Additionally, it is difficult to accurately remove just 
AVE tissue, resulting in either partial ablation and/or the mechanical disruption of 
surrounding tissue, not to mention the presumable regeneration of the ablated tissue. 
These factors make results difficult to interpret and subtle functions unable to detect.  
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Gene targeting studies in mice has allowed the identification of many genes and 
signalling molecules required for head formation (Beddington and Robertson, 1999). 
Although this approach enables the role of a particular gene to be identified, it does 
not address the role of the tissue as a whole. Furthermore, genetic compensation by 
other genes may complicate the analysis of gene knock-out experiments. For example 
when Lefty1, Cerl or Dkk1 are knocked-out, correctly patterned embryos still develop 
(Meno et al., 1998; Shawlot et al., 2000; Mukhopadhyay et al., 2001). Even in Cerl 
and Lefty1 compound mutants, only a proportion show patterning defects (Perea-
Gomez et al., 2002), while the others are rescued, possibly due to ectopic expression 
of Lefty2 functionally compensating (Yamamoto et al., 2004). This indicates that a 
degree of redundancy exists within the AVE, and that any residual AVE function in a 
mutant embryo might not be revealed using this approach.  
 
This Chapter describes a novel approach aimed to find additional functions of the 
AVE and DVE precursors. In an attempt to circumvent the problems associated with 
microsurgical ablation experiments, the strategy involves the generation of a mouse 
line in which diphtheria toxin A (DTA) has been knocked-in to the Hex locus by 
homologous recombination. DTA is activated by Cre-mediated recombination, 
causing Hex-expressing cells, such as those in the AVE/DVE, to be genetically 
ablated in vivo. The generation of this mouse line, and a primary characterisation of 
genetically ablated mutants is described.  
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5.2. Results 
 
5.2.1. A genetic strategy for AVE/DVE ablation  
To address the function of the AVE as a whole and in vivo, this project aimed to carry 
out a targeted ablation of the AVE. Diphtheria toxin A (DTA) was knocked-in to the 
Hex locus by homologous recombination in embryonic stem (ES) cells. DTA 
catalyses the inactivation of elongation factor 2, resulting in termination of protein 
synthesis and apoptosis of the target cell (Collier, 1975; 2001). In positively targeted 
ES cells, DTA is under the control of the endogenous Hex regulatory sequence. 
However, the toxin is initially rendered inactive due to the presence of a sequence 
rich in termination codons, the reversed Pgk-neo gene, between its ATG codon and 
the rest of the DTA open reading frame (a similar strategy is described by Lee et al., 
2000). This sequence is flanked by loxP sites and can therefore be deleted by Cre-
mediated recombination (Nagy, 2000). When these mice (Hex-XneoX-DTA) are 
crossed with mice harbouring Cre recombinase, Pgk-neo is excised and DTA can be 
translated resulting in the death of Hex-expressing cells (Figure 1). 
 
5.2.2. Characterisation of positively targeted clones 
The Hex-XneoX-DTA targeting construct produced two positively targeted ES cell 
clones, named HDS118 and Hexd32. A probe 5’ external to the site of recombination 
was used to confirm integration into the Hex locus (Fig. 2A). In addition, a DTA 
probe confirmed the targeting vector had integrated once, excluding the possibility of 
the random integration of multiple copies (Fig. 2B). To functionally test the efficiency 
of the Hex-XneoX-DTA ablation, HDS 118 ES cells were transiently transfected with 
the Cre expression plasmid Turbo-Cre and cultured.  
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Figure 1 - Strategy for ablation of the AVE.  
The first line represents genomic organization in the Hex locus. The boxes represent 
the 4 Hex exons. The second line is the targeting vector that will be used to generate 
the knock-in of the diphtheria toxin (DTA) into the Hex locus. The first ATG is the 
Hex ATG. The second ATG is the DTA’s ATG. This ATG is separated from the rest 
of the DTA coding region by the positive selection cassette (the neomycin gene 
driven by the pgk promoter-Neo) flanked by LoxP sites (black triangles). The 
orientation of transcription of the selection cassette is inverse to the orientation of the 
transcription of DTA. This cassette contains translational stop codons in all reading 
frames. An IRES sequence is present upstream of the DTA ATG to ensure correct 
initiation of the translation of the DTA. The third line represents the locus of the 
knock-in allele after homologous recombination of the targeting vector. ES cells 
containing this recombination event will be used to generate mice that carry this Hex 
allele. The fourth line represents the result of excising the selection cassette 
(containing the translational stop codons) by Cre recombination. This event will place 
the DTA under the control of the Hex regulatory sequences and will therefore allow 
the activation of the DTA in the Hex expressing cells of the AVE. The approximate 
position of the 5’ probe for Southern blot analysis has been indicated. 
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Figure 2 – Molecular and functional characterisation of positively targeted ES 
cell clones 
ES cell genomic DNA was digested with EcoRV and hybridised with either a 5’ probe 
(A) or DTA probe (B) to confirm the presence of the targeted allele. (C)  HDS 118 ES 
cells were plated at low density in a 6-well plate and transiently transfected with Cre 
expression plasmid. Negative control wells underwent the transient transfection 
procedure with a GFP-expressing plasmid. One day after transfection cells were 
cultured in medium without LIF to encourage differentiation. Scale bar 20 μm (D) 
Mouse genomic DNA derived from chimeric Hexd32 x 129sv cross was digested with 
EcoRV and hybridised with a 5’ probe to confirm germline transmission of the 
targeted allele. (E) Standard PCR using genomic DNA derived from Hexd32 x ?-actin 
Cre cross demonstrating proof of principal by Cre-mediated excision of the Pgk-neo 
cassette.  
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Non-Cre transfected cells were transfected with a GFP-expressing plasmid to control 
for cell death due to the transfection procedure. One day post-transfection there 
appeared to be little difference between the Cre-treated and non-treated cells, with 
similar levels of confluency and cell morphology (Fig. 2C). At day 2 the non-Cre 
transfected control cells were confluent whilst large cell-free patches were apparent in 
the Cre-treated cells. In addition, there were a greater number of floating dead cells in 
these wells compared to non-treated wells. On day 3 this pattern continued; non-
treated cells were now over-confluent whilst Cre-treated cells continued to show large 
cell-free patches and increased cell death. Although this experiment used a transient 
transfection and therefore not all cells would be expected to die, these results indicate 
that cell death could occur as a result of Cre-mediated recombination, demonstrating 
that the DTA ablation system was functional in vitro.  
 
5.2.3. The ablation system is functional in vivo 
Both targeted clones were karyotyped, and injected into C57BL6 blastocysts by the 
CSC Microinjection facility. This resulted in 10 chimeras, 7 of which transmitted the 
targeted allele through their germline as confirmed by PCR and Southern blot analysis  
(Fig. 2D). Mice heterozygous for the unrecombined Hex-XneoX-DTA allele were 
viable and fertile (Table 1), and the mouse line was named Hexd32.  
 To generate embryos expressing the activated Hex-DTA allele, Hexd32 mice 
were crossed to either ?-actin Cre or to female Sox2 Cre mice. Both lines express Cre 
ubiquitously from the 1-2 cell stage enabling recombination in all cells (Lewandoski 
et al., 1997; Hayashi et al., 2003, Vincent et al., 2003). Standard PCR analysis 
confirmed that in compound Hexd32/+; ?-actin Cre/+ heterozygotes, recombination 
was successful as demonstrated by excision of the Pgk-neo cassette and the 
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subsequent failure to produce a PCR product (Fig. 2E). To test the timing and 
efficiency of ablation in vivo, the Hex-expressing domain was assessed by 
wholemount in situ hybridisation (WISH) and/or HexGFP expression at different 
embryonic stages. The HexGFP domain of Hexd32/+; ?-actin Cre/+ mutants was 
indistinguishable from non-activated embryos at 5.5 dpc (Fig. 3A+A’). However, one 
day later at 6.5 dpc, the majority of Hex transcript in the AVE had been abolished 
(Fig. 3B+B’; n=3/4,). This result was confirmed by a large reduction in the HexGFP 
domain in mutants from both Cre lines (Fig. 3C+C’; n=2/2; G+G’), suggesting that 
ablation was taking place between 5.5-6.5 dpc. Morphologically, activated and non-
activated embryos were indistinguishable, although the efficiency of ablation 
appeared greater in the ?-actin Cre cross in which fewer residual GFP-postive cells 
remained. For this reason, subsequent analysis of mutant embryos was done 
exclusively from crosses with the ?-actin Cre mouse line. A reduction in the Hex-
expressing domain was not observed in littermate embryos from any other genotype, 
indicating the specific nature of the genetic ablation.  
 By 7.5 dpc, the Hex-expressing population of the definitive endoderm was 
observed in DTA-active mutants, with Hex transcripts and GFP expression spanning a 
similar-sized domain and comparable levels to non-activated embryos (Fig. 3D-E’; 
n=4/4,). The inability to differentiate activated mutants from non-activated embryos 
by comparing the pattern of Hex transcript was also apparent at 9.5 dpc, with all 
embryos showing robust expression in the liver, thyroid and intersomitic regions 
(Martinez-Barbera et al., 2000) (Fig. 3F+F’; n=5/5). The failure of the Hex-
expressing population to diminish between 7.5-9.5 dpc suggested that the efficiency 
of ablation was in some way impaired.  
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Figure 3 – In vivo characterisation of the genetic ablation system 
(A-F’) Embryos at various stages derived from Hexd32 x ?-actin Cre cross. (A+A’) 
Fluorescence/brightfield overlay of 5.5 dpc mutant and non-mutant embryos. DVE is 
expressing HexGFP (green) and can be seen in both embryos. (B+B’) At 6.5 dpc, 
mutant embryos display vastly reduced Hex transcript domain as assessed by 
wholemount in situ hybridisation (WISH) analysis (red arrow), compared to non-
mutant counterparts. (C+C’) Ablation of Hex-expressing population is confirmed by a 
reduction in HexGFP (green) domain in mutants at 6.5 dpc (red arrow). (D+D’) WISH 
analysis of Hex at 7.5 dpc indicates that the Hex-expressing cells of the anterior 
definitive endoderm (ADE) are present in mutant embryos. (E+E’) 
Fluorescence/brightfield overlay of 7.75 dpc mutant and non-mutant embryos show 
that HexGFP-expressing cells are present in the ADE and blood islands (BI). (F+F’) 
WISH analysis of Hex at 9.5 dpc indicates that the Hex-expressing cells of the liver 
(orange arrow), thyroid (blue arrow) and intersomitic regions (yellow arrow) are 
present in mutant embryos. (G+G’) Fluorescence/brightfield overlay of 6.5 dpc 
mutant and non-mutant embryos derived from Hexd32 x Sox2 Cre (maternal) cross. 
Red arrow points to the AVE domain which shows are marked reduction compared to 
non-mutant littermates. Scale bar 40 μm in A+A’; 60 μm in B-C’, G+G’; 80 μm in 
D+D’; 90 μm in E+E’; 400 μm in F+F’.  
 
 
 
 
 
 
 136
 
 137
Genotype Chi-square 
test results 
Genetic 
background 
 
Total 
number 
of 
offspring 
Expected 
number 
of 
DTA/+ 
Observed 
number 
of 
DTA/+ 
Expected 
number 
of +/+ 
Observed 
number 
of +/+ 
?2 P 
value 
CD1 28 14 11 14 17 1.29 0.26 
129sv
a
 87 43.5 44 43.5 43 0.01 0.91 
 
Table 1. Frequency of genotypes among offspring from Hexd ? Wildtype crosses. 
Distribution of offspring among genotypes does not deviate from the expected 
Mendelian frequency (P > 0.05). 
a
 indicates that Hexd heterozygotes were 
backcrossed twice with 129sv mice.  
 
 
Hexd ? ?-actin Cre Genotype Chi-square test 
results 
Stage 
(dpc) 
Total Expected 
number of 
mutants 
Observed 
number of 
mutants 
Expected 
number of 
non-
mutants 
Observed 
number of 
non-
mutants 
?2 P value 
5.5 20 5 6 15 14 0.26 0.60 
6.5 180 45 40 135 140 0.74 0.39 
7.5 41 10.25 15 30.75 26 2.94 0.09 
9.5 81 20.25 17 60.75 64 0.70 0.40 
11.5 41 10.25 7 30.75 34 1.37 0.24 
Weaning 156 39 18 117 138 15.08 0.0 
 
Table 2. Genotyping results of Hexd ? ?-actin Cre crosses at various embryonic 
stages and weaning age. Observed numbers did not significantly deviate from the 
expected Mendelian frequencies at any embryonic stage analysed (P > 0.05). 
However, there was a highly significant deviation between observed numbers of 
weaned mutant mice and the expected number (P < 0.01, bold font). This indicates 
that mutants were dying between 11.5 dpc and weaning age.  
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Hexd ? Sox2 Cre  Genotype Chi-square test 
results 
Stage 
(dpc) 
Total Expected 
number of 
mutants
 a
 
Observed 
number of 
mutants 
Expected 
number of 
non-
mutants 
Observed 
number of 
non-
mutants 
?2 P value 
6.5 11 5.5 4 5.5 7 0.82 0.37 
7.5 18 9 8 9 10 0.22 0.64 
9.5 13 6.5 7 6.5 6 0.08 0.78 
 
 
Table 3. Genotyping results of Hexd ? Sox2 Cre crosses at 6.5-9.5 dpc. Observed 
numbers did not significantly deviate from the expected Mendelian frequencies at any 
embryonic stage (P > 0.05). 
a 
indicates that when the Sox2 Cre allele is maternally 
inherited, all progeny possess Sox2 Cre irrespective of the genotype. Therefore 
mutants are expected at 1:1 instead of the typical 1:3 ratio.  
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Indeed between 5.5-11.5 dpc, the frequency of mutants did not significantly deviate 
from the expected Mendelian ratio (P > 0.05) when Hexd32 mice were crossed with 
either Cre line (Table 2+3), indicating that the ablation system was not embryonically 
lethal between this period. However this analysis would not detect the loss of a small 
number of mutants that might die in this period due to the ablation system.  
Interestingly, the frequency of observed mutants at weaning age from the ?-
actin Cre cross did significantly deviate from expected Mendelian ratios (P < 0.01, 
Table 2). The ablation system was responsible for embryonic death in approximately 
54% of mutant embryos between 11.5 dpc and weaning age. The significance of the 
surviving mutants will be discussed in Section 6.1.  
 
5.2.4. The decrease in Hex-expressing cells is accompanied by a reduction in 
other AVE markers 
The onset of Hex expression in the DVE at 5.0 dpc, followed by its disappearance by 
6.5 dpc, suggests the ablation system in vivo was taking no longer than 36 hours to 
kill Hex-expressing cells. To test how the loss of Hex-expressing cells of the AVE 
affected the expression of other AVE genes, DTA-activated mutants were 
characterised by in situ hybridisation analysis at 6.5 dpc.  
 Five markers were used to characterise the AVE; Cerl, Sfrp5, Lefty1/2, Lim1 
and Dkk1. With the exception of Dkk1, in a proportion of mutants the expression 
domains of these markers showed variable degrees of reduction, ranging from a total 
absence of transcript (Cerl, n=1/11; Lefty1/2, n=2/5; Lim1, n=1/10), to partial 
reduction in both intensity of transcript and the size of expression domain (Cerl, 
n=2/11; Sfrp5, n=1/3; Lim1, n=4/10) (Fig. 4A-D’).  
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Figure 4 – Characterisation of the AVE domain in 6.5 dpc mutant embryos 
The expression of a selection of AVE markers was assessed in DTA-activated mutant 
embryos derived from the Hexd32 x ?-actin Cre cross. (A+A’) Cerl, (B+B’) Sfrp5, 
(C+C’) Lefty1/2 (Lefty1 expression in AVE, Lefty2 expression in primitive streak 
(PS)), (D+D’) Lim1 (in AVE and PS), (E+E’) Dkk1. Red arrows point to reduction of 
transcript expression in AVE. (F-G’) TUNEL staining showing variation in apoptotic 
nuclei irrespective of genotype. Scale bar 60 μm. 
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The remaining mutants showed normal transcript expression as compared to non-
activated littermates, which equated to approximately 56% of the mutants showing an 
absence or perturbed patterning of the AVE. Interestingly, there was a tendency for a 
small patch of expression to remain in the anterior region of the AVE (Fig. 4B’+C’). 
This observation was supported by analysis of the anterior AVE marker Dkk1, whose 
domain was unaffected in all mutants observed (Fig. 4E+E’; n=7/7). This suggests 
that after 5.5 dpc, Dkk1-expressing cells do not co-express with Hex-expressing cells 
of the AVE, unlike the other markers analysed whose co-expression can be inferred 
by the variable reduction in their expression patterns.  
To test if the anterior portion of the AVE was recalcitrant to ablation, mutants 
were TUNEL stained, as DTA-induced death had been previously shown to go 
through an apoptotic pathway (Collier, 2001). The prediction was that AVE would be 
distinguishable by a high density of apoptotic nuclei, whilst the anterior portion would 
show a relative reduction. In fact levels of apoptosis varied so much throughout the 
embryonic ectoderm and VE, irrespective of genotype, that this experiment was 
unable to address the specific question, though intriguingly in all embryos apoptosis 
was almost exclusively absent from the extra-embryonic ectoderm (Fig. 4F-G’; 
n=31).   
 
5.2.5. The ability to correctly position the primitive streak is impaired in a 
proportion of mutants 
It is well documented that one of the roles of the AVE is to correctly position the site 
of primitive streak formation (reviewed in Perea-Gomez et al., 2001b; Beddington 
and Robertson, 1999). To test the ability of DTA-activated mutants to establish a 
primitive streak, markers of this tissue were analysed by WISH analysis at 6.5-7.5 
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dpc. At 6.5 dpc over half of the mutants showed some form of AVE patterning defect 
as described in the previous section. Despite this fact, the Lefty2 expression domain in 
Lefty1/2 in situs was always present in mutants towards one side of the proximal 
epiblast as expected, albeit at a reduced intensity compared to non-activated 
littermates (Fig. 4C+C’; Fig. 5A+A’; n=4/5). When Lim1 transcript was absent from 
the AVE at 6.5 dpc, a reduced and/or patchy expression domain in the epiblast was 
still evident (Fig. 4D+D’; n=5/10). This indicates that the AVE still has partial 
function and is able to restrict the site of primitive streak formation; although the 
reduced epiblast expression suggests the AVE might be further responsible for 
enhancing expression of primitive streak genes once their position has been 
determined.  
 One day later at 7.5 dpc, robust expression of T and Lim1 within the primitive 
streak was clear in the vast majority of embryos (Fig. 5B+B’; C+C’). In 1/6 mutant 
embryos the expression of T was absent from the anterior of the primitive streak (Fig. 
5B’’). A further 10% (n=2/20) of mutant embryos displayed a severely retarded 
phenotype characterised by a much smaller, rounder morphology than non-mutant 
counterparts and the inability to form a primitive streak as judged by the absence of 
either T or Lim1 expression (Fig. 5B’’’+C’’). This suggests that ablating the AVE 
results in variable patterning defects of the primitive streak in a proportion of mutant 
embryos. 
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Figure 5 – Characterisation of primitive streak formation in mutant embryos 
The expression of a selection of primitive streak markers was assessed in DTA-
activated mutant embryos derived from the Hexd32 x ?-actin Cre cross. (A+A’) 
Lefty1/2 expression at 6.5 dpc appears to be lost in the AVE (Lefty1) but detected in 
the PS (Lefty2, red arrow) at low levels compared to non-mutant embryos. (B-B’’’) T 
expression at 7.5 dpc showing either no change in primitive streak formation (B’), 
absence of anterior primitive streak domain (B’’, orange arrows), or failure to induce 
any T expression (B’’’). (C-C’’) Lim1 expression at 7.5 dpc showing either no change 
in primitive streak formation (C’), or a failure to induce Lim1 expression (C’’). Scale 
bar 50 μm in A+A’; 60 μm in B-C’’. 
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5.3. Discussion 
 
This Chapter described a novel approach to address the function of the AVE. To 
achieve this, a Cre inducible form of Diphtheria toxin fragment A (DTA) was targeted 
to the Hex locus, one of the earliest expressed AVE genes, by homologous 
recombination in ES cells. The timing of this ablation system was tested by crossing 
mice harbouring the targeted allele to mouse lines ubiquitously carrying Cre 
recombinase, allowing the kinetics and efficiency of in vivo ablation to be determined.  
Ablation of Hex-expressing cells was evident by 6.5 dpc using both Sox2 Cre 
and ?-actin Cre lines, as determined by the loss of Hex transcript and/or a HexGFP 
domain in mutant embryos. By 7.5 dpc the Hex-expressing domain was re-established 
in the anterior visceral endoderm although it is unclear whether this corresponded to 
Hex-expressing cells of the AVE, ADE or both populations. Nevertheless, by 11.5 
dpc the frequency of observed mutants significantly deviated from the expected 
Mendelian ratio (Table 2). Interestingly the 56% of mutants at 6.5 dpc exhibiting an 
absence or mispatterning of the AVE corresponds nicely to the 54% of mutants that 
fail to survive to weaning age. This suggests that the ablation system is effective at 
reducing or abolishing the AVE in over half of the mutants at 6.5 dpc, and that these 
mutants die by 11.5 dpc. 
 
Given that Hex is expressed in the primitive endoderm of the blastocyst (Thomas et 
al, 1996; Chazaud and Rossant, 2006; Mesnard et al., 2006), and that both Cre mouse 
lines used should induce recombination in all cells of the embryo at or before the 
blastocyst stage (Lewandoski et al., 1997; Hayashi et al., 2003, Vincent et al., 2003), 
perhaps it seems surprising that Hex-expressing cells are not ablated even before DVE 
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induction. Furthermore, the fact that mutants are not dying by 11.5 dpc, and are 
actually indistinguishable from non-mutant littermates, indicates that not all Hex-
expressing cells are being ablated as one would expect a phenotype at least as severe 
as that observed in Hex null mice (Martinez-Barbera et al., 2000b). Both of these 
points suggest that the efficiency of the ablation system is in some way compromised.  
 
This ablation system relies firstly on the Cre-mediated recombination of loxP sites, 
followed by the transcription, translation and cytotoxic action of DTA in Hex-
expressing cells. Therefore the onset of ablation is dependant on multiple steps that 
are likely to be influenced by factors such as the type of Cre line used, and the nature 
of the cells type to be ablated. Certainly a variation in the time taken for ablation to 
occur is evident in the literature; Ivanova proposed a minimum time lapse of around 
16-20 hours between the onset of Cre expression and cell ablation in their system 
(Ivanova et al, 2005) whilst Brockschneider reported a longer time lapse in their 
system of 36-48 hours (Brockschneider et al, 2005). The efficiency of our system 
seems to be partially dependant on the type of Cre line used. Specifically the 
proportion of Hex-expressing cells that remained in 6.5 dpc mutants using Sox2 Cre 
was greater than when ?-actin Cre was utilised.  
Moreover, despite ?-actin Cre being reportedly a ubiquitous deleter from the 
1-2 cell stage (Lewandowski et al., 1997), in our hands this appears not to be the case. 
When ?-actin Cre mice were crossed to the ROSA26 LacZ reporter line (Soriano, 
1999), double heterozygous blastocysts at 3.5 and 4.5 dpc displayed salt and pepper 
distribution of blue and white cells throughout their tissues, indicating that ubiquitous 
recombination was not achieved at this stage (see Appendix II). This might impair the 
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efficiency of the ablation system if these non-recombined cells happened to express 
Hex.  
 
It is also likely that the time taken for ablation to take place can be overcome in a 
rapidly dividing cell population. This factor is unlikely to apply to cells of the AVE 
which divide very slowly (this thesis; Snow, 1977; Lawson and Pederson, 1987) but 
will could in the Hex-expressing population of the ADE which divide more rapidly 
(Lawson et al., 1991; Snow, 1977). Another possibility is that the targeting of DTA 
into the genome has induced some form of silencing of this allele. The ability of a 
genome to epigenetically silence an allele which harbours foreign DNA is well 
documented and includes methylation of the affected region (Doerfler et al., 2001; 
Muller et al., 2001). This might account for those mutants that are born with a 
seemingly ‘activated’ DTA allele.  
 
Despite impairment in the efficiency of the ablation system, the loss of Hex-
expressing cells was associated with a reduction or absence of AVE markers in 
approximately 56% of mutant mice at 6.5 dpc. Intriguingly the expression of Dkk1 
was unaffected in all mutant embryos, suggesting that Hex- and Dkk1-expressing cells 
comprise discrete cell populations. Variation in the expression of other AVE markers 
following ablation indicates transient overlap of Cerl, Lefty1, Lim1 and Sfrp5 in Hex-
expressing cells, supporting the idea that the AVE comprises a mixed population of 
cells. 
 The ability of a mispatterned/ablated AVE to correctly position the primitive 
streak was tested by analysing the expression of posterior genes between 6.5-7.5 dpc. 
In 10% (2/20) of mutants at 7.5 dpc a primitive streak was unable to form. This 
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corroborated to the 11% (4/36) of mutants that showed a complete absence of AVE 
expression at 6.5 dpc, suggesting that the whole AVE is required to initiate primitive 
streak formation. Other mutants showed reduced expression levels of primitive streak 
markers or a loss of its anterior portion. Together these results indicate that ablation of 
the AVE is responsible for a variety of primitive streak patterning defects; reiterating 
the importance of this tissue in A-P axis establishment. The relationship between the 
AVE and primitive streak formation has been further explored in the next Results 
chapter.  
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Chapter 6 – Characterisation of Hexd
act
 embryos 
6.1. Introduction 
The previous Chapter described the creation and primary characterisation of a mouse 
line in which DTA had been knocked-in to the Hex locus. This approach of Cre-
mediated activation of DTA has been extensively utilised to address the in vivo 
function of specific cell lineages or tissues. Tissue-specific promoters have been used 
to drive DTA expression for the ablation of skeletal muscle (Grieshammer et al, 
1998), cardiac myocytes (Lee et al, 1998), lens fibre cells in the ocular lens (Breitman 
et al, 1990) and the neural roof plate (Lee et al, 2000). Alternatively, DTA has been 
knocked into the ubiquitously expressed ROSA26 locus allowing the ablation of 
specific cell populations depending upon tissue-specific Cre expression (Ivanova et 
al., 2005; Wu et al., 2005; Brockschnieder et al., 2004).  
In the context of the Hexd32 knock-in mouse line, this system allowed Cre-
inducible expression of DTA in cells that express Hex, therefore allowing specific 
ablation of this cell population. In mutants harbouring the knock-in allele and Cre 
recombinase, 56% displayed patterning defects in the AVE, 11% of which showed a 
total loss of AVE markers. This corresponded to a similar percentage of mutants that 
were unable to initiate gastrulation. A further proportion of mutants displayed patchy 
and/or weak expression of primitive streak markers. Despite this fact, about half of 
the mutants survived and were born. These mice presumably possess the recombined 
allele (Hexd
act
), but for some reason were not susceptible to the effects of ablation. 
This Chapter describes the phenotypic analysis of embryos derived from Hexd
act
 
mice.  
 
 
 151
6.2. Results 
6.2.1. Hexd
act
 embryos display two Classes of phenotype depending on the time 
of ablation 
Hexd
act
 embryos were divided into two classes of phenotype by virtue of their 
morphology and timing of the loss of Hex and/or HexGFP expression. Class I mutants 
were grossly morphologically normal at 5.5 dpc (Fig. 1A+A’), but by 6.5 dpc 
confocal analysis indicated a disorganised epiblast structure and a failure of complete 
proamniotic cavitation (Fig. 1B-B’’). Class I mutants at 6.5 dpc showed a reduced or 
absent HexGFP domain (Fig. 1B-B’’; n=5/5) and an absence of Hex transcript (Fig. 
1C+C’; n=6/6) indicating that Hex-expressing cells of the AVE are ablated between 
5.5-6.5 dpc. However, Class I embryos were able to gastrulate and at 7.5 dpc the Hex 
domain of expression in the anterior definitive endoderm was present and 
indistinguishable from non-mutants (Fig. 1D-E’). The observed numbers of mutants 
did not deviate from the expected number between 5.5-8.5 dpc (Table 1+2).  
Class II embryos were rare (4.4% of the mutants, n=14), and distinguishable at 
5.5 dpc by a small and rounded egg cylinder (Fig. 1A+A’’). These mutants had an 
absence of HexGFP-expressing cells in the DVE at this stage, suggesting that these 
cells had been ablated prior to 5.5 dpc (Fig. 1A’’). Class II mutants were observed at 
7.5 dpc (n=8), but were unable to gastrulate. Due to the infrequency of the Class II 
phenotype, the total observed number of mutants did not significantly deviate from 
the expected number, however the Class II phenotype was observed in both 
heterozygous (Hexd
act
/+) and homozygous (Hexd
act
/ Hexd
act
) embryos (Table 1+2). 
6.2.2. Class I mutants display severe patterning defects of the AVE 
To further characterise the extent of patterning defects in Class I mutants, the 
expression of five AVE markers were tested at 6.5 dpc.  
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Hexd
act
 ?  CD1 Genotype Chi-square test 
results 
Stage Total Expected 
number 
of 
mutants 
Observed 
number 
of 
mutants 
Expected 
number 
of non-
mutants 
Observed 
number 
of non-
mutants 
?2 P value 
5.5 18 9 7 9 11 0.89 0.35 
6.5 36 18 13 18 23 2.78 0.10 
7.5 42 21 15 21 27 3.43 0.06 
8.5 14 7 4 7 10 2.57 0.11 
Weaning 95 47.5 33 47.5 62 8.85 0.0 
 
Table 1. Genotyping results of Hexd
act
 ? CD1 crosses at various embryonic stages 
and weaning age. Observed numbers did not significantly deviate from the expected 
Mendelian frequencies at any embryonic stage (P > 0.05). However, there was a 
highly significant deviation between observed numbers of weaned mutant mice and 
the expected number (P < 0.01, bold font). This indicates that mutants were dying 
between 8.5 dpc and weaning age.  
 
 
 
Hexd
act
 ?  
Hexd
act
 
Genotype Chi-
square 
test results 
Stage Total Expected 
number of 
homozygous 
mutants 
Observed 
number of 
homozygous 
mutants 
Expected 
number of 
heterozygous 
mutants 
Observed 
number of 
heterozygous 
mutants 
Expected 
number 
of 
wildtype 
Observed 
number 
of 
wildtype 
?2 P 
value 
6.5 145 36.25 46 72.5 65 36.25 34 3.54 0.17 
7.5 269 67.25 66 134.5 131 67.25 72 0.45 0.80 
8.5 38 9.5 6 19 21 9.5 11 1.74 0.42 
Weaning 21 5.25 0 10.5 9 5.25 12 14.14 0.0 
 
Table 2. Genotyping results of Hexd
act
 ? Hexdact intercrosses at various embryonic 
stages and weaning age. Observed numbers did not significantly deviate from the 
expected Mendelian frequencies at any embryonic stage (P > 0.05). However, there 
was a highly significant deviation between observed numbers of weaned mutant mice 
and the expected number (P < 0.01, bold font). This indicates that mutants were 
dying between 8.5 dpc and weaning age.  
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Figure 1 – Characterisation of the genetic ablation system in Hexd
act
 embryos 
(A-B’’, D+D’) Hexd
act
 embryos staged between 5.5-7.5 dpc were analysed by 
confocal microscopy. Nuclear stain (blue); F-actin (red). (A) Wildtype embryo at 5.5 
dpc. HexGFP cells are present in the DVE (green). (A’) Class I embryo at 5.5 dpc 
showing HexGFP expression in the DVE (cyan arrow). (A’’) Class II embryo at 5.5 
dpc showing small and rounded morphology and an absence of HexGFP-expressing 
cells. (B) Wildtype embryo at 6.5 dpc. HexGFP cells are present in the AVE (orange 
arrow). (B’+B’’) Class I embryos at 6.5 dpc showing an absence of HexGFP 
expression in the AVE. Incomplete proamniotic cavitation shown by yellow arrow in 
(B’’). (C) WISH analysis of Hex showing expression in the AVE of a wildtype 
embryo at 6.5 dpc. (C’) WISH analysis of Hex in a Class I mutant embryo at 6.5 dpc 
showing an absence of Hex transcript in the AVE. (D) Wildtype embryo at 7.5 dpc 
showing expression of HexGFP in the anterior definitive endoderm (green). (D’) 
Class I mutant embryo at 7.5 dpc showing expression of HexGFP in the anterior 
definitive endoderm (green). (E) WISH analysis of Hex in the anterior definitive 
endoderm of a wildtype embryo at 7.5 dpc. (E’) WISH analysis of Hex in Class I 
mutant embryo at 7.5 dpc showing expression in the anterior definitive endoderm. 
Scale bar 40 μm in A-A’’; 60 μm in B-B’’; 90 μm in C+C’; 100 μm in D-E’.  
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Figure 2 – Characterisation of the AVE domain in 6.5 dpc Class I mutants 
The expression of a selection of AVE markers was assessed in Hexd
act
 Class I mutant 
embryos by WISH analysis. (A) Wildtype and (A’) mutant embryo showing 
expression of Lefty1/2. L1, Lefty1 expression in the AVE; L2, Lefty2 expression in the 
primitive streak. (B) Wildtype and (B’) mutant embryo displaying expression of Fz8 
in the AVE. (C) Wildtype and (C’) mutant embryo displaying expression of Cerl in 
the AVE. (D) Wildtype and (D’) mutant embryo displaying expression of Sfrp5 in the 
AVE. (E) Wildtype and (E’) mutant embryo displaying expression of Dkk1 in the 
AVE. (F) Wildtype and (F’) mutant embryo displaying expression of Ttr in the 
extraembryonic visceral endoderm. Scale bar 90 μm. 
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WISH analysis revealed AVE patterning defects in 30% of mutant embryos 
(n=26/86). This consisted of a vast reduction or total absence of transcript of some 
markers (Lefty1/2, n=13/28; Fz8, n=4/13; Cerl, n=7/16; Sfrp5, n=2/14) (Fig. 2A-D’), 
but no change in the expression of Dkk1 and Sfrp5, two markers of the anterior 
portion of the AVE (Dkk1, n=15/15; Sfrp5, n=12/14). This indicates that cells 
expressing these genes do not overlap with Hex-expressing cells (Fig. 2D-E’). It was 
apparent that despite the AVE patterning defects caused by genetic ablation system, 
the visceral endoderm remained intact and showed no evidence of a loss of integrity. 
Miura and Mishina found that microsurgical ablation of the DVE caused the 
embryonic visceral endoderm to acquire extraembryonic visceral endoderm character 
(Miura and Mishina, 2007). To test this possibility the expression of transthyretin 
(Ttr) was examined. At 6.5 dpc, Ttr is expressed exclusively in extraembryonic 
visceral endoderm (Makover et al., 1988). This was consistent in all of the embryos 
tested in this study irrespective of genotype, suggesting that the embryonic visceral 
endoderm does not adopt an extraembryonic character in Class I mutants (Fig. 2F+F’; 
n=16).  
 
6.2.3. Class I mutants show a failure to specify the anterior primitive streak and 
exhibit EMT defects 
To explore the effect of AVE ablation in Hexd
act
 mice on the formation of the 
primitive streak, the expression of a selection of primitive streak markers were 
analysed by WISH. At 6.5 dpc, Lefty2 is normally expressed in the primitive streak. 
At this stage the Lefty2 domain observed in Lefty1/2 in situs was absent in a 
proportion of mutants (Fig. 2A+A’, n=7/28). Eomes expression, which is normally 
expressed in the extraembryonic ectoderm and posterior epiblast at this stage, was 
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also absent in the epiblast in a proportion of mutants (Fig. 3D+D’, n=2/11). However, 
the expression of T and Cripto were all initiated or restricted (in the case of Cripto) to 
the posterior side of mutant embryos (Fig. 3B+B’, F+F’, T, n=7; Cripto, n=9). This 
suggests the onset of some markers was delayed, possibly due to defects in the 
initiation of primitive streak formation.  
Once the primitive streak is initiated, epiblast cells traverse through the 
primitive streak and adopt a mesodermal or endodermal fate (Introduction in this 
thesis, Fig. 3; reviewed in Tam and Behringer, 1997). WISH analysis revealed that 
whilst mutant embryos displayed robust expression of T and Eomes in the 
extraembryonic mesoderm and intermediate primitive streak, a proportion displayed a 
lack of expression in the mesodermal derivatives of the anterior primitive streak (Fig. 
3C+C’, E+E’; T, n=3/14; Eomes, n=3/18). This suggested that mesoderm cells 
expressing these markers were unable to extend anteriorly or were incorrectly 
patterned, unlike the expression domains in the wildtype situation (Fig. 3C+E). The 
node and anterior mesendoderm marker, HNF3?, was expressed normally in mutant 
embryos indicating that these particular anterior primitive streak derivatives were 
unaffected (Fig. 3A+A’, n=8/8). Additionally expression of Wnt3 and the paraxial 
mesoderm marker Tbx6 in mutant embryos was indistinguishable from non-mutant 
counterparts (Fig. 3G-H’; Wnt3, n=11/11; Tbx6, n=13/13) further indicating that only 
a subset of mesoderm cells were affected in a proportion of Class I mutants.  
To test if the failure to anteriorly extend T- and Eomes-expressing cells of the 
primitive streak was due to defective cell movements, expression of FGF8 and its 
downstream target Snail were analysed. FGF8 has been shown to have a crucial role 
in controlling the morphogenesis of mesoderm at the primitive streak, in part by 
controlling Snail expression (Ciruna and Rossant, 2001; Cano et al., 2000).  
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Figure 3 – Characterisation of primitive streak formation in Class I mutants 
The expression of a selection of primitive streak markers was assessed in Class I 
mutants by WISH analysis. (A) Wildtype and (A’) mutant embryo displaying 
expression of HNF3? in the node at 7.5 dpc. (B) Wildtype and (B’) mutant embryo 
displaying expression of T in the primitive streak at 6.5 dpc. (C) Wildtype and (C’) 
mutant embryo displaying expression of T in the primitive streak and axial 
mesendoderm at 7.5 dpc. The mutant embryo shows an absence of T expression in the 
anterior primitive streak (orange arrowheads). (D) Wildtype and (D’) mutant embryo 
displaying expression of Eomes in the extraembryonic ectoderm and primitive streak 
at 6.5 dpc. Green arrow signifies absence of epiblast expression. (E) Wildtype and 
(E’) mutant embryo displaying expression of Eomes in the extraembryonic ectoderm 
and primitive streak at 7.5 dpc. The mutant embryo shows an absence of Eomes 
expression in the anterior primitive streak (yellow arrow). (F) Wildtype and (F’) 
mutant embryo displaying expression of Cripto in the primitive streak at 6.5 dpc. (G) 
Wildtype and (G’) mutant embryo displaying expression of Wnt3 in the intermediate 
and extraembryonic mesoderm at 7.5 dpc. (H) Wildtype and (H’) mutant embryo 
displaying expression of Tbx6 in the paraxial mesoderm at 7.5 dpc. (I) Wildtype and 
(I’) mutant embryo displaying expression of FGF8 in the mesoderm at 7.5 dpc. 
Mutants embryos show reduced expression in the intermediate mesoderm 
compartment (cyan arrow). (J) Wildtype and (J’) mutant embryo displaying 
expression of Snail throughout the primitive streak at 7.5 dpc. Mutants show reduced 
expression in the primitive streak (red arrow). (K) Wildtype and (K’) mutant embryos 
derived from a Hexd x Sox2Cre (male) cross. Expression of T observed throughout 
the mesoderm at 7.5 dpc in both wildtype and mutant embryos. Scale bar 90 μm. 
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Indeed, a proportion of Class I Hexd
act
 mutants exhibited reduced expression of both 
FGF8 and Snail throughout the primitive streak (Fig. 3I-J’; FGF8, n=5/17; Snail, 
n=3/15). Interestingly, the extraembryonic mesoderm expression of both markers 
appeared unaffected in all mutants as in wildtype embryos, indicating that any 
morphogenetic defects of the primitive streak were unlikely to affect this mesoderm 
compartment (Fig. 3I-J’). It appears that ablating the Hex-expressing population of 
AVE cells affects the patterning/correct placement of the anterior primitive streak, 
possibly as a result of inappropriately regulating cell movements.  
 
6.2.4. There are no apparent defects in the anterior definitive endoderm of Class 
I mutants 
The expression of the definitive endoderm markers Cerl and Sox17 were analysed in 
Class I Hexd
act 
mutants and found to be present and indistinguishable from wildtype 
embryos at 7.25-7.5 dpc, suggesting that the anterior definitive endoderm is not 
ablated in these mutants (Fig. 4A-E’; Cerl, n=14; Sox17, n=14). To rule out the 
possibility that patterning defects in the anterior primitive streak were not simply due 
to ablation of Hex-expressing cells of the ADE, Hexd mice were crossed to male 
Sox2Cre mice. This allowed the ablation system to be activated in epiblast-derived 
Hex-expressing cells, but not extraembryonic tissues such as the AVE (Hayashi et al., 
2002). Any anterior primitive streak defects would be a result of ablation of the ADE 
and not as a consequence of AVE ablation. Embryos were dissected at 7.5 dpc and T 
expression was examined. Unlike the anterior primitive streak patterning defects 
observed in a proportion of Hexd
act
 mutants, all mutants resulting from Sox2Cre 
activation had complete T expression domains (Fig. 3K+K’; n=9/9).  
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Figure 4 - Characterisation of the definitive endoderm and anterior 
neurectoderm in Class I mutants 
The expression of a selection of definitive endoderm and neurectoderm markers were 
assessed in Class I mutants by WISH analysis. (A) Wildtype and (A’) mutant 
embryos showing expression of Cerl in the AVE and definitive endoderm (DE) at 
7.25 dpc. (B) Wildtype and (B’) mutant embryos showing expression of Cerl at 7.5 
dpc. (C) Wildtype and (C’) mutant embryos showing expression of Sox17 in the AVE 
and definitive endoderm (DE) at 7.25 dpc. (D) Wildtype and (D’) mutant embryos 
showing expression of Sox17 at 7.5 dpc. Red arrow points to expression in the 
definitive endoderm (E+E’) Anterior view of the same embryos are shown. Red arrow 
points to expression in the definitive endoderm. (F) Wildtype and (F’) mutant 
embryos showing expression of Otx2 in the anterior neurectoderm at 7.5 dpc. (G) 
Wildtype and (G’) mutant embryos showing expression of Hesx1 in the anterior 
neurectoderm at 7.5 dpc. (H) Wildtype and (H’) mutant embryos showing expression 
of Hesx1 in the forebrain at 8.5 dpc. (I+I’) Anterior view of the same embryos are 
shown. (J) Wildtype and (J’) mutant embryos showing expression of Six3 in the 
forebrain at 8.5 dpc. (K+K’) Anterior view of the same embryos are shown. (L) 
Wildtype and (L’) mutant embryos showing expression of FGF8 in the isthmus 
(green arrowhead) and commissural plate (magenta arrowhead) at 9.5 dpc. The 
mutant embryo has the genotype Hexd
act
/Hexd;?-actin Cre/+, and shows an anterior 
truncation of the forebrain, reminiscent of the Hex null phenotype. Scale bar 90 μm in 
A-G’; 250 μm in H-K’; 500 μm in L+L’. 
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This strongly suggested that the observed primitive streak defects were a consequence 
of AVE ablation.  
 
6.2.5. There are no apparent defects in the anterior neurectoderm of Class I 
mutants 
To determine how the anterior neurectoderm is patterned in Class I mutants the 
expression of Otx2 and Hesx1 were analysed. At 7.5 dpc both genes were correctly 
expressed in the anterior ectoderm of Class I mutants (Fig. 4F-G’; Otx2, n=11; Hesx1, 
n=12). This anterior neurectoderm patterning is maintained in Class I embryos at 8.5 
dpc as indicated by the expression of Hesx1 and Six3 in the forebrain of all mutants 
examined (Fig. 4H-K’; Hesx1, n=13; Six3, n=14). The absence of forebrain defects at 
this early headfold stage indicates that the ADE is continuing to pattern the 
underlying ectoderm. This is the stage when Hex null embryos start exhibiting 
forebrain defects (Martinez-Barbera et al., 2000a), and normal forebrain patterning in 
Class I mutants suggests the efficiency of the ablation system is impaired. The only 
instance when forebrain truncations were observed was at 9.5 dpc in homozygous 
Hexd
act
 mutants. In this situation an absence of endogenous Hex phenocopies the null 
mutant as indicated by an absence of FGF8 expression in the commissural plate (Fig. 
4L+L’). In summary, Class I mutants can correctly specify the definitive endoderm 
and are able to correctly pattern the anterior neurectoderm suggesting that the ADE is 
only ablated after it has patterned this tissue.  
  
6.2.6. Class II mutants are unable to gastrulate 
Class II mutants comprised 4.4% of the total mutants analysed, which hindered 
characterisation of the phenotype. Morphologically, embryos are small and round, and 
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could be detected up to 7.5 dpc. Ablation of Hex-expressing cells occurs prior to 5.5 
dpc as indicated by a loss of HexGFP expression in the DVE (Fig. 5A+A’, n=1), and 
therefore constitutes an earlier ablation than that seen in Class I mutants. At 6.5 dpc, 
the Cerl expression domain is absent in the AVE signifying the loss of this tissue 
(Fig. 5B+B’, n=1). One out of two Class II embryos displayed an expansion of 
expression of Ttr into the embryonic visceral endoderm (Fig. 5C+C’, n=1/2). This 
supports the finding of Miura and Mishina (2007) who found that when DVE was 
ablated at/prior to 5.5 dpc, ectopic expression of extraembryonic visceral endoderm 
markers was observed. At 6.5 dpc, Eomes transcript is normally detected in the 
extraembryonic ectoderm (ExE) and the site of primitive streak formation. However, 
despite the Class II mutant analysed showing robust expression in the ExE, there was 
a failure to induce epiblast expression (Fig. 5D+D’, n=1). This was not due to cells 
prematurely differentiating down a different lineage as the pluripotency marker Oct4 
was robustly expressed throughout the epiblast at 7.5 dpc in mutant and control 
embryos (Fig. 5E+E’, n=1).  
Wnt3 is normally expressed before gastrulation in the proximal epiblast of the 
egg cylinder, before being restricted to the posterior proximal epiblast and eventually 
the primitive streak (Liu et al., 1999). At 7.5 dpc, Class II mutants expressed Wnt3 in 
the proximal epiblast, but showed no sign of any posterior restriction (Fig. 5F+F’, 
n=2). Additionally both T, which marks the primitive streak and axial mesoderm, and 
HNF3?, which is expressed in the node, were both absent at 7.5 dpc indicating the 
lack of primitive streak and node tissue formation (Fig. 5G-H’; T, n=2; HNF3?, n=2). 
The inability of Class II mutants to gastrulate results in their reabsorption as they are 
not detected later than 7.5 dpc.  
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Figure 5 - Characterisation of Class II mutants 
The expression of a selection of markers was assessed in Class II mutants. (A) 
Confocal slices of wildtype and (A’) mutant embryos at 5.5 dpc. HexGFP is expressed 
in the DVE of the wildtype embryo (green), but is absent from the mutant (A’). 
Nuclear stain (blue); F-actin (red). (B) Wildtype and (B’) mutant embryo showing 
expression of Cerl in the AVE at 6.5 dpc. Cerl is absent from the mutant embryo (B’). 
(C) Wildtype and (C’) mutant embryo showing expression of Ttr in the 
extraembryonic visceral endoderm at 6.5 dpc. One out of two Class II embryos 
analysed showed ectopic expression in the embryonic visceral endoderm (red 
arrowhead). (D) Wildtype and (D’) mutant embryo showing expression of Eomes in 
the extraembryonic ectoderm (green arrow) and primitive streak (blue arrow) at 6.5 
dpc. Primitive streak expression is absent in the Class II mutant (D’). (E) Wildtype 
and (E’) mutant embryo showing expression of Oct4 in the epiblast at 7.5 dpc. (F) 
Wildtype and (F’) mutant embryo showing expression of Wnt3 at 7.5 dpc. Class II 
mutants show expression of Wnt3 in a ring around the proximal epiblast (F’).  (G) 
Expression of T at 7.5 dpc in a wildtype embryo is throughout the primitive streak. 
(G’) T expression is not observed in Class II mutants. (H) Wildtype expression of 
HNF3? at 7.5 dpc is in the node. (H’) HNF3? expression is not observed in Class II 
mutants. Scale bar 40 μm in A+A’; 60 μm in B-D’; 70 μm in E-H’. 
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6.2.7. Nodal signalling is aberrant in both Classes of mutant 
The AVE and DVE secrete antagonists of Nodal signalling that restrict its activity to 
the proximal, then posterior epiblast where it can impart primitive streak-inducing 
activity (reviewed in Beddington and Robertson, 1999; Perea-Gomez et al., 2001b). 
To test the consequence of tissue ablation of the AVE on Nodal signalling, Hexd
act 
mutants underwent WISH analysis. At 6.5 dpc, Nodal transcript should be restricted 
to the posterior epiblast (Fig. 6A). However, 29% of Class I mutants showed proximal 
but not posterior restriction of Nodal transcript and the level of expression was weak 
(Fig. 6A’, n=8/28). The Class II mutant analysed also displayed weak expression but 
throughout the epiblast (Fig. 6A’’, n=1). This suggested that Class I mutants in which 
the AVE had been ablated were unable to effectively restrict Nodal to the posterior of 
the epiblast, whilst Class II mutants that showed an earlier ablation were not capable 
of restricting Nodal expression at all.  
 It was curious that Nodal transcripts appeared weaker in activated mutants 
compared to non-mutants. Was it possible that the AVE not only restricts the site of 
Nodal expression but also regulates its expression levels? To test this possibility, 
Hexd
act
 mutants were crossed to Nodal
LacZ/+
 mice. This cross would halve the levels of 
endogenous Nodal. In heterozygous Nodal
LacZ/+ 
embryos the site of ?-Gal staining is 
correctly positioned and the A-P axis is correctly established (Norris et al., 2002; Fig. 
6B). If the AVE was involved in increasing the activity of Nodal signalling, then one 
might expect a greater proportion of Hexd
act
; Nodal
LacZ/+
 mutants to exhibit defects in 
Nodal restriction and/or expression levels.  
 Of the eight Hexd
act
; Nodal
LacZ/+
 mutants examined at 6.5 dpc, six showed 
low-level ?-Gal staining in the proximal but not posterior epiblast (Fig. 6B’, n=6/8). 
This indicated that halving the levels of Nodal within the epiblast of ablated mutants 
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caused an increase in the incidence of proximally restricted Nodal. A further two 
displayed ?-Gal staining throughout the epiblast-a defect not observed in Class I 
mutants with two copies of Nodal (Fig. 6B’’, n=2/8). The consequence of this 
observation on primitive streak formation was tested by examining the expression of 
T in these mutants at 7.5 dpc.  
Previously, an absence of T expression in the anterior primitive streak had 
been observed in Class I mutants (Fig. 3B+B’, n=3/14). In six Hexd
act
; Nodal
LacZ/+
 
mutants analysed, one showed a lack of T expression in the anterior primitive streak 
consistent with this phenotype (Fig. 6C’, n=1/6). Another mutant showed expression 
throughout the proximal epiblast which had not been seen before (Fig. 6C’’, n=1/6). 
These results suggest that the combination of ablation in a reduced Nodal background 
increases the frequency and severity of patterning defects in the primitive streak (33% 
of mutants display defects when Nodal is halved versus 20% of mutants when two 
copies of Nodal are present). This implies that in addition to the role of the AVE in 
restricting Nodal expression, this tissue also assists in augmenting Nodal activity prior 
to primitive streak formation.  
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Figure 6 – Nodal signalling is affected in both Classes of mutant 
(A-A’’’) In situ analysis of Nodal expression at 6.5 dpc. (A) Wildtype embryo 
displaying posterior restriction of Nodal transcript. Green line demarcates anterior (A) 
and posterior (P) boundary. (A’) Class I mutants display proximal restriction of Nodal 
transcript as indicated by the green line. P and D corresponds to proximal and distal 
respectively. (A’’) The Class II mutant displays Nodal transcript throughout the 
epiblast. (B-B’’) Embryos derived from Hexd
act/+
 x Nodal
LacZ/+
 cross at 6.5 dpc. (B) 
Wildtype embryo displaying posterior restriction of ?-Galactosidase (b-Gal) activity. 
(B’) Compound mutant showing a smaller proximal domain of ?-Galactosidase  
activity. (B’’) Compound mutant showing ?-Galactosidase activity throughout the 
epiblast. (C-C’’) Embryos derived from Hexd
act/+
 x Nodal
LacZ/+
 cross at 7.5 dpc. (C) 
Wildtype embryo showing expression of T throughout the primitive streak. (C’) 
Compound mutant showing an absence of T in the anterior portion of the primitive 
streak (red arrowheads). (C’’) Compound mutant showing expression of T in the 
proximal epiblast as indicated by the orange line. Scale bar 100 μm in A-B’’; 120 μm 
in C-C’’.  
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6.3. Discussion 
 
This Chapter characterised Hexd
act
 embryos derived from mice that possess the 
activated DTA allele but survive and are fertile. The most likely reason for their 
survival is the epigenetic silencing of the knocked-in allele, thereby circumventing 
cell death caused by the ablation system. During germ-cell development, epigenetic 
marks such as DNA methylation are generally erased by a currently unknown 
mechanism (reviewed in Reik, 2007). This meant that in the context of this ablation 
system, the Hexd
act 
allele should be re-activated and have the capacity to kill Hex-
expressing cells.  
 This indeed was the case. Two classes of mutant were observed depending on 
the timing of the genetic ablation. Class I embryos were morphologically normal but 
30% exhibited a loss or severe reduction of AVE markers between 5.5 and 6.5 dpc. A 
similar proportion of Class I mutants were unable to restrict Nodal expression to the 
posterior of the embryo, suggesting that this was a functional consequence of an 
absence of AVE tissue. Class II mutants were observed at a frequency of 4.4%. In 
these mutants, Hex-expressing cells were lost before 5.5 dpc as determined by an 
absence of the HexGFP domain. Accordingly, Nodal expression at 6.5 dpc was 
observed throughout the epiblast, consistent with an absence of DVE tissue. The exact 
timing of ablation in Class II mutants was not precisely determined. As the DVE was 
not present at 5.5 dpc, it is possible that ablation might have occurred in Hex-
expressing cells in the primitive endoderm. Considering the widespread expression of 
Hex transcript in the primitive endoderm of 4.5-4.75 dpc embryos (Chazaud et al., 
2006b; Mesnard et al., 2006), it is unlikely the whole population was ablated without 
recapitulating the peri-implantation defects of mutants where primitive endoderm fails 
 173
to form (examples include Grb2 and Fgfr2 null embryos (Chazaud et al., 2006b; 
Arman et al., 1998)).  
It is worth noting that both phenotypic classes were present when the Hexd 
allele was activated by Cre recombination, as discussed in Results Chapter 3. This 
indicated that the Hexd
act
 allele could function in the re-activated context to produce 
the two classes of mutant observed previously. The advantage of using mice with the 
activated allele was the increased frequency of mutant embryos due to heterozygous 
Hexd
act/+
 crosses resulting in 75% mutant embryos instead of the typical 25% from the 
Hexd x ?actin Cre cross.  
 
Almost one fifth (n=6/32) of Class I mutants showed an absence of the anterior 
primitive streak as determined by loss of Eomes or T transcript in this region. The 
possibility that this was due to cell ablation in the Hex-expressing population of the 
anterior definitive endoderm was discounted as (i) other markers of this tissue (Cerl 
and Sox17) were correctly localised and (ii) when the ablation system was restricted 
to epiblast-derived tissues (such as the definitive endoderm) by paternal Sox2Cre 
activation, T was expressed throughout the primitive streak in all mutants analysed. 
This meant that lack of anterior primitive streak tissue was a result of AVE ablation, 
but by what mechanism?  
 
Diagnostic in situ hybridisation analysis demonstrated that FGF8 and its target Snail 
were weakly expressed in the middle streak (n=8/32), unlike the strong expression 
found in non-mutant counterparts. Both of these genes are key regulators in 
controlling morphogenetic cell movements of mesoderm. FGF signalling has been 
shown to control Snail expression, and Fgfr1 null mutants are unable to maintain 
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Snail expression resulting in a mispatterned primitive streak (Ciruna and Rossant, 
2001; Cano et al., 2000). Snail is required for mesendoderm formation and in Snail 
null embryos, T is expressed but does not extend rostrally-as seen in Class I mutants 
(Carver et al., 2001). It is possible that in Class I mutants, mesoderm cells are 
specified but fail to extend anteriorly due to defective cell movements. Defects in cell 
movements might also explain the disorganised epiblast morphology at 6.5 dpc 
detected by confocal analysis. Arnold and colleagues recently reported that Eomes 
expression in the posterior epiblast was essential for epithelial-to-mesenchymal 
transition in the primitive streak (Arnold et al., 2008). Although FGF8 and Snail 
expression were unaffected in these mutants, they too showed a lack of T expression 
in the anterior primitive streak.  
In the case of the primitive streak defects observed in Class I mutants, a failure 
to detect anterior mesoderm might be a consequence of the inability of cells to 
appropriately extend the primitive streak due to EMT defects. However, other anterior 
streak derivatives such as the node and definitive endoderm were present and 
correctly located. An alternative possibility is that specific patterning defects within 
the primitive streak have caused certain cell populations to be mis-specified.  
 
In support of this second possibility, different levels of Nodal activity have previously 
been shown to specify different cell fates in the mouse embryo (Norris et al., 2002; 
Vincent et al., 2003; Dunn et al., 2004). Specifically, specification of the anterior 
streak derivatives can be curtailed by knocking-out Smad2 from the epiblast (Vincent 
et al., 2003b), or FoxH1 (Hoodless et al., 2001) or lowering the level of Nodal 
activity in Nodal?
600/+
embryos (Norris et al., 2002). Was it possible that the anterior 
primitive streak defects could be a result of inappropriate levels of Nodal signalling? 
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Both classes of mutant showed defects in the restriction of Nodal transcript. Class II 
mutants expressed Nodal throughout the epiblast-a characteristic also observed when 
the DVE was microsurgically ablated (Miura and Mishina, 2007). The inability of this 
class to gastrulate might be a result of them not reaching the required number of cells 
(Snow, 1977), or levels of Nodal not being sufficiently great to initiate target genes. 
Class I mutants were unable to restrict Nodal expression to the posterior of the 
epiblast at 6.5 dpc and showed reduced intensity of transcript compared to non-
mutants. Furthermore, when crossed to a Nodal
LacZ/+ 
background, compound 
heterozygotes (Hexd
act/+
;Nodal
LacZ/+
) showed an increased frequency of proximal 
Nodal expression at 6.5 dpc. At 7.5 dpc these mutants displayed an absence of the 
anterior primitive streak or a failure to rotate the proximodistal axis as determined by 
proximal T expression-a phenotype not previously observed when both copies of 
Nodal were present. As Nodal
LacZ/+ 
mutants display no A-P patterning defects, these 
results suggest that the AVE cooperates with Nodal signalling to correctly establish 
the A-P axis.  
 
Despite a proportion of Class I embryos displaying a loss of AVE at 6.5 dpc and a 
loss of anterior primitive streak mesoderm at 7.5 dpc, all embryos showed correct 
localisation of anterior neurectoderm markers at 7.5-8.5 dpc. The current model of 
establishing anterior identity is that AVE initiates, and as gastrulation proceeds these 
signals are stabilised and embellished by anterior streak derivatives (Kimura et al., 
2000; Perea-Gomez et al., 2002; reviewed in Beddington and Robertson, 1999; 
Martinez-Barbera and Beddington, 2001). Maybe in the context of this ablation 
system, any residual AVE that was not ablated (such as Dkk1- and Sfrp5-expressing 
cells) was sufficient to initiate neural identity. Alternatively the AVE might have 
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already performed its initiating function before being ablated at 6.5 dpc. Either way, it 
is clear that the anterior primitive streak defects observed at 7.5 dpc do not perturb 
anterior neurectoderm development.  
This is contrary to the experiments of Thomas and Beddington who 
demonstrated microsurgical ablation of the AVE diminished Hesx1 expression in the 
anterior neurectoderm (Thomas and Beddington, 1996). Although in this experiment 
the AVE was ablated at 6.5 dpc, so most likely anterior definitive endoderm was also 
removed. This would explain the loss or reduction of Hesx1 expression in the 
underlying ectoderm as the source of maintenance signals from the definitive 
endoderm had been removed.  
 
It is perhaps surprising that Class I embryos do not phenocopy Cerl
-/-
;Lefty1
-/-
 
compound mutants, considering that both these gene expression domains are absent 
from the AVE in Hexd
act
 embryos. In Cerl
-/-
;Lefty1
-/-
 embryos, the primitive streak 
can develop ectopically and primitive streak patterning defects are present but can be 
rescued after removal of one copy of the Nodal gene (Perea-Gomez et al., 2002). In 
Class I mutants, the site of primitive streak formation is specified but Nodal is not 
correctly restricted and is expressed at lower levels. Furthermore, the patterning 
defects observed in the anterior primitive streak are augmented when one copy of 
Nodal is removed. The differences in phenotype between these two mutants suggest 
that ablating the whole AVE has revealed an additional function on top of its Nodal-
antagonising role: not only does the AVE restrict the position of Nodal expression, 
but prior to this it also enhances its activity. The AVE could be increasing the level of 
Nodal, perhaps by secreting activating co-factors or aiding the sorting of Nodal-
 177
positive cells to the posterior (Lu and Robertson, 2004). These possibilities need 
testing. 
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Chapter 7 - General discussion 
 
The anterior visceral endoderm (AVE) is an extraembryonic tissue required for 
restricting the site of primitive streak formation (Perea-Gomez et al., 2002) and 
specifying anterior pattern in the mouse embryo (reviewed by Martinez-Barbera and 
Beddington, 2001). This thesis has addressed two aspects of AVE function. Firstly, 
the contribution of proliferation to AVE movements, and secondly a novel approach 
to genetically ablate this tissue and thereby glean insight into additional roles during 
A-P axis establishment.   
 
7.1. Proliferation during AVE movements 
The AVE is induced at the distal tip of the embryo and at 5.5 dpc migrates to the 
prospective anterior (Thomas et al., 1998). This movement is essential for converting 
the existing proximal-distal axis into an anterior-posterior axis (reviewed by 
Beddington and Robertson, 1999). How these movements take place is still not well 
understood. One suggestion is that differential proliferation within the visceral 
endoderm passively displaces the AVE towards the anterior side, which has 
reportedly lower levels of proliferation than the posterior side (Yamomoto et al., 
2004). Another possibility is that the AVE actively migrates to the anterior side, 
possibly in response to cues inherent to the embryo. 
 Data presented here show low levels of proliferation within the visceral 
endoderm throughout the time of AVE movements. Furthermore, no regional 
differences in the levels of proliferation were observed between the anterior and 
posterior visceral endoderm, with both cell populations cycling at similar rates. This 
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finding does not support the differential proliferation model for directing AVE 
movements.  
The most compelling evidence for studying AVE cell movements has come 
from directly visualising embryos in real time using transgenic lines that express GFP 
in an AVE-specific manner (Srinivas et al., 2004). Movements occur within 4-5 
hours, with cells projecting filopodial processes in the direction of movement-
indicative of an active migratory process (Srinivas et al., 2004). Further evidence for 
active migration comes from knocking out Nap1 and showing that polarised cell 
movements are perturbed (Rakeman and Anderson, 2006). The direction of DVE 
movements might be determined by guiding these cells towards Dkk1 (an antagonist 
of Wnt/?-catenin signalling) expressed in the prospective anterior of the embryo and 
away from a repellant Wnt3a signal found in the posterior of the embryo, (Kimura-
Yoshida et al., 2005).  
 
Although proliferation within the visceral endoderm seems not to specifically direct 
AVE movements, a more general requirement for proliferation was observed in this 
study. Blocking cell division throughout the embryo prevented AVE migration, as did 
blocking Nodal signalling (Fig. 1). Interestingly when Nodal signalling was blocked, 
proliferation levels in the epiblast dramatically fell whilst levels in the visceral 
endoderm were unaffected. Indeed the role of Nodal in promoting proliferation in the 
epiblast has previously been inferred (Mesnard et al., 2006; Yamamoto et al., 2004). 
Perhaps by reducing proliferation in the epiblast, the physical interaction between this 
tissue and the overlying visceral endoderm is affected, resulting in AVE movement 
defects.  
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Figure 1 – Schematic representation of proliferation in the mouse embryo during 
AVE movements 
(A) At 5.5 dpc, the anterior visceral endoderm precursors (green) are located at the 
distal tip of the conceptus. Low levels of dividing cells are randomly distributed 
throughout the visceral endoderm at this stage (red dots). When embryos are cultured 
for 12 hrs, the anterior visceral endoderm moves anteriorwards until cells reach the 
embryonic-extraembryonic ectoderm boundary. Cells in the visceral endoderm 
continue to divide at a low rate and with no regional bias. (B) When 5.5 dpc embryos 
are cultured for 12 hrs in the cell cycle inhibitor Okadaic acid, cell division 
throughout the epiblast and visceral endoderm is abolished. The AVE fails to move 
anteriorwards in these conditions. (C) When 5.5 dpc embryos are cultured for 12 hrs 
in the Nodal/activin inhibitor SB-431542, proliferation within the epiblast 
significantly falls. Proliferation throughout the visceral endoderm is unaffected, 
indicating that cell division within this tissue is independent of Nodal/activin 
signalling, unlike the epiblast. The anterior visceral endoderm fails to move 
anteriorwards in cultured embryos, despite the levels of cell division in this tissue 
remaining unaffected.  
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There remain many intriguing questions concerning the nature of AVE movements. 
For example, what is the exact mechanism behind determining the direction of DVE 
movements and how does the AVE know when to stop when it reaches the boundary 
between the epiblast and extraembryonic ectoderm? Recent advances in imaging and 
genetic techniques are enabling less invasive observations into the cellular basis of 
AVE movements ex vivo. Concurrently, a better understanding of in vitro cell 
differentiation systems have allowed extraembryonic endoderm (XEN) cells to be 
derived and characterised (Kunath et al., 2005), enabling further insight into the 
developmental program of this lineage.   
 
7.2. Genetic ablation in Hexd embryos 
The AVE functions in part by repressing the expression of posterior genes in the 
anterior epiblast (Kimura et al., 2000; Perea-Gomez et al., 2001a), resulting in 
primitive streak formation on the opposite side of the embryo (Perea-Gomez et al., 
2002). Additionally the AVE, in combination with anterior epiblast tissue, is able to 
induce ectopic neural structures in non-neural ectoderm (Tam and Steiner, 1999). In 
an attempt to elucidate further roles of the AVE, this thesis described a genetic 
ablation system that allowed the inducible expression of DTA in Hex-expressing 
cells, enabling the specific ablation of this cell population.  
 
Depending on the time of cell death, two distinct classes of phenotype were observed.  
Embryos in which the ablation had occurred prior to 5.5 dpc displayed a failure to 
restrict Nodal transcript, which was expressed weakly throughout the epiblast. When 
the AVE was ablated between 5.5-6.5 dpc, Nodal was restricted proximally but not 
posteriorly.  
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Figure 2 – Schematic representation of the defects in Hexd embryos from 5.5 to 
7.5 dpc 
(A) At 5.5 dpc, anterior visceral endoderm precursors (green) are located at the distal 
tip of the conceptus. These cells express antagonists of Nodal signalling (red 
antagonist arrows). At the onset of gastrulation at 6.5 dpc, anterior visceral endoderm 
cells have moved anteriorwards, reaching the boundary between the epiblast and 
extraembryonic ectoderm. These cells continue to secrete Nodal antagonists resulting 
in the restriction of Nodal transcript (olive green) to the posterior of the epiblast cup. 
This marks the site of primitive streak formation. During gastrulation the primitive 
streak elongates and two new germ layers are formed: the mesoderm (purple) and 
definitive endoderm (brown). At 7.5 dpc, the definitive endoderm displaces the 
anterior visceral endoderm and signals to the underlying ectoderm, which becomes 
anterior neurectoderm (turquoise). (B) Class I Hexd mutants have anterior visceral 
endoderm precursors at 5.5 dpc, but not anterior visceral endoderm at 6.5 dpc. Nodal 
is therefore restricted proximally but not posteriorly, and at a lower intensity than in 
the wildtype situation. During gastrulation at 7.5 dpc, definitive endoderm is formed 
and anterior neurectoderm develops, but the anterior primitive streak is absent. (C) 
Class II Hexd mutants do not have anterior visceral endoderm precursors at 5.5 dpc, 
or any signs of anterior visceral endoderm at 6.5 dpc. Nodal transcript is found 
throughout the epiblast at this stage. Class II mutants do not initiate a primitive streak 
and fail to gastrulate.  
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This is consistent with the idea that the AVE is a signalling centre that restricts the 
expression of Nodal to the posterior of the embryo by secreting Lefty1 and Cerl 
(Meno et al., 1997; Belo et al., 1997; Perea-Gomez et al., 2002). Therefore in the 
absence of this antagonism, Nodal is inappropriately restricted (Fig. 2).  
In addition to the role of the AVE in suppressing signalling molecules to the 
anterior epiblast, results from this thesis suggest an additional role is to increase the 
activity of Nodal signalling in the epiblast. Firstly, a proportion of ablated embryos 
formed a primitive streak that was missing its anterior portion. This phenotype is 
reminiscent of the anterior primitive streak patterning defects observed when Nodal 
activity is reduced in the epiblast (Hoodless et al., 2001; Norris et al., 2002; Vincent 
et al., 2003b; Dunn et al., 2004). This is supported by the fact that by further reducing 
the levels of Nodal in AVE ablated embryos increased the frequency and severity of 
the phenotypes observed.  
 
Mechanistically, how is the AVE able to enhance Nodal signalling? Perhaps the AVE 
secretes a factor that is able to feed into the autoregulatory loop of Nodal. Two 
candidates might be Nodal itself or BMP2 which have previously been shown to be 
expressed in the visceral endoderm at the time of DVE induction (Varlet et al., 1997; 
Coucouvanis and Martin, 1999) and also demonstrated to enhance Nodal activity in 
mouse and chick (Saijoh et al., 2003; Norris et al., 2002; Piedra and Ros, 2002; 
Fujiwara et al., 2002; Schlange et al., 2002). It would be interesting to test whether 
reduced Nodal transcript levels equates to a reduction in active signalling. This could 
be assessed by analysing the expression of pSmad2/3 and pSmad1/5/8 in AVE ablated 
embryos.  
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Another possibility is that the AVE facilitates the sorting of Nodal-expressing cells in 
a posterior direction. A model whereby cells showing higher levels of Nodal 
signalling will sort to the posterior of the embryo was initially proposed by Lu and 
Robertson (2004). To test this the position and number of Nodal-expressing cells 
could be determined in AVE ablated embryos. The prediction would be that if the 
AVE had a role in directing these movements, the distribution of Nodal-positive cells 
would be randomly scattered throughout the proximal epiblast in ablated embryos.  
 
Therefore during A-P axis establishment, the DVE/AVE acts in a feedback loop. First 
it is induced at 5.0 dpc by Nodal signalling from the epiblast (Brennan et al., 2001; 
Mesnard et al., 2006). Once the DVE/AVE is established, it acts to either increase 
Nodal signalling levels in the epiblast or to cause a sorting of Nodal-positive cells to 
the proximal, then posterior epiblast. This would ensure sufficient Nodal expressing 
cells are found in the posterior for initiation and proper formation of the primitive 
streak to take place (Conlon et al., 1994; Brennan et al., 2001). During this process 
the extraembryonic ectoderm also plays a critical role by secreting the convertases 
that process Nodal and further enhances the activity of this pathway (Beck et al., 
2002). Nodal activity is further increased by another feedback loop between the 
epiblast and the extraembryonic ectoderm whereby Nodal maintains BMP expression 
in the extraembryonic ectoderm and in turn BMP maintains Nodal expression via 
Wnt3a in the epiblast (Winnier et al., 1995; Mishina et al., 1995; Beppu et al., 2000; 
Ben-Haim et al., 2006).  
 A second role for the AVE, and opposite to the first role, is to secrete Cerl and 
Lefty1, two antagonists of Nodal signalling that inhibit Nodal activity in the anterior 
of the embryo (Meno et al., 1997; Belo et al., 1997). This ensures primitive streak 
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formation occurs only in the posterior of the embryo (Perea-Gomez et al., 2002). It is 
therefore a series of reciprocal interactions between the epiblast, AVE and 
extraembryonic ectoderm that establishes the A-P axis in the mouse embryo.  
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Appendix I 
 
M2 embryo dissection media 
Stock Solution   Component  Final Concentration    Vol/L  
                (mM)   (ml) 
 
Solution A:   NaCl    94.66    100 
KCl    4.78  
KH2PO4   1.19  
MgSO4•7H2O   1.19  
Sodium lactate  23.28  
Glucose   5.56  
 
 Solution B:  NaHCO3   4.15    16 
Phenol Red  0.00028 
 
 Solution C:  Sodium Pyruvate  0.33    10 
 
 Solution D:  CaCl2•2H2O  1.71    10 
 
 Solution E:  HEPES  20.85    84 
Phenol Red  0.00028 
(NaOH to adjust pH to 7.4) 
 
Stock solutions were made up in advance, filter sterilised and stored at -20 °C.    
To make 1 litre of M2 the appropriate volumes of each solution were added to 700 ml 
of tissue culture water (Gibco).  100ml of tissue culture characterised Fetal Calf 
Serum and 10 ml of 100X Penicillin/Streptomycin solution was added and the final volume 
made up to 1 litre with additional tissue culture water. 
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